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Abstract 
The impairment of ocular haemodynamics has been reported in primary open angle glaucoma 
(POAG) patients using various blood flow measurement techniques. Studies have shown 
hypotension may accelerate progression in POAG and a marked nocturnal blood pressure 
reduction (NBPR) was reported to further expedite the neuro-degenerative disease. It has been 
suggested that extreme NBPR may be a form of systemic vascular dysregulation that is 
manifested as an ocular dysregulation, but this hypothesis has never been tested. In addition, the 
relationship, if any, of retinal haemodyanamics to magnitude of the NBPR is also unknown. A 
prototype Doppler spectral domain optical coherence tomographer (SD-OCT) together with the 
more established bi-directional Laser Doppler velocimetry with simultaneous vessel 
densitometry (BLDV-SVD) methodology (Canon Laser Blood Flowmeter, CLBF) were utilized 
to see if the NBPR is associated to impaired retinal haemodynamics in glaucoma patients. 
The specific aims of this thesis were: (1) To evaluate the association between retinal 
hemodynamics of healthy eyes with age, as derived by Doppler SD-OCT, (2) To evaluate retinal 
blood flow (RBF) in patients with early POAG and differing NBPR profiles, (3) To investigate 
the relationship between Doppler SD-OCT derived retinal haemodynamics and the retinal nerve 
fiber layer (RNFL) thickness in patients with early POAG and healthy age-matched controls, (4) 
To evaluate the vascular reactivity in patients with early POAG with different NBPR profiles 
using a normoxic hypercapnia provocation stimulus. Perfusion to the retina was not altered with 
increasing age among healthy people in the range of 20 to 70 years. Patients with early POAG 
who exhibited an exaggerated nocturnal reduction in mean arterial pressure also demonstrated 
lower RBF values as shown by the measurement of Doppler SD-OCT. The change in retinal 
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circulation in early POAG was related to reduced RNFL thickness and a larger venous area may 
be associated with thicker RNFL among controls. Patients with early POAG who exhibited an 
exaggerated NBPR also demonstrated disturbance of retinal vascular reactivity. 
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1 Introduction  
Vascular perfusion is necessary to maintain ocular function, while keeping the temperature 
constant and retaining the best optical quality.  
1.1 Ocular blood supply  
Blood travels from the heart to the eye flowing through the aorta, common carotid artery, 
internal carotid artery, and ophthalmic artery (OA). The OA branches into short posterior ciliary 
arteries (SPCA), long posterior ciliary arteries (LPCA), and central retinal artery (CRA) to form 
separate circulatory systems in the eye (Figure 1.1). 
The CRA generates a retinal circulatory system that nourishes three quarters of the retina (layers 
except the RPE and the photoreceptors). The retina has low flow but highest oxygen 
consumption per tissue volume in the body,
1
 and it accounts for 4% of the total blood supply to 
the eye. This circulatory vascular bed is thought to lack autonomic innervation and therefore 
perfusion is mainly regulated through local factors released by endothelial cells and local tissue.
2
 
The CRA pierces 12mm behind the optic nerve head (ONH) and travels in the centre of the optic 
nerve to surface on the retina. It then bifurcates into 4 major arteriolar branches typically 
supplying the superonasal-, superotemporal-, inferonasal-, and inferotemporal-retinal quadrant. 
The arterioles and venules from the CRA will stay in nerve fiber layer (NFL) and the capillary 
does not go further than the inner nuclear layer of the retina.  Two capillaries bed forms separate 
layers with the superficial capillary plexus located at the level of ganglion cell and nerve fiber 
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layers, and a deeper plexus at inner nuclear layer. The CRA also sends pial branches for the optic 
nerve before entering the retina.
3
 
The SPCAs and LPCAs form the uveal circulatory system which supplies the iris, ciliary body 
and choroid. Around 15 to 20 SPCAs pierce the sclera around the optic nerve, and forms the 
posterior choroid.  The vessels terminate at the choriocapillaris, which in effect is a single layer 
capillary that supplies critical nourishment to the outer retina (the photoreceptors and RPE). The 
SPCAs also supply the ONH, particularly at the lamina cribosa layer and also via the pial 
vessels. The posterior choriocapillaris from the SPCA merge with the anterior choriocapillaris 
which is supplied by the LPCA.  The LPCA together with anterior ciliary arteries (originating 
from the rectus muscles) forms the major arterial circle (MAC) of the iris. The choroidal 
vasculature has a high flow, due to low resistance, but has a low oxygen extraction of about 4%.
4, 
5
 The choroidal vessels supply 85% of the total blood flow to the eye.
2
 This system has the 
greatest density of autonomic innervations in the body, in stark contrast to the inner retina 
vessels which have no functioning autonomic innervation.
1
 
The blood from the inner retina drains via the central retinal vein, and superior ophthalmic vein. 
The uvea drains out the blood via 4 vortex veins, and then to either the superior or inferior 
ophthalmic vein. The anterior part of the eye drains the blood via anterior ciliary veins which are 
located in the rectus muscles, and then to the respective superior or inferior ophthalmic vein 
(Figure 1.1). 
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Figure 1.1: Anatomy of the ocular vascular supply. Drawings by Dave Schumick in Anand-Apte and Hollyfield6. 
[Image reproduced with permission from Elsevier Publications.] 
1.2 Blood supply to the ONH 
The ONH is divided into 4 regions, namely the (i) superficial NFL, (ii) prelamina layer, (iii) 
lamina cribosa area, and (iv) retrolamina area (Figure 1.2). The superficial NFL is supplied by 
the retinal arterioles and their branches, and in some individuals the temporal area of the NFL 
may also be supplied by the SPCAs or the cilioretinal artery.
3
 The prelaminar region which 
consists of the nerve fibers receives its blood supply from the peri-papillary choroid (Figure 1.3). 
The CRA and peri-papillary choriocapillaris have no influence on this structure.
3, 7
 The lamina 
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cribosa is an elastic collagenous structure continuous with the sclera. It has fenestrations for the 
axon bundles going out from the eye travelling to the cortex. This layer is supplied by centripetal 
branches from SPCA or sometimes from the intrascleral circle of Haller and Zinn (if it present, 
considering interindividual variations in form, position and branches
8
).  The circle of Haller and 
Zinn also branches into the peri-papillary choroid.
9
 Supply to the retrolamina region mainly 
comes from the centripetal system formed by the peri-papillary choroid with additional pial 
branches from the CRA or from the other orbital arteries (Figure 1.3).
3
 
 
Figure 1.2: Divisions of the optic nerve head. (A) Surperficial nerve fiber layer. (B) Prelaminar region. (C) Lamina 
cribosa region. (D) Retrolaminar region. Adapted from Allingham et al.
10
 [Image reproduced with permission from 
Lippincott Williams & Wilkins.] 
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Figure 1.3: Abbreviations used in figure: A = arachnoid, C = choroid, CRA = central retinal artery, Col Br. = 
collateral branches, CRV = central retinal vein, D = dura, LC = lamina cribrosa, OD = optic disc, ON = optic 
nerve, ONH = optic nerve head, PCA = posterior ciliary artery, PR = prelaminar region, R = retina, S = sclera, 
SAS = subarachnoid space.  Taken from Hayreh SS.
3
 [Image reproduced with permission from Elsevier 
Publications.] 
1.3 Retinal blood vessel structures 
The blood vessel wall consists of: 1) innermost layer of endothelial cells, 2) middle layer of 
smooth muscle cells, and 3) outermost adventitia layer.
2
 The endothelial layer consists of a single 
cell layer and is important in the regulation of blood flow by secretion of vasoreactive 
substances. The arteriolar middle smooth muscle cell layer around the optic disc is thicker than 
those located at the equator and peripheral retina (7 to 8 layers of smooth muscle cells 
immediately around the ONH, while only one to two layers of smooth muscle cells are present in 
the peripheral arterioles).
11
  The smooth muscle cell layer controls lumen size as a result of 
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contraction or relaxation.
12
 The adventitial layer consist of elastic collagen fiber that is important 
for structural function especially in the arterioles. Its contribution to vascular tone is unclear, but 
results from experimental tissue culture indicated that it can respond to vasoactive agents.
13
 The 
diameter of the arterioles and venules diameter ranges from 20-150µm (with the venular system 
being actually a little larger in diameter than equivalent arteriole) and they become smaller in 
diameter as they course towards their final branch into the capillary beds. Arterioles in particular 
are important in regulating blood flow as it has the ability to change its diameter size, hence they 
are regarded as “resistance” vessels. 
Capillaries are smaller in size, 6-10µm, and are composed of an endothelial cell layer, 
surrounded by basal lamina, and pericytes.
11
 In the retina, capillaries are arranged in laminar 
fashion, with greater number of layers in the central retina than in the periphery.
14
 Exchange of 
tissue metabolites and blood gasses is facilitated by the capillaries (hence regarded as 
“exchange” vessels), in conjunction with the pericytes allowing “fine tuning” of capillary 
perfusion.
14
 The pericytes are paired with the endothelial cells at ratio 1:1, and this organization 
is unique to the retinal capillaries.
15
 The capillaries are responsive to local blood gases 
concentrations and vasoreactive factor, thus playing a part in regulating retinal perfusion. 
Endothelial cells have tight junctions (zona-occludens) and form the blood-retina barrier, 
preventing leaking of macromolecules to the interstitial space.
11
 
1.4 Retinal blood flow 
Blood flow (Q) is the temporal quantity, in volume, of blood that passes through a vessel of a 
given diameter. Blood velocity is the speed of red blood cells that travel through a vessel. Two 
7 
 
condition of flow may happen in a vessel, namely the laminar flow, or the turbulent flow.
16
 
Laminar flow is a type of blood flow when concentric layers of blood move in parallel fashion 
through vessel and with the maximum velocity occurs in the centre of the vessel while the 
minimum velocity occurs at the vessels wall (reduced velocity due to friction; Figure 1.4). 
Turbulent flow has a random flow pattern and its occurrence is usually at vessel’s bifurcation. 
Experimentally, plug flow may exist, characterized by constant and equal velocity throughout a 
vessel. But true type of flow does not occur in retinal vessels due to friction between vessel wall 
and blood column and the elevated viscosity of blood (relative to a liquid with Newtonian 
properties). 
 
Figure 1.4: The laminar flow.  
Following Ohm’s law, Q is proportional to perfusion pressure (pressure difference along a blood 
vessel between two given points, ∆P), and is inversely proportional to vascular resistance, R 
(Equation 1.1). The law assumes a steady, laminar flow of a Newtonian fluid in a rigid, straight 
tube. Consequently, blood moving in a vessel will deviate from the relationship due to pulsitility 
and/or turbulent nature of the flow pattern. Regardless, this relationship is a fair estimation for 
studying blood flow in the microvasculature.  
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               Equation 1.1 
R depends on the vessel’s length (L), blood viscosity (η), and fourth power of vessel’s radius (r), 
as given by the formula: 
  
   
   
                 Equation 1.2 
Applying both formulas together, flow is proportionate to perfusion pressure and fourth power of 
capillary radius, and inversely proportional to vessel’s length and blood viscosity.17 This formula 
is known as Hagen-Poiseuille’s law.  
  
     
   
          Equation 1.3 
1.5 Ocular perfusion pressure (OPP) 
OPP is the pressure that drives the blood through the intraocular vasculature. It is influenced by 
the resistance, which is effected by vessel lumen diameter.
4, 18
 OPP is the difference between 
arterial and venular blood pressure (Pa and Pv, respectively).
4
 Since there is no means of 
measuring the ocular blood pressure, a surrogate measurement from the brachial artery is taken 
to estimate the ophthalmic arterial pressure. However, the brachial arterial pressure is not 
equivalent to the ocular arterial pressure because of the gravitational effect also known as the 
hydrostatic column effect.
4
 When a person is sitting or standing, the ocular arterial blood 
pressure is lower than the brachial arterial pressure due to the fact that the eye is situated higher 
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than the heart and therefore blood has to be pumped up to the eye against the force of gravity. 
The calculation of OPP using the brachial arterial pressure should be corrected for this reason. 
Venous pressure in the eye is roughly equal to intraocular pressure (IOP),
19
 although it is 
debatable. IOP has been shown to be a reasonable approximation to the venous pressure in 
animal studies, although there was a study that showed the venous pressure being higher than 
IOP in glaucomatous human eyes.
20
 In the seating position, OPP can be calculated by: 
18
 
     
  
   
                Equation 1.4 
where MAP stands for mean arterial pressure. In the supine position, OPP can be calculated by: 
    (
   
   
   )             Equation 1.5 
The factor used for MAP in Equation 1.4 is usually simplified to 2/3 in most of the literature.  
Increase of the IOP and/or the reduction of the BP will reduce the OPP. OPP reduction in turn 
will affect perfusion in tissue with vascular dysregulation. Flow reduction causes ischaemia 
leading to atrophy of ganglion cells.
21
 Numerous epidemiological studies have indicated that 
reduction of OPP is a risk factor for incidence, prevalence and progression of glaucoma.
22-28
 This 
suggests the involvement of impaired perfusion in pathogenesis of glaucoma. 
10 
 
1.6 Intraocular pressure (IOP)  
IOP is the pressure that is generated by the fluid that fills the eye which is opposed by the rate of 
aqueous outflow and the rigidity of the outer coats of the globe. The amount of pressure depends 
on the formation (Faq) and drainage (Caq) rate of aqueous humor, and also on the episcleral 
venous pressure (Pev). 
    
   
   
             Equation 1.6 
The aqueous humor is secreted by the ciliary body in the posterior chamber, specifically by non-
pigmented epithelial cells.
29
 Via a convection current, the aqueous moves to the anterior chamber 
primarily through the pupil. The fluid is drained mostly through the trabecular meshwork into 
Schlemm’s canal, and a fraction into the suprachoroidal space known as uveoscleral drainage.29 
Measurement of IOP is actually a measurement of the transcorneal pressure gradient between the 
atmosphere and IOP, using a tonometer.
30
 The IOP is considered clinically normal between 10-
21mmHg. However confounding factors such as the central corneal thickness, time of 
measurement, and body position may affect the measurement, hence, IOP values should be 
interpreted cautiously. Elevated IOP is the major modifiable risk factor for glaucoma.
4
 IOP of 
more than 21mmHg usually calls for further investigation. An absence of glaucomatous optic 
neuropathy in the presence of elevated IOP is termed as ocular hypertension (OH). Reduction of 
IOP in people with OH has been shown to prevent or delay the onset of primary open angle 
glaucoma (POAG).
31
 Normal tension glaucoma (NTG), according to some clinicians, is a subset 
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of POAG with IOP value of less than 21mmHg. Nevertheless, this classification is arbitrary as it 
is loosely based only on IOP values.  
1.7 Blood pressure (BP) 
BP refers to the pressure exerted by blood on the arterial walls as the heart beats. BP is maximal 
during ventricular contraction, i.e. systolic BP, and minimal during ventricular relaxation, i.e. 
diastolic BP. BP reduces in magnitude as it moves away from the heart. Clinically, systemic BP 
is measured at the brachial artery. BP is considered normal when systolic BP is <120 mmHg and 
diastolic BP is <80 mmHg.  The diagnosis of pre-hypertension is when systolic BP is between 
120 to 139 mmHg and diastolic BP is 80 to 89 mmHg. Stage I hypertension is when the systolic 
BP is 140-159 mmHg and diastolic BP is 90 to 99 mmHg, while stage II is >160 mmHg systolic 
BP and >100 mmHg diastolic BP.
32
 Mean arterial pressure can be calculated by
29
: 
                
 
 
                           Equation 1.7 
Any association of BP and glaucoma is controversial (Table 1.1). Some authors found a 
significant association with hypertension, while others found a significant association with 
hypotension. A few epidemiological studies have even associated glaucoma to both hypertension 
and hypotension.
25, 33
 Table 1.1 summarizes studies that have investigated any association 
between BP and glaucoma. 
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Studies Findings 
Thessaloniki Eye Study
34
 
Early Manifest Glaucoma Trial
23
 
The Barbados Eye Study
24
 
Leske et al.
35
 
Kaiser et al.
36
 
 
Glaucoma is associated with 
arterial hypotension  
Rotterdam Eye Study
37
 
Blue Mountains Eye Study
26
 
Beaver Dam Eye Study
38
 
Egna-Neumarkt Glaucoma Study
22
 
 
Glaucoma is associated with 
arterial hypertension 
Baltimore Eye Survey
33
 
Los Angeles Latino Eye Study
25
 
Glaucoma is associated with both 
arterial hypotension and 
hypertension 
Table 1.1: Summary of studies on blood pressure association with glaucoma.  
1.7.1 Arterial hypotension and glaucoma 
From the vascular perspective, low BP leads to reduction of OPP, which in turn leads to ischemia 
and neuropathy. It has been demonstrated that aggressive systemic hypertensive treatment 
exacerbates glaucoma progression. A population study on a non-glaucomatous cohort reported 
an increase in cupping and cup-to-disc ratio in treated hypertensive subjects, compared to 
untreated and normal subjects.
34
 In another study on glaucoma patients, it was found that 
systemic diuretic usage was related to glaucoma development.
39
 A similar result was reported by 
a 6 month longitudinal study which reported that degenerative changes and impaired blood flow 
were evident among glaucoma patients who take antihypertensive medication in the evenings.
40
 
This raises the concerns about any possible effect of hypertensive treatment on glaucoma. 
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1.7.2 Arterial hypertension and glaucoma 
It is counter intuitive to associate hypertension to glaucoma, considering that high BP results in a 
high OPP.
18
 The Baltimore Eye Study
33, 41
 showed that relationship of hypertension to glaucoma 
is age dependent where it appears to be protective in younger patients but not in older patients. 
They speculated that blood vessels around the ONH experience atherosclerosis with age, 
becoming rigid and narrow, and thus compromising perfusion. Hypertension is therefore 
suggested to be a chronic risk factor that involves a long-term changes of the vascular beds 
which impairs perfusion.
42
 
1.7.3 Effect of BP on tissue flow 
It is expected that high arterial pressure will increase blood flow in tissues. The increase of 
perfusion pressure in a vessel will increase the blood velocity and at the same time will tend to 
distend the lumen size but this will be opposed by increase in tone, which in turn will increase 
flow. The relationship between BP and blood flow is exponential; increasing BP two fold will 
cause 4 to 6 folds of increase in flow.
16
 However, this is not evident in a peripheral system like in 
the eye as autoregulation ensures stable perfusion despite BP changes. It was reported that retinal 
flow remains stable during dynamic exercise.
43
 A study on healthy retinal arteriolar showed there 
was 2.5% arteriolar constriction with 21.8mmHg increase in MAP from baseline, suggesting a 
resistance to vasodilation in the retinal arteriolar vessels despite large change in MAP.
44
 
Choroidal flow
45, 46
 and retrobulbar flow
47
 was also reported to remain stable during dynamic 
exercise. 
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1.7.4 Effect of BP on IOP 
Epidemiological studies have consistently reported an association between high BP and IOP.
22, 33, 
37, 38
 Animal studies have shown that the IOP is elevated upon stimulation of hypertension.
48, 49
 It 
is, however, unclear how hypertension increases IOP. It has been proposed that BP elevation 
tends to elevate ciliary artery pressure which leads to elevation of ultrafiltration of aqueous 
production and hence IOP elevation. Alternatively, increased arterial pressure may also lead to a 
small elevation to the venous pressure, which may reduce the aqueous outflow and then increase 
IOP.
42
 However, the change in IOP induced by BP is small (0.2-0.4mmHg IOP increase per 
10mmHg BP increase),
50
 thus it is unlikely that there is an association of glaucoma with high BP. 
1.7.5 Ambulatory blood pressure monitoring (ABPM) 
BP is influenced by factors which include physical and emotional status, environmental 
circumstances, the autonomic nervous system, the renin-angiotensin-aldosterone system, and 
neurohumoral factors.
51-53
 BP measurement in a doctor’s office may mask the real BP value 
where a “white coat reaction” has been reported to cause an increase of 20% in the BP value in 
suspected-hypertensive and hypertensive patients.
54
 Masked hypertension on the other hand may 
also occur where a patient produces a normal office BP value despite having hypertension.
51, 53
 
As a result, a continuous BP measurement is pivotal which is permissible using ambulatory 
device. The International Database in Ambulatory BP monitoring in relation to Cardiovascular 
Outcome (IDACO) suggested normal daytime ambulatory BP should be <130/85 mmHg, 
nighttime BP <110/70 mmHg, and 24-hour BP <125/75 mmHg.
55
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1.8 Sleep 
Sleep is a form of unconsciousness from which a person can be aroused by sensory or other 
stimuli (differently to coma which is unconsciousness without ability for arousal).
56
 Sleep is 
important for homeostasis and restores natural balances among the neuronal centres.
56
 Sleep can 
be categorized into rapid eye movement (REM) and non-REM type.
57, 58
 These sleep cycles run 
cyclically throughout the night. Non-REM sleep is a restful, deep sleep. The peripheral vascular 
tone, blood pressure, respiratory rate and basal metabolic rate decreases during this sleep.
56
 REM 
sleep carries 20-25% of the total sleep duration
57
 and usually occurs during second half of the 
night. REM sleep is characterized by the rapid movement of the eyes, electroencephalography 
(EEG) arousal, and atonia.
58
 This sleep is not so restful with heart and breathing rate becoming 
irregular, and active dreaming takes place.
56
 REM sleep can further divided into tonic and phasic 
subtypes, where in the phasic stage the sympathetic activity increases and may exceed the level 
during wakefulness,
57, 58
 potentially causes haemodynamic variability during REM sleep. 
1.8.1 Circadian rhythm in pressure parameters 
Circadian rhythm is defined as a biological cycle within a period of 24 hours and is pivotal to 
maintaining homeostasis in physiological systems. It has been established that IOP varies as a 
function of the circadian clock.
59
 Recently, it has been indicated that blood pressure,
60
 OPP
61
and 
ocular blood flow
62
 also follows the circadian variation.  
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1.8.1.1 Circadian variation in BP 
Classically, systolic BP is observed to rise abruptly after waking by 20-25 mmHg while diastolic 
BP rises by 10-15 mmHg.
63
 BP climbs a little to reach a peak in the afternoon and then decline in 
the evening, continuing to reduce to its lowest during sleep. Typically, BP will fall during the 
first hour of sleep, then rise markedly in the morning upon waking. This nocturnal BP reduction 
(NBPR) normally value between 10 to 20% from the diurnal value,
51
 and occurs in both 
normotensive and hypertensive individuals.
4
 In some patients, high reduction (NBPR>20%) or 
low reduction (NBPR<10%) may also occur.
4, 60, 64, 65
 Rarely, nocturnal blood pressure elevation  
may also occur.
66
 Two thirds of the normal population is believed to have the normal NBPR 
value.
67
 NBPR is calculated using the formula below: 
         
                       
          
          Equation 1.8 
Subjects with low NBPR have been shown to have poorer cardiovascular outcome.
51
 It has been 
reported that low NBPR is associated with left ventricular hypertrophy,
68
 silent cerebrovascular 
disease,
69
 microalbuminuria,
70
 and renal damage.
71
 Reduced NBPR pattern may be due to 
autonomic dysfunction, steroid use, renal problems, bad sleep quality or postmenopausal state.
4
 
Advancing age
72
 and female gender
73
 are also associated with reduced NBPR. An exaggerated 
nocturnal hypotensive condition, in theory, may cause ischemia to organs such as the eye, 
especially in people with impaired autoregulation.
67, 74, 75
 Subjects with high NBPR may also be 
accompanied with increased BP variability.
76
 High NBPR may occur naturally, or may be 
induced by medication such as anti-hypertensive drugs. By calculation, the OPP is increased 
about 15mmHg when a person takes a supine position to sleep due to hydrostatic column 
17 
 
pressure.
4
 Thus, the nocturnal blood pressure (NBP) should fall more than 15mmHg, or more 
than 20% to potentially cause an ischemic insult.  
The decline in nocturnal BP is thought to be due to physiological attenuation in the sympathetic 
tone.
57, 58, 77
 However, the sympathetic tone may also rise nocturnally during the phasic REM 
sleep.
58
 This sympathetic activity fluctuation will result in a similar effect in the cardiovascular 
function, which may in turn result to a repetitive ischaemic-reperfusion cycle. Repetitive 
reperfusion has been shown to be damaging as it promotes the formation of free radicals and 
induce oxidative damage.
78
 Patients with NTG have been shown to have different sympathetic 
activity during nocturnal hours, upon analysis of 48-hours heart rate variability.
79
 
It has been implied that chronic hypertension may cause microvascular damage, while 
hypotension may cause local ischaemia. In situations where IOP is elevated, and/or vascular 
dysregulation exist, both hypertension and hypotension are possible causes of glaucomatous 
damage. The association between BP and glaucoma is inconclusive but most have associated 
hypotension to glaucoma. In addition, a high degree of BP variability has also been associated 
with glaucoma.
80
 Table 1.2 summarizes the findings in the literature on NBP and its relationship 
to glaucoma. Also note the differences in ambulatory blood pressure monitoring (ABPM) 
methods between studies, which could affect the determination of NBP, or NBPR calculations. 
The location of ABPM measurement is also of importance since hospital setting measurement 
does not really reflect a patient’s usual circadian rhythm. Sleep lab or hospital conditions may 
create environments that influence circadian rhythms. 
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Authors Participants BP measurement 
method 
Findings 
Kaiser et al.
36
 78 POAG 
39 NTG 
32 healthy 
24-hours ABPM 
Night: 10pm-8am(60 
min interval) 
HS 
 Reduced diurnal and nocturnal systolic 
BP in NTG and progressive POAG 
Hayreh et al.
81
 21 POAG 
67 NTG 
53 AION 
24-hours ABPM 
Night: 11pm-6am (20 
min interval) 
HS 
 Greatest diastolic NBP reduction in NTG 
 NBPR was associated with field 
progression in patients on 
antihypertensive medication  
Bechetoille et 
al.
82
 
16 NTG 
16 POAG 
24-hours ABPM 
Night: 10pm-6am (60 
min interval) 
HS 
 NBPR was not different between groups 
 Reduced diurnal BP in NTG 
 Greater systolic NBP variability in NTG 
Orgul et al.
83
 9 POAG 
11 NTG 
24-hours ABPM 
Night: 10pm-8am (60 
min interval) 
Measurement site 
unknown 
 Reduced NBPR was correlated with 
vasospasm  
Graham et al.
67
 38 NTG 
46 POAG 
11 healthy 
24-hours ABPM 
Night: 10pm-6am (30 
min interval) 
HS for glaucoma, 
HmS for healthy  
 Greater reduction in NBP parameters 
relative to the diurnal’s in progressive 
patients 
Bressen-
Dumont et al.
80
 
83 POAG 24-hours ABPM 
Night: 10pm-6am (60 
min interval) 
Measurement site 
unknown 
 Greater BP variability in progressive 
patients 
 Greater NBPR in progressive POAG  
Meyer et al.
84
 20 NTG 
20 healthy 
24-hours ABPM 
Night: 10pm-6am (40 
min interval) 
HS 
 Greater NBPR in NTG 
Detry et al.
85
 36 POAG 24-hours ABPM 
Night: 10pm-6am 
(interval not known) 
HS 
 
 Patients with reduced NBPR associated 
with progressive glaucoma 
19 
 
Follman et al.
86
 100 glaucoma 
60 healthy 
24-hours ABPM 
Night: 10pm-6am (60 
min interval) 
HS 
 Reduced NBP in glaucoma 
 Visual field loss was associated with 
reduced NBP 
Harris et al.
87
 9 POAG 
9 healthy  
Manual BP at 9pm, 
12am, 3am, and 6am 
HS 
 No difference between diurnal and 
nocturnal BP 
 
Collignon et 
al.
88
 
51 POAG 
19 NTG 
24-hours ABPM 
Night: 10pm-6am (30 
min interval) 
Low NBPR <5%, 
Normal 5-10%, High 
NBPR >10% 
HS 
 High NBPR and low NBPR associated 
with progression 
Hayreh et al.
75
 114 AION 
131 NTG 
30 POAG 
24-hours ABPM 
Night: 11pm-6am (20 
min interval) 
HS 
 Reduced NBP in NTG 
 NBPR was associated with field 
progression of patients on 
antihypertensive medication 
 Reduced diastolic NBP in progressive 
patients 
Kashiwagi et 
al.
89
 
43 NTG 
226 healthy 
49-hours ABPM 
Night: according to 
subject sleeping time 
(30 min interval) 
Low NBPR <10%, 
Normal >10% 
HmS 
 No differences in NBPR between groups. 
 Greater NBPR in stable NTG than the 
progressive NTG 
 BP fluctuated in progressive NTG 
Harris et al.
90
 5 NTG 
10 POAG 
15 healthy 
Night ABPM only 
from 10.30pm – 6am 
(20min) 
HS 
 NBPR was not different between groups 
Yazici et al.
91
 18 NTG 
22 POAG 
19 OHT 
24-hours ABPM 
Night: 11pm-6am (30 
min interval) 
HmS 
 No differences in BP data between 
groups 
 Individual BP data showed greater NBPR 
in NTG 
Riccadonna et 
al.
92
 
17 NTG 
13 POAG 
17 healthy 
24-hours ABPM 
Did not mention 
nocturnal period. 30 
min interval 
Measurement site 
unknown 
 No differences in BP data between 
groups 
 Reduction in diurnal heart rate variability 
in NTG 
 Reduction in diastolic NBP variability in 
NTG 
20 
 
Liu et al.
61
 24 glaucoma 
24 healthy 
24-hours ABPM 
Night: 11pm-7am (120 
min interval) 
HS 
 Reduced NBP in glaucoma 
Tokunaga et 
al.
93
 
23 NTG 
15 POAG 
48-hours ABPM 
Night: according to 
subject sleeping time 
(30 min interval) 
Low NBPR <10%, 
Normal10-20%, High 
NBPR >20% 
HmS 
 High NBPR and low NBPR was 
associated with progression 
Plange et al.
94
 51 NTG 
28 healthy 
24-hours ABPM 
Night: 12am-6am (30 
min interval) 
Low NBPR <10%, 
Normal >10% 
HS 
 No difference in NBPR between group 
 Higher diastolic NBP and nocturnal MAP 
in NTG 
 Greater NBP variability in NTG 
Joe et al.
95
 54 NTG 24-hours ABPM 
Night: 12am-6am (30 
min interval) 
Low NBPR <5%, 
Normal 5-10%, High 
NBPR >10% 
HS but encourage for 
normal diurnal 
activities 
 More than 50% patients have high NBPR 
 BP variability was pronounced in patients 
with high NBPR 
Kim et al.
96
 24 NTG 
22 healthy 
Manual BP until 11pm 
No measurement 
during sleep 
Low NBPR <5%, 
Normal 5-10%, High 
NBPR >10% 
HS 
 No differences in BP parameters between 
groups 
 NTG have larger morning BP reduction 
 Patients with high NBPR showed 
variability in MAP and MOPP 
Costa et al.
97
 29 POAG 
24 healthy 
Manual BP until 11pm 
Night: 12am-6am (120 
mins) 
Low NBPR <10%, 
Normal 10-20%, High 
NBPR >20% 
 86% of POAG patients have low NBPR 
 96% of healthy controls have low NBPR 
21 
 
HS 
Krasinska et 
al.
98
 
69 POAG 24-hours ABPM 
Night: 12am-6am (120 
mins) 
Low NBPR <10%, 
Normal 10-20%, High 
NBPR >20% 
HS 
 Patient with >10% NBPR associated with 
nerve degeneration, and visual field 
deterioration 
Table 1.2: Summary of findings relating NBPR and glaucoma, partially adapted from Werne et al.
65
 and Graham et 
al. 
99
 [ABPM = ambulatory blood pressure monitoring, BP = blood pressure, NTG = normal tension glaucoma, 
POAG = primary open angle glaucoma, OHT = ocular hypertension, AION = anterior ischaemic optic neuropathy, 
NBPR = nocturnal blood pressure reduction, NBP = nocturnal blood pressure, HS = measurement at hospital, HmS 
= measurement at home] 
 
1.8.1.2 Circadian variation in IOP 
In healthy subjects, nocturnal IOP is higher than diurnal and it peaks towards the end of sleep 
before awakening.
100, 101
 It has been shown that the nocturnal IOP, measured while a person is 
supine or sitting, is significantly higher than the diurnal value measured while a person is 
sitting.
102, 103
 This elevation can partly be explained by the body posture (from sitting to supine 
when one sleeps), but the increment change can be detected even without postural change 
indicating IOP follows a true circadian rhythm.
104
 The true reason behind the IOP increase at 
night is unknown, especially when the aqueous production is decreased nocturnally,
104
 and 
episcleral venous pressure does not account for differences between different postures. 
Circadian variation of the IOP has been demonstrated in patients with glaucoma as well, only the 
peaks occurring outside normal clinic hours.
105
 Again, this observation suggests that IOP has real 
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circadian rhythm, and disturbance to this endogenous factor may be important in the 
pathogenesis of glaucoma. It is also observed that glaucomatous damage is associated with 
greater diurnal fluctuations, rather than a constant high pressure alone.
106-108
 Considering the IOP 
having its peak value at night, glaucoma management should incorporate a 24-hour IOP 
measurement.  
1.8.1.3 Circadian variation in OPP 
By calculation, OPP decreases at night as a result of increasing IOP and decreasing BP, and this 
has been confirmed in healthy subjects
109
 and also in glaucoma patients.
110
 Glaucoma subjects 
with ocular vascular dysregulation may experience a severe reduction of OPP at night that may 
negatively impact the ONH morphology secondary to perfusion insufficiency. Sehi and co-
workers
111
 proposed that the diurnal OPP percentage changes as a risk factor for glaucoma. This 
is agreed by Choi and associates
112
 as they identified that OPP fluctuations following circadian 
variation as the most consistent risk factor for the severity in glaucoma. They noticed that 
patients with greater variation in circadian OPP have the worst visual field and thinner RNFL. It 
was hypothesized that OPP variations lead to repetitive ischaemic-reperfusion injury. Sung and 
co-workers
113
 in their 4 years longitudinal study also reported that OPP fluctuation as the most 
consistent prognostic factor for glaucoma progression. 1mmHg increase in OPP fluctuation was 
reported to associate with 27% higher hazard ratio of progression.  
Choi and co-workers
114
 measured 24-hour OPP on 132 NTG clustered patients based on NBPR 
status. They observed a significantly lower nocturnal OPP in patients with high NBPR compared 
to patients with normal NBPR and low NBPR. Sehi and co-workers
115
 reported that the lowest 
OPP and the highest IOP was observed in the morning in their glaucoma patients. At the same 
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time, BP is relatively low in the early morning. This suggests that glaucoma patients may 
experience regulatory failure to maintain OPP in the face of changes in the IOP and BP that 
occur nocturnally.
65
 Table 1.3 summarizes the findings in the literature regarding OPP circadian 
variation. 
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Study  Participants Findings  
Liu et al.
109
 16 young healthy 
16 elderly healthy  
 OPP increases at night in both groups 
 Diurnal to nocturnal increase ratio is higher in the 
elderly  
Okuno et al. 
116
 12 NTG 
12 healthy 
 No diurnal variation in OPP 
Sehi et al.
111, 115
 14 untreated POAG 
14 healthy 
 Diurnal increase in OPP for both groups 
 OPP change is lower in glaucoma 
Choi et al.
114
 132 NTG  Circadian OPP fluctuation associated with patients 
with high NBPR and worse field defect 
 High NBPR patients have reduced OPP at night 
Choi et al.
112
 113 NTG  Larger variability in OPP associated with field defect 
and morphological change 
Kida et al.
101
 15 healthy young 
15 healthy elderly 
 No differences between diurnal and nocturnal OPP in 
elderly group, but reduced nocturnal OPP in younger 
group 
Sung et al.
113
 101 NTG  OPP fluctuation was associated with greater field 
progression 
 24-hour OPP fluctuation was highly predictive to filed 
progression 
Renard et al.
117
 22 NTG  Rhythm OPP was found in all subject, about equal 
distribution of acrophase diurnally and nocturnally 
 OPP amplitude was not associated with progression 
Ramli et al.
110
 72 NTG 
55 healthy 
 Night OPP is lower in the NTG group 
 No difference in day OPP between the groups 
 
Table 1.3: Summary of findings relating to circadian variation in OPP, partially adapted from Werne et al.
65
 [NTG 
= normal tension glaucoma, POAG = primary open angle glaucoma, OPP = ocular perfusion pressure, NBPR = 
nocturnal blood pressure reduction]  
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1.8.1.4 Circadian variation in ocular haemodynamics 
There should be relatively little variation of perfusion in a healthy eye, due to autoregulation that 
will ensure a steady RBF over a range of OPP. This has been confirmed in a few studies which 
found no variation in haemodynamics in healthy eyes,
62, 118
 and by other centers with multiple 
glaucoma studies that included the recruitment of controls.
87, 90, 119
 Kida and co-workers
101
, 
however, reported that macula and ONH blood flow reduced at night only in their elderly healthy 
group despite a stable OPP. Their younger healthy groups on the contrary experienced a 
nocturnal reduction in OPP, but stable flow. They speculated that aging may compromise 
autoregulatory mechanisms. 
In a compromised vascular bed, like that which is hypothesized to occur in some glaucoma 
patients, inefficiency or failure of the autoregulatory system may cause hypoxia or transient 
ischemia even in a steady perfusion state. It is difficult to interpret collective findings in the 
literature pertaining to perfusion circadian variability, considering the different techniques that 
have been used on different vascular beds.  Regardless, there has been a general indication that 
perfusion is altered throughout the day in glaucomatous eyes.
111, 119
 However, there were also 
studies that failed to find circadian variation in perfusion among glaucoma cohorts.
87, 90, 120
 Table 
1.4 summarizes the reports available in the literature pertaining perfusion variation following 
circadian rhythm. 
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Study  Participants Method Findings 
Claridge et al.
120
 8 healthy 
8 POAG 
10 OHT 
POBF  No change in the haemodynamics from diurnal 
to nocturnal 
 Large individual variation exist   
Harris et al.
87
 9 healthy 
9 POAG 
CDI  No change was observed to blood velocity in 
the ophthalmic artery 
 Resistance decreases at night in both groups 
Evans et al.
119
 20 healthy 
20 POAG 
CDI  Blood velocity in ophthalmic and central retinal 
arteries reduces in glaucoma patients at night 
 
Osusky et al.
62
 15 healthy LCD  Mean flow and volume decrease at midnight  
 Velocity did not change at midnight 
Gherghel et 
al.
121
 
193 POAG CDI  Patients with high NBPR have lower blood 
velocity and higher resistance in the central 
retinal artery  
Harris et al.
90
 15 healthy 
15 glaucoma 
CDI  Blood velocity did not change in central retina, 
ophthalmic, and middle cerebral arteries during 
nocturnal BP hypotension 
Sehi et al.
111
 14 healthy 
14 untreated POAG 
HRF  Mean ONH rim flow did not change diurnally 
 Diurnal change was present in region with 
greatest diurnal change in rim topography  
Kida et al.
101
 15 healthy young 
15 healthy elderly 
LDF  No difference between diurnal and nocturnal 
flow in younger group, but reduced nocturnal 
flow in elderly group 
Karadag et al.
118
 59 healthy CDI  No significant difference in the haemodynamics 
between patients with normal NBPR (>10%) 
and low NBPR (<10%) 
Krasinska et 
al.
98
 
69 POAG with 
hypertension 
CDI  Hypertensive glaucoma patients with >10% 
NBPR have slower blood velocity, and higher 
resistance in ophthalmic and central retinal 
arteries 
Krasinska et 
al.
40
 
66 POAG with 
hypertension 
CDI  Taking antihypertensive medication for 6 
months before sleep induces normal NBPR 
patients into having high NBPR 
 Blood velocity decreases in the short posterior 
ciliary arteries in the high NBPR group relative 
to normal NBPR group, and relative before 
taking antihypertensive drugs 
Table 1.4: Summary of findings relating to circadian variation in ocular haemodynamics, partially adapted from 
Werne et al.
65
 [NBPR = nocturnal blood pressure reduction, NTG = normal tension glaucoma, POAG = primary 
open angle glaucoma, BP = blood pressure, OPP = ocular perfusion pressure, CDI = color Doppler imaging, 
POBF = pulsatile ocular blood flow, HRF = Heidelberg retinal flowmeter, LDF = laser Doppler flowmetry] 
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1.9 Retinal blood flow regulation 
The retina lacks a functioning autonomic innervation, unlike the choroid. Perfusion control is 
regulated through local metabolic, myogenic, and humoral mechanisms.
11
 These mechanisms 
may directly promote the release of endothelial vasoactive substances which cause dilation or 
constriction, by their action on the vascular smooth muscle cells.
11
 The varying lumen diameter 
regulates the amount of blood that perfuses into the tissue.  
1.9.1 Autoregulation 
Autoregulation is “the ability of the vasculature to maintain blood flow at relatively constant 
levels despite moderate variations in perfusion pressure”.16 Autoregulation in a healthy retina 
and ONH is effective over a substantial range of systemic BP and IOP.
122, 123
 It is reported that 
flow is constant until autoregulation breaks down when MAP rises 40% from baseline,
124, 125
 and 
IOP rises above 30 mmHg.
126, 127
 In the ONH, flow is constant until OPP increased 34% above 
baseline,
128
 and IOP rises above 40-45 mmHg.
129, 130
 
1.9.1.1 Metabolic autoregulation / Vascular reactivity  
Metabolic autoregulation, plays an important role in the regulation of retinal and ONH perfusion. 
Flow is regulated in accordance to the metabolic demand. Perfusion is changed following 
accumulation or dissipation of metabolites that is produced by the retinal tissues especially the 
vascular endothelium. The concentration of oxygen (O2), carbon dioxide (CO2), nitric oxide, 
endothelin-1 or adenosine plays a role in metabolic autoregulation.
122
 The study of metabolic 
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autoregulation, by means of varying the concentration of the metabolic components, is often 
termed as vascular reactivity. 
Vascular reactivity is the magnitude of change in the retinal haemodynamics elicited by 
provocative stimuli. Provocations manipulating OPP, light flicker, cold-stress, or blood gas 
concentration may be used on healthy or diseased groups. Provocation studies in glaucoma will 
be elaborated at the end of this chapter.  
1.9.1.2 Myogenic autoregulation 
The myogenic response, also known as the Bayliss effect,
131
 assesses the function of the vascular 
smooth muscles to contract or to relax in response, respectively to increase or decrease of the 
transmural pressure.
122
 Via myogenic mechanisms, flow is kept constant despite an increase in 
arterial BP by smooth muscle contraction, thereby reducing flow. Conversely, smooth muscle 
relaxes at low arterial pressure to allow more flow. Pressure change activates the calcium ion 
channels in the vascular smooth muscle which mediate contraction or relaxation. Myogenic 
mechanism seems to be evident in all parts of the vascular system, and the magnitude of any 
myogenic-driven response may depend on vessels diameter.
132
 Vasoactive substances from the 
endothelium are speculated to play a big role in the myogenic induced contraction.
133
 
1.9.1.3 Humoral autoregulation 
Circulating and locally produced hormones regulate the blood flow by signalling endothelial 
cells, vascular smooth muscle cells and pericytes.
134
 Angiotensin-II receptor binding sites have 
been found to exist in ocular tissue, leading to evidence that the renin-angiotensin-system may 
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also play its part in ocular regulation.
135
 Angiotensin-II is a potent vasoconstrictor, however, its 
administration in the human studies  showed no alteration to choroidal and ONH flow.
136
 
Epinephrine causes vasoconstriction through the adrenergic receptors in the retina
137
 but 
mediates dilation in other vascular beds.
138
 In the same line, its effect on the retinal and ONH 
circulation is not well established.  
1.9.1.4 Neurologic autoregulation 
Unlike the retinal vessels, choroidal vessels are rich with neural innervations. Perfusion in the 
choroid, along with the posterior ciliary arteries and the extraocular CRA, are regulated by 
autonomic nerves.
134
 Animal studies have shown that sympathetic stimulation reduces,
139
 and 
denervation increases, choroidal flow.
140
 It is also possible  that parasympathetic excitement 
increases choroidal flow.
122
 
1.9.2 Endothelial derived vasoactive factors 
The endothelial cells lining the retinal vessels, stimulated by either chemical or physical stimuli, 
produce vasoactive substances in response to these stimuli to regulate the blood flow. These 
vasoactive substances induce primarily the vascular smooth muscle cells, and to a much lesser 
extent, the pericytes, to contract or relax. Blood flow is regulated by controlling the amount of 
flow by constricting or dilating the vessels. In the face of changes in systemic BP, IOP, or 
metabolic demands, different substances will be released accordingly to maintain stable 
perfusion. Two vasoactive groups being released to control blood flow are namely the 
endothelium derived constricting factors (EDCF) and the endothelium derived relaxing factors 
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(EDRF).
11
 A balance between these factors regulate the vascular tone, thus reduction of one 
vaso-substance will result to vasoconstriction or vasodilation.
7
 
EDCFs such as endothelin-1 (ET-1), angiotensin-II, cyclooxygenase products (i.e. thromboxane 
A2 and prostaglandin H2) promote vessels constriction.
2
 ET-1 is the most potent constricting 
factor.
134
 ET-1 binds to the vascular smooth muscle at ETA receptor to mediate vasoconstriction, 
or on the endothelial cell itself at receptor ETB to mediate vasodilatation.
134
 Although it has been 
shown that ET-1 may mediate dilation or constriction, Rubanyi and Polokoff
141
 debated that the 
overall response of ET-1 in vivo is sustained and powerful constriction. Studies have reported of 
increased levels of ET-1 in plasma,
142, 143
 and aqueous
144
 in glaucoma patients. Nicolela and co-
workers
145
 reported an increased plasma ET-1 after cold-provocation in POAG patients. A study 
by our group
146
 reported a lower level of plasma ET-1 in untreated and newly treated POAG at 
baseline and normoxic hypercapnia condition, compared to controls and progressive POAG. On 
the other hand, other studies have reported of no significant difference in the ET-1 plasma level 
between POAG, NTG and healthy individuals.
147
 
EDRFs such as nitric oxide (NO), prostacyclin, and endothelium-derived hyperpolarizing factors 
promote vessels dilation. NO is the most potent vasodilator released by the endothelium.
148
 The 
NO activity contributes to autoregulation and provides protection against pathologic stressors 
implicated in diseases such as glaucoma, ischaemia and diabetes.
149
 NO synthase (NOS) 
catalyses the conversion of L-arginine into NO and L-citrulline. NO formation increases the 
production of cyclic guanosine monophosphate (cGMP) leading to the reduction of calcium ions 
and thereby causing vasodilation.
150, 151
 There was evidence which linked glaucoma patients with 
an altered ocular L-arginine/NO pathway.
152
 Laude and associates
153
 have reported a reduced 
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levels of cyclic GMP (NO activity indicator), together with a lower blood velocity in the 
ophthalmic artery of NTG patients. Additionally, there was also evidence of polymorphisms in 
the endothelium specific NOS (eNOS) in familial glaucoma.
154
 Other studies also suggested 
polymorphisms in the eNOS in both high and normal tension glaucoma.
155
 
1.10 Manipulation of blood gas 
Vascular reactivity provocation can be achieved by changing the arterial partial pressures (Pa) of 
CO2 and O2 and this phenomenon has been extensively studied. Raising the PaCO2 level while 
maintaining normal PaO2 level is termed normoxic hypercapnia, and increasing PaO2 level while 
maintaining PaCO2 level is termed normocapnic hyperoxia. Hypercapnia induces vasodilation 
while hyperoxia induces vasoconstriction. The control of gases in most studies in the literature, 
however, has been generally poor although a few have published data to support or refute this 
statement. A few centers, including the Hudson Lab, have attempted to use a stable, standardized 
and repeatable breathing stimulus to assess reactivity that carefully controls inhaled gas 
mixtures. 
1.10.1 Respiration, and ventilation gas exchange 
Respiration is the process of supplying O2, and removal of CO2 in the body. O2 and CO2 are 
transferred between atmosphere and pulmonary capillaries followed by red blood cells and 
tissues. The total amount of air at a given time (total ventilation, Ve) during inspiration does not 
participate in alveolar gas exchange. The leftover gas forms the physiological dead space (Vpds) 
that remains in the airways and is exhaled first during expiration. The volume of air that 
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participates in alveolar gas exchange, termed as alveolar ventilation (VA), is the difference 
between Ve and Vpds.
16
 
The amount of CO2 in expired gas represents the concentration of the gas in the alveoli (FACO2) 
and can be presented in fractional value (FETCO2). PaCO2 concentration in the blood can be 
substituted with end-tidal partial pressure (PET) CO2, which is the amount of exhaled CO2, when 
using a partial rebreathing circuit. However, non-standardized techniques that use a non-
rebreathing circuit or the manual addition of CO2 into breathing air, show only an increase in 
PETCO2, while tending to effectively fail to increase PaCO2.
156, 157
 Additionally, studies using 
hypercapnic stimuli fail to adequately consider concomitant O2 control.
158-162
 In order to 
accurately study vascular reactivity, it is important to use a standardized method to elicit 
repeatable stimuli to avoid any confounding effects. 
The usage of a sequential gas delivery (SGD) breathing circuit with an automated gas sequencer 
has resulted in the desired control of the level of PETO2 and PETCO2 with precision. In the 
Hudson lab, a prospective gas targeting system (Respiract
TM
, Thornhill, Toronto) has been used 
which allows independent control of PaO2 and PaCO2 to elicit repeatable provocation stimuli. It 
has been demonstrated that by using this gas blender, the PETCO2 is correlated with PaCO2.
156, 163
 
The SGD breathing circuit is a mask with a clamping ability to stably maintain normoxia/ 
normocapnia irrespective to minute ventilation changes (Figure 1.5). Respiract
TM
 uses metabolic 
O2 and CO2 consumption, resting and target PET data which has been pre-programmed in the 
software to determine the precise concentration of gas to be used to achieve a desired stimulus.  
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Figure 1.5: Schematic diagram of sequential gas delivery (SGD) circuit. An SGD breathing circuit comprised of two 
gas reservoirs and a face mask. The automatic gas sequencer supplies fresh gas into the inspiratory reservoir, while 
breathed gas fills the expiratory reservoirs. Each reservoir is connected to the mask with a separate one-way valve. 
The two reservoirs are interconnected by a positive end-expiratory pressure (PEEP) valve, which enables 
participants to rebreathe the exhaled gas in situations where fresh gas reservoir is emptied. 
1.10.2 Normoxic hypercapnia 
Normoxic hypercapnia induces vasodilation and increased blood flow in the human retina.
160-162, 
164, 165
 The involvement of NO has been implicated to this vasodilation,
166, 167
 but the exact 
mechanism is still debated. However, Hessellund and co-workers
168
 suggest that acidosis is 
responsible for the relaxation vascular tone in the porcine retina. This mechanism is associated 
with hyperpolarization in the smooth muscle cells and a constant decrease of Ca
2+
. However 
most of the studies conducted to study retinal flow using hypercapnia did not control the 
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concomitant change in PETO2, which may have confounded the magnitude of the 
vasoconstriction effect. It has been reported that hypercapnia may cause hyperventilation which 
affect PETO2 level unpredictably.
169
 The findings in the Hudson lab, using a stable normoxic 
hypercapnia stimulus, showed increased blood flow in the retinal arterioles.
170, 171
 
1.10.3 Normocapnic hyperoxia 
Normocapnic hyperoxia induces vasoconstriction and this has been shown in many studies.
159, 
160, 171-175
 The involvement of ET-1 is advocated to the constriction of the vessels.
176
 However 
most studies did not control the PETCO2 level. O2 addition to breathing has been shown to induce 
hyperventilation thus resulting in a concomitant reduction of PaCO2 pressure.
177
 The findings in 
our lab, using a stable normocapnic hyperoxia stimulus, showed reduction in blood flow in the 
retinal arterioles.
171, 174
 
1.11 Ocular blood flow quantification techniques 
It is not surprising that there are only a relatively few techniques that are commercially available 
to non-invasively assess ocular blood flow given the intricate morphology of the ocular perfusion 
network. A relatively small number of techniques have been proven to be of value for the 
investigation of various aspects of ocular haemodynamics but all have their limitations in terms 
of interpretation and utility. The use of the current techniques is limited to research laboratories 
around the world because it has yet to be proven that retinal blood flow imaging has any value as 
a diagnostic procedure and because measurement variability can be very high for certain 
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techniques and the process of assigning a gold standard technique against which all other 
techniques can be assessed is on-going.  
1.11.1 Color Doppler Imaging (CDI) 
The CDI has been used extensively to study ocular haemodynamics and reactivity. It uses sound 
waves, inherent from the ultrasound technique, to measure retro bulbar blood velocity and 
vascular resistance.
178
 Briefly, sound waves propagated from the probe into the eye are reflected 
from stationary structures without frequency change. However, sound waves reflected from 
moving particles such as blood, undergo frequency change. The frequency shift, the Doppler 
shift, is measured, and used to calculate blood velocity. The principles of Doppler will be 
elaborated later in this chapter. 
Flow measurement is impossible as the technique is unable to measure vessel diameter. Velocity 
measurement is also restricted to big vessels such as the central retinal, SPC, LPC, and 
ophthalmic vessel(s) because of low resolution of the technique. The technique requires an 
experienced operator for a repeatable values.
179
 The potential errors that may arise relate to how 
the measurement is carried out; (1) minimal pressure must be applied to the globe via the probe 
as not to induce an IOP rise and that impact OPP, (2) derived velocities values are dependent 
upon probe angle relative to moving blood cells, and (3) the ability to detect correctly and 
identify specific vessels from the sophisticated retro bulbar anatomical vascular structures can be 
very difficult. 
Using CDI, glaucoma patients have been found to have a reduced velocity and higher resistance 
index value in comparison to healthy subjects.
180, 181
 Progressive glaucoma was reported to have 
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reduced velocity in the CRA relative to healthy people.
182
 In response to hypercapnia, a 
decreased magnitude of reactivity was evident in glaucomatous eyes compared to OHT and 
control subjects.
183
 
1.11.2 Pulsatile ocular blood flowmeter (POBF) 
The POBF estimates choroidal blood flow based on the ocular pulsatility, i.e. the changes in 
ocular volume and pressure during cardiac cycle.
184
 The pneumatonometer is used to 
continuously measure IOP at a rate of 200Hz for 5 to 20 seconds, to produce a pulsatile 
waveform corresponding to systolic/diastolic time, ocular pulse amplitude and heart rate. Based 
on the assumption that there is a constant correlation between eye pressure and eye volume, it is 
taken that IOP is proportional to blood volume. The instrument calculates flow by analyzing the 
IOP waveforms during systolic and diastolic phase, assuming a general scleral rigidity and 
constant aqueous humor outflow. 
This method does not measure flow directly, since it estimates flow by mathematical calculation 
from the ocular pulse volume variation. In addition, measurement is affected by scleral rigidity, 
axial length, refractive error, gender, BP, pulse rate, and age.
185, 185-187
 Despite these limitations, 
measurement on patients with glaucoma have reported a reduced flow.
188
 A study reported that 
POAG and OHT patients with IOP more than 25mmHg were found to have reduced flow, 
compared to OHT patients with IOP less than 25mmHg.
189, 190
 The non significant difference 
observed upon comparison between OHT and POAG with IOP above 25mmHg, however, 
indicates that POBF reading is dependent on the IOP.  
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1.11.3 Blue field entoptic stimulation 
The blue field entoptic phenomenon is based on the perception of leukocytes flowing in the 
retinal vessels in the macula. Blood velocity quantification using this phenomenon is subjective, 
where the subject notes the presence of leukocytes upon looking at diffuse blue light (430nm 
wavelength) in an area of 10 to 15° surrounding fixation.
191
 Blood velocity is measured by 
asking the subject to make a match between his entoptic perception to stimulated moving particle 
field of different speeds.  
This method requires patient’s cooperation and perception, questioning its validity. Large 
variations between patients exist and data is limited in the perifoveal region.
192
 The pathologic 
and physiologic state of the retina at any point in time will influence the measurement. 
Measurement on patients with cataract may be difficult. It is still debated whether leucocyte flux 
is proportional to blood flow under pathological conditions.
193
 
1.11.4 Laser interferometry 
Laser interferometry is a fundus pulsation technique that is used to determine choroidal flow.
194
 
Heartbeat-induced changes cause the distance between anterior corneal surface and retinal 
reflected light to pulsate i.e. this phenomenon is used to calculate pulsation amplitude. Using 
illumination from a single mode-diode laser (783nm wavelength), reflections from both the 
anterior cornea and retina form a non-localized concentric interference pattern. Distance change 
inflicted by rhythmic filling of blood during the cardiac cycle is analyzed as change in 
interference order. The systolic phase decreases the distance between cornea and retina, and vice 
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versa. A charged-coupled device (CCD) camera captures the interference image at high temporal 
resolution, which can be used to analyze the fundus pulsation amplitude (FPA).
195-197
 
This method may be limited for patients with opaque media. Only the pulsatile component of 
flow is measured and the ratio between the pulsatile component and blood flow is unknown.
198
 
How the pulsatility is affected by diseases is also an interesting question. It has been reported 
that the FPA is decreased in POAG.
199
 
1.11.5 Retinal vessel analyzer (RVA) 
The RVA enables a continuous and real time diameter measurement of a vessel segment in 
relative units.
198
 It comprises of a fundus camera, a video camera with a real time monitor and 
vessel diameter analysis software. Briefly, the brightness profile of an examiner-defined vessel is 
acquired and saved in a video recording device. The brightness profile, or densitometry image, is 
made by focusing wavelengths of 420 to 600nm perpendicular to the vessel. The wavelength 
values are chosen for optimal absorption by erythrocytes. Reflected light by different layers of 
retina and vessel is captured by a CCD sensor and is analyzed to determine vessel diameter. 
Twenty five diameter measurements are acquired per second
160, 161
 and the system stops 
automatically if a subject blinks or moves. Measurement is resumed once a movement or blink 
has ceased.
200
 
RVA usage may be limited in subjects with clear media and good fixation ability. Vessels that 
are close in proximity may also impossible to be measured as the RVA is unable to differentiate 
vessels apart.
201
 Resolution is also limited (less than 1µm), thus measurement is only possible for 
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vessels greater than 90µm of diameter.
201
 Measurement by the RVA represents the reaction of 
retinal vessel diameter, a haemodynamic parameter that is a surrogate of blood flow. 
1.11.6 Laser Doppler techniques 
1.11.6.1 Doppler shift effect 
Light waves undergo a shift in frequency upon reflection from a moving particle (f’), relative to 
its pre-reflected state, or relative to reflected frequency from neighbouring stationary particles (f, 
Figure 1.6). This observation of frequency shift in waves is known as the Doppler shift (Δf).  
                    Equation 1.9  
The magnitude of shift is proportional to the velocity of moving particles. Doppler shift can be 
observed by illuminating volume of a retinal vessel. In a blood column experiencing Poiseuille’s 
flow, the central maximum velocity (Vmax) vector is considered. Assuming light illuminates an 
entire cross section of a vessel, light scattered from the moving blood is shifted in frequency by: 
   
                   
 
        Equation 1.10 
where ϑ is the angle between velocity vector and incident light, and θ is the angle between 
velocity vector and reflected (scattered) light (Figure 1.5).
202
 n is the refractive index of the 
medium and λ is the wavelength of the illumination light. Knowing the value of Doppler shift, 
maximum central line blood velocity, Vmax, can be calculated. 
      
      
               
          Equation 1.11 
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Figure 1.6: Illustration of the Doppler shift effect in a blood vessel. 
 
1.11.6.2 Laser Doppler velocimetry (LDV) 
The LDV uses the Doppler shift effect, enabling the measurement of absolute centre blood 
velocity of the retina. The maximum Doppler shift corresponds to the maximum centre velocity 
of a vessel. Most of the approaches for measuring centerline blood velocity in retinal arterioles 
and venules are based on the LDV technique.
184
  
1.11.6.3 Laser Doppler flowmetry (LDF) 
LDF is a non-invasive technique designed to measure relative blood velocity, volume and flow 
within a sampled tissue. The technique is based on light scattering properties in tissues, assuming 
that relative velocity and blood volume of the erythrocytes is related to complete randomization 
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of light directions after impinging the erythrocytes.
203
 A 50µm diameter circular area on the 
retina is projected by laser, while a photodetector collects scattered light from 150µm circular 
area surrounding the laser spot. A larger scatter area indicates a Doppler shift from deeper 
sources in the retina. The photodetector analyses the Doppler shift to produce relative flow 
values.
204
 Scanning laser Doppler flowmetry (SLDF) combines the LDF technology with 
scanning laser tomography. The Heidelberg Retina Flowmeter (HRF) is an example of a 
commercialized LDF, confocal version instrument (400µm focal plane thickness), which enables 
relative flow measurement of the retinal and ONH vasculature.
204
 
Limitations of the LDF include; (1) only relatives flow values are measured, a by-product value 
from velocity and volume, (2) variation in scattering properties between subjects is high due to 
differing anatomy, (3) since the system is not depth plane specific, non-foveal measurement may 
be biased from both vasculature of retina and choroid.
184, 204
 Findings from our lab using HRF 
showed that untreated POAG patients having the least reactivity to normoxic hypercapnia in the 
ONH compared to progressive POAG and controls.
146
 In another study, LDF was used to 
measure 5 sites around the ONH in POAG and healthy group. Mean flow was reduced in the 
glaucoma group.
205
 Upon comparison with glaucoma suspects, flow between a glaucoma group 
and a glaucoma-suspect group were not significantly different but the glaucoma-suspect group 
had lower flow than controls.
206
 
1.11.6.4 Bi-directional laser Doppler velocimetry (BLDV) 
The use of two photodetectors separated by a known angle enables a more accurate measurement 
of the centreline blood velocity. Unlike the LDV which is impacted by the Doppler angle 
because it uses a single photodetector, the BLDV (uses 2 photodetectors) is able to calculate the 
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Doppler angle from the difference in Doppler shift between 2 photodetectors.
207
 This results in 
an accurate velocity calculation.   
The maximum frequency shifts from the centreline vessel (δf1 and δf2) are detected 
simultaneously by photodetectors, K1 and K2, in two directions, separated by a fixed angle, Δα 
(Figure 1.7). Wave frequency can be calculated by dividing velocity by wavelength (f = v/λ), 
thus the maximum frequency shift from both photodetectors of a known separate angle can be 
calculated by: 
              
           
 
          Equation 1.12 
where α1 and α2 are the angles between the velocity vector Vmax and K1 and K2, respectively. 
Maximum velocity, Vmax, can be calculated by: 
     
       
           
         Equation 1.13 
where Δf is taken from Equation 1.12.   
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Figure 1.7: Illustration of the Doppler angle measurement in the bi-directional laser Doppler velocimetry.  
 
An average flow in a Poiseuille condition is located in between of centreline and the vessel 
wall.
202
 Thus, the mean velocity (Vmean) can be calculated by dividing half of the Vmax.
17
 If the 
cross sectional area (S) of where the fluid with the Vmean is known, then the flow rate (F) can be 
calculated by: 
  
    
 
              Equation 1.14 
Assuming that vessel has a circular cross section, F can be calculated by: 
  
 
 
                           Equation 1.15 
 where D is vessel diameter. 
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1.11.6.5 Canon Laser Blood Flowmeter (CLBF) 
The CLBF derives volumetric blood flow of the retina in absolute units (µL/min). It 
simultaneously measures blood velocity and diameter of a single vessel, to derive a flow value. 
The CLBF comprises a fundus camera incorporating a pair of photodectors as well as lasers. 
Velocity measurement is done every 0.02s across 2s measurement windows using red diode laser 
(675nm, 80µm x 50µm oval), producing a velocity-time tracing data. A separate green HeNe 
laser (543nm, 1500µm x 150µm rectangle), perpendicular to the measured vessel is used to 
measure diameter.
208
 Diameter is measured every 4ms during the first and final 60ms of the 2s 
measurement window. The green laser also tracks eye movement and stabilizes laser position at 
the measurement site.
209
 Two sequential measurements are acquired for the machine to give a 
valid averaged flow reading. The measurement is influenced by axial length and refractive 
error,
210
 thus corrections are made by calibrating the optics accordingly. The software allows 
post-acquisition modification of velocity measurements, for example in cases where large 
tracking errors occur due to saccadic eye movement.
208
 
The CLBF is limited to the measurement of one vessel at a time and it can only measure vessel 
diameters of 60µm or larger. Using systemic provocation, retinal vascular reactivity assessed 
using the CLBF is extrapolated on the assumption that a single site assessment is representative 
of global reactivity across the retina. Using normoxic hypercapnia as provocation, our group 
found that untreated and progressive POAG patients have decreased reactivity compared to 
controls and treated POAG.
146 
Homeostatic baseline however revealed no significant difference 
between groups. In a different study, Berisha and co-workers
211
 reported a significant lower 
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velocity and lower flow in the inferior temporal artery of early stage POAG patients compared to 
healthy controls.  
1.11.6.6 Doppler spectral-domain optical coherence tomography (Doppler SD-OCT) 
OCT is a high-resolution imaging methodology that can be used to quantify ocular morphology, 
particularly the ONH and retina. Consequently, it is routinely used in the clinical diagnosis and 
management of eye diseases. Of late, its fast acquisition and high resolution facility has also 
been applied to detect the Doppler shift in retinal vessels. OCT employs low coherence infrared 
light to image, which is divided into a sample arm and a reference arm/channel. Backscattered 
reflection from the sample arm (i.e. retina) interferes with that from the reference arm/channel, 
producing interference echoes. This interference echoes is detected by spectrometer, and Fourier 
transformed to create a measurement of light echoes versus depth, or A-scan.
212, 213
 Combination 
of successive A-scans produce a B-scan image of the tissue. Doppler shift is measured by 
detecting the phase difference between sequential axial A-scans on each pixel.
214-216
 
The RTVue SD-OCT (Optovue Inc., Freemont, CA) employs an 841nm light source with a 
bandwidth of 49nm. It has an axial resolution of 5.6µm in tissue and transverse resolution of 
20µm. It uses a custom spectrometer with 1024-pixel line scan camera to detect backscattered 
light. The double circular scan protocol consist of two concentric rings of 3.4 and 3.75mm in 
diameter to measure total retinal blood flow.
217, 218
 Centred on the ONH, the rings transect all 
vessels that traverse into and out from the eye at two locations. From the difference in the vessel 
positions in the concentric ring, the Doppler angle (θ) is measured for the Doppler shift 
calculation: 
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           Equation 1.16 
A smaller Doppler angle produces a weak Doppler shift, however an angle too large will cause 
extreme Doppler shift that may be out of the detection range of the SD-OCT. A reliable blood 
flow measurement needs a Doppler angle of between 5 to 15°. Four pairs (includes the inner and 
outer concentric circles) of scans are taken over two cardiac cycles in each scan (Figure 1.8).
216, 
219
 For measuring the total retinal blood flow, six scans are usually taken. During the blood flow 
scans, the Doppler angle is maximized by decentering scan angle minimally to the superonasal 
and inferonasal.  
 
Figure 1.8: The blood flow double circular scan protocol. (A) Two concentric circles with different radius (r1= 
3.4mm and r2 = 3.75mm) centred on the optic nerve head transecting all vessels traversing into and out from the 
eye. (B) OCT images corresponding from each circular scan pattern showing vessels with Doppler shift (blue and 
red colour dots). Doppler angle is measured between OCT beam line (yellow) and vessel line (red). Adapted from 
Wang et al.
218
 
A semi-automated software named the Doppler optical coherence tomography of retinal 
circulation, DOCTORC (Centre for Ophthalmic Optics and Lasers, CA, USA) is used to evaluate 
47 
 
the quality of the scans, and to calculate flow. A description of Doppler data grading and using 
the DOCTORC has appeared elsewhere.
220
 Total retinal blood flow (TRBF) is calculated by 
summing flows from all detectable venules. Velocity is calculated by dividing flow in each valid 
venule by the cross sectional area of valid venule.
218, 220
 This technique assumes that the venular 
flow is equal to the arteriolar flow, taking that inflow must be equal to outflow in any closed 
system that obeys law of conservation of mass.
218
 
The TRBF using this technique was shown to have coefficient of variation (COV) value of 
10.9% in healthy eyes, and 14.3% in diseased eye. This technique alsoshowed a good intra class 
correlation coefficient (ICC) of 0.85.
218
 Our group found the COV median for young healthy 
subjects of 7.5% and for elderly healthy subjects of 9.2%.(Tayyari F., in press) These results 
indicate that the Doppler SD-OCT blood flow measurement is reliable and repeatable. Konduru 
and co-workers
220
 studied the reproducibility of measurements derived from DOCTORC among 
two trained graders. They reported an ICC value of 0.933 with mean difference TRBF value of 
3.84µL/min. Our group similarly compared haemodynamics results derived from DOCTORC 
from two, novice and experienced, graders. An overall analysis showed an ICC of 0.935 for the 
TRBF, with values from both graders being no different.
326
 These results indicate that 
reproducible measurement is possible using semi-automated DOCTORC software. Retinal blood 
flow measurement using the Doppler SD-OCT has been shown to be lower in patients with 
POAG compared to healthy people. The reduction of flow was also correlated with the severity 
of field loss.
218
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1.12 Glaucoma 
Glaucoma is an optic neuropathy that results in chronic, progressive loss of retinal ganglion cells 
and their neurons. The clinical characteristics include optic disc cupping, nerve fiber layer loss 
and visual field defects.
221
 Glaucoma is one of the leading causes of irreversible blindness in the 
world.
222
 
1.12.1 Classification  
Classification of glaucoma is important to ensure the best clinical management available for a 
patient. There are different treatment options for different types of glaucoma. In general, 
glaucoma can be classified based on the anterior chamber angle, either an open angle or a closed 
angle. IOP elevation, a strong risk factor of this disease, is associated with the aqueous outflow 
anatomy structure. Both types of glaucoma may further be classified as primary or secondary. 
Secondary glaucoma may occur as a result of other eye disease or abnormality, or systemic 
diseases. Primary open angle glaucoma (POAG) may either be associated with an increased or a 
normal IOP, which results in the term high tension glaucoma or normal/low tension glaucoma 
(NTG), respectively. NTG is considered a spectrum of POAG. Eyes with high IOP but without 
glaucomatous damage are termed as ocular hypertensive (OHT). Other classifications are related 
to the onset of the disease, e.g. congenital or infantile glaucoma, and juvenile glaucoma.
223
 In 
this thesis, the scope is confined to POAG, which includes both high and normal tension 
subdivision. 
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1.12.2 Risk factors of POAG 
There is no real cure for glaucoma and current treatment modalities are aimed at preserving 
vision. Earlier detection of glaucoma is thus important for for a better prognosis. It is important 
to differentiate the risk factors that can lead to glaucoma, and the risk factors that lead to 
glaucoma progression.
224, 225
 Risk factors that may lead to the disease include those that are 
associated with IOP elevation. 
1.12.2.1 Age 
Age is a major risk factor for the development and progression of glaucoma
42, 225
 It has been 
noted that POAG seldomly occurs at ages younger than 40 years old.
222
 It has been demonstrated 
that prevalence of glaucoma steadily increases with each decade after 55 years of age.
226, 227
 A 
gradual rise of IOP and a reduced number of ganglion cells have been proposed as the causal 
factors.
225
 Alternatively, it is hypothesized that the ganglion cells susceptibility to IOP insult 
increases with advancing age.
228
 Ageing may also reduce the efficiency of blood flow 
autoregulation in the maintenance of stable perfusion in the face of OPP fluctuation.
42
  
1.12.2.2 IOP 
IOP has long been identified as a strong risk factor for the development and progression of 
glaucoma; the higher the IOP, the higher the likelihood of developing glaucomatous optic 
neuropathy (GON) and increased disease progression. Even in NTG, IOP may also play a role in 
the process of the disease.
229
 Fluctuations of IOP may also contribute to the development and 
progression of glaucoma, and this includes circadian and day-to-day fluctuations.
224, 229
 All of the 
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treatment modalities that are currently available involve reducing IOP. Reducing the IOP is of 
benefit even in OHT individuals. Longitudinal studies have indicated that the use of IOP 
lowering drugs delays or prevents POAG onset.
31
 
1.12.2.3 Race 
Although it is difficult to distinguish genetic risk factors from those by socioeconomic 
influences, POAG has been shown to be more prevalent among persons of African descent.
230, 231
 
Patients with African ancestry often have higher IOP and greater risk factor to experience 
GON.
225
 The prevalence of POAG among black populations is at an earlier age compared to 
whites.
232
 NTG is more prevalent among people of Japanese ancestry.
233
 
1.12.2.4 Family history 
The likelihood of an individual having POAG is increased with a family history of the 
disease.
234-236
 Genetic studies have advocated protein coding defects, and gene mutations among 
POAG and NTG patients. Several genes loci such as MYOC and OPTN, and other chromosomal 
locations, have been subject of active investigations.
237
 The interactions of genetic with 
environmental factors may play a part in glaucoma.
231
 
1.12.2.5 Myopia 
The Barbados Eye Study
238
, Blue Mountains Eye Study
239
, and Beijing Eye Study
240
 all reported 
a higher prevalence of glaucoma among myopic eyes. Axial myopia is more susceptible to the 
development and progression of glaucoma. An elongated axial length has been associated with a 
thinner sclera and lamina cribosa,
241
 that in turn exacerbates the IOP inflicted stress at the ONH. 
51 
 
The Kandy eye study from Sri Lanka, reported that longer axial length was a significant risk 
factor for glaucoma, together with age and IOP. 
242
 There were also reports of ONH connective 
tissues abnormalities in myopic eyes.
241, 243, 244
 
1.12.2.6 Central corneal thickness (CCT) 
Thinner CCT showed a strong relationship with the development of POAG.
24, 245
 The Ocular 
Hypertension Treatment Study (OHTS) showed that CCT is a powerful predictor of POAG 
development, even after adjusting the effect of IOP, age, cup disc ratio, and pattern standard 
deviation.
246
 The OHTS reported that patients with CCT of <555µm were at a 3 times greater 
risk of developing glaucoma than those with CCT of >588µm. The exact mechanism is still 
unclear. It is suggested that CCT may reflect scleral thickness, and thus a thin lamina cribosa 
may possesses a potential mechanical disadvantage.
247
 Thinner structure can easily bend, hence 
may reduce the pores size hosting the axons traffic. This in turn causes kinking of the axons and 
blood vessels and triggers apoptosis and ischaemia. 
1.12.2.7 Diabetes mellitus (DM) 
The association between DM and glaucoma is controversial as some epidemiological studies 
have reported a negative relative risk,
248-253
 while others found no association
254-257
. 
Experimental studies, however, suggest that diabetes may exaggerate the vulnerability of the eye 
towards insult such as increasing pressure.
258
 Metabolic changes that occur in diabetes promote 
vascular damage and exacerbate glaucoma progression via ischaemic insult. The relationship 
between these two diseases has been reviewed elsewhere.
259
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1.12.2.8 Vasospasm 
Vasospasm is considered as risk factor in glaucoma.
134, 260
 Vasospasm or vascular 
dysregulation
260
 can be described as an inappropriate constriction or insufficient dilation of a 
vessel to stimuli such as stress or coldness, which results to inadequate blood flow to tissue and 
consequent hypoxia/ischaemia. Simultaneous vessel dilatations in neighbouring tissues may 
occur as a by-product of dysregulation in vasospastic individuals.
261
 Glaucoma patients who 
show evidence of vasospasm have a higher risk of field progression.
145
 Vasospasm may affect 
the whole body but certain organs may be especially prone to vascular dysregulation.
262
 It has 
been shown that women are more frequently affected by vasospasm, and this correlates with the 
observation that NTG is twice as common in women.
263
 Vasospasm is also more common in 
Japanese than Caucasian patients, which again corresponding with the high prevalence of NTG 
in Japan.
262, 264
 Pache and Flammer
260
 in their review argued that vasospasm in glaucoma may 
occur due to imbalances of endothelial derived vasoactive factors, stemming from endothelial 
dysfunction.  In addition, it is also suggested that vasospastic patients may experience more 
fluctuations in perfusion, which leads to reperfusion damage. 
1.12.2.9 Migraine 
Migraine has been proposed as a risk factor for glaucoma progression as it has been shown to 
have an association with field progression.
265
 The Collaborative Normal-Tension Glaucoma 
Study Group in their analysis on field progression risk factors found that migraine was attributed 
for faster field deterioration.
266
 Migraine has often been described as a spectrum of vasospastic 
disorders.
134
 The occurrence has been shown to decrease with age.
260, 267
 Its pathogenesis has 
been associated with functional vasospasm of the vessels in the brain.
260
 It affects more women 
53 
 
than men and is more common in patients with NTG.
268
 Literature on migraine and glaucoma 
shows varying results. Using headache questionnaires, a large sample size study by Phelps and 
Corbett,
269
 showed higher prevalence of migraine-like symptom in NTG compared to OHT and 
controls. Smaller studies in Japan however did not find association.
270
 The Beaver Dam Eye 
Study failed to associate migraine and glaucoma,
271
 however, the Blue Mountains Eye Study 
suggested an association in patients of 70-79 years of age.
267
 
1.12.2.10 Systemic BP 
Systemic hypotension has been observed to be involved in glaucoma development and 
progression.
39, 40
 Furthermore, nocturnal hypotension was shown to be more prevalent in 
progressive glaucoma.
67, 75, 84, 86, 98
 Glaucoma patients with excessive nocturnal hypotension also 
showed reduced blood flow compared to glaucoma patients with normal and low nocturnal 
hypotension.
121
 
1.12.2.11 Obstructive sleep apnea syndrome (OSAS)  
In the recent decades, OSAS has been listed as a plausible risk factor for the development of 
glaucoma, especially NTG.
272-275
 Significant associations were reported ranging from 5.7 to 27% 
in patients with OSAS.
57
 OSAS can be described as repetitive collapse of the pharyngeal airway 
during sleep, with episodes usually terminating by arousal when the upper airway muscle tone 
increases.
276
 The exact pathogenesis of OSAS in glaucoma is not clear.
277
 It is assumed that 
OSAS may result in large swings in BP and severe hypoxia and hypercapnia. The repetitive 
nature of the episodes may cause reperfusion injury and contribute to ONH damage.
278
 However, 
a review paper by Dhillon and co-workers
277
 suggested that the proposed association between 
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OSAS and glaucoma is unlikely. They concluded that obstructive sleep apnea may not directly 
impact the development of glaucomatous optic neuropathy and anecdotally claimed association 
being related to the confounder of aging. This was supported by a very large retrospective study 
that was unable to identify an association between OSAS and glaucoma.
279
  
1.12.3 Pathophysiology of POAG 
There are many theories proposed to explain the pathogenesis of glaucoma, but the exact 
mechanisms behind the optic neuropathy remain unknown. The most discussed theories in the 
literature are the mechanical theory and the vascular theory. Most likely these mechanisms are 
not mutually exclusive although the relative contribution is unclear. 
1.12.3.1 Mechanical and Vascular theory 
The mechanical theory of glaucoma proposes that chronic IOP elevation promotes remodelling 
of the lamina cribosa, leading to mechanical compression of the ganglion axons. This lamina 
cribosa remodelling in turn affects the anterograde and retrograde axoplasmic transport, thus 
interrupting the transport of neurotrophic factors from the lateral geniculate nucleus to the 
ganglion cell body, and eventually causing ganglion cell death and apoptosis.
280
 The central 
argument in this theory is that IOP elevation leads to GON, however it fails to explain glaucoma 
that occurs in the “normal range” of IOP, i.e the NTG. Glaucoma that occurs in normal IOP 
indicates involvement of other important factors in GON.  
The vascular theory argues that the GON is a result of hypoxia/ischaemia that is secondary to 
perfusion insufficiency. Perfusion inadequacy may be a direct result of elevated IOP and/or other 
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risk factors such as vascular dysregulation or autoregulation deficit.
244
 The lamina cribosa 
retrograde bowing induced by elevated IOP causes vessels to compress, affecting the perfusion 
and leading to hypoxia/ischaemia. Failure in autoregulation or vascular dysregulation causes 
tissue ischaemia and cellular injury, and eventually ganglion cell apoptosis. Indeed, ocular 
haemodynamic studies in the retinal,
217, 281
 ONH,
199, 282, 283
 choroidal,
188, 190
 and retrobulbar
282, 284
 
showed low homeostatic values in glaucoma patients. 
1.12.3.2 ONH insults in glaucoma 
It is well-accepted that the primary insult of ganglion cell axons is at the lamina cribosa. 
Elevated IOP may be responsible for such insult modulated by the biomechanical properties of 
the lamina cribosa,
285
 and the cerebrospinal fluid (CSF) pressure level.
286-289
 CSF surrounds the 
ONH. CSF pressure has a positive relationship with the BP, where high BP causes CSF pressure 
to increase (to prevent dangerous levels of pressure in cerebral vasculature) and vice versa. The 
pressure gradient between the CSF pressure and IOP is called the trans-lamina cribosa pressure 
difference.
290
 As such, low BP; by means of taking hypotensive medication, nocturnal 
hypotensive episode, or hypotension elicited by postural change, will reduce the pressure 
gradient. A low trans-lamina gradient may cause harm even when IOP in its “safe” value, as the 
relatively higher IOP pushes lamina cribosa outward and put pressure on the ganglion axons.
30, 
291
 It should be realized that glaucoma can happen at any level of IOP. Studies have shown that 
NTG and POAG patients have lower intra cranial pressure compared to OHT and controls.
286, 287
  
Low OPP may cause primary insults by creating an ischaemic state in the ONH leading to cell 
death.
290
 Again, low OPP may arise from systemic hypotension or elevated IOP. In theory, a, 
fully functional intrinsic autoregulation system should be able to keep perfusion stable. 
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Glaucomatous eye with abnormal autoregulation, or having vascular dysregulation, may be 
unable to keep perfusion constant. In addition, Chereacheanu and co-workers
290
 suggested that 
reduced OPP may be associated with neurovascular coupling breakdown, where the hyperemic 
reaction to visual stimulation is defective (will be elaborated in 1.13.4).  
In susceptible eyes with autoregulatory dysfunction, the tissues suffer from unstable perfusion in 
the face of systemic BP or IOP change. It is speculated that dysregulation may occur because of 
atherosclerosis of the vessels resulting from chronic hypertension. The hardening vessels thereby 
reduce available reserve to accommodate for the perfusion challenges. Autoregulatory 
dysfunction may also be caused by an abnormal vascular response to autonomic stimulation, 
local hormones and metabolites. As a result, the ONH may not only suffer from ischaemic insult, 
but also reperfusion injury due to inconsistent perfusion.
18
 
Reperfusion injury refers to oxidative stress that is associated with the production of reactive 
oxygen species (ROS) such as free radicals, hydrogen peroxide, and singlet oxygen.
78
 ROS are 
mainly produced in mitochondria.
292
 The involvement of oxidative stress in GON due to hypoxia 
has long been debated,
293
 and ischaemia and ischaemic-reperfusion are identified as ROS 
generators.
78
 Considering the circadian variability in BP, OPP, IOP, and ocular haemodynamics 
that we have discussed earlier, reperfusion injury and oxidative stress, may contribute heavily to 
glaucoma pathogenesis. On the bright side, oxidative stress offers a potential area for 
neuroprotection in glaucoma. Strategies such as ROS inhibition, antioxidant supplement for ROS 
detoxification, or stimulation of gene expression for increasing mitochondrial antioxidant 
defence, may be a subject of interest in future glaucoma studies.
294
 Interestingly, ginkgo biloba 
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has been used as an adjuvant therapy for glaucoma on the possibility of its neuroprotective 
effect,
295, 296
 although it is controversial.  
The cardiovascular system has a close relationship with the autonomic nervous system (ANS), 
regulating BP through sympathetic and parasympathetic system. Extreme nocturnal hypotension 
has been associated with glaucoma,
39, 67, 99
 probably causing ischaemia to the ONH. Thus, ANS 
dysregulation has also been implicated in GON.
58
 A few studies have reported systemic 
sympathetic and parasympathetic neuropathies in POAG patients.
92, 297-300
 Although it is not 
directly measuring the ANS activity, the cold stress test has been shown to reduce ocular blood 
flow in POAG patients.
301
 Studies pertaining to this issue are still lacking and a concrete 
involvement of ANS as a true risk factor is still to be proven. More research is needed to validate 
this matter. 
1.12.4 Management 
IOP is the only modifiable risk factor in glaucoma and is used to manage the disease. Thus, 
glaucoma management is confined to treat the IOP so that it goes lower than its current level, 
either by decreasing aqueous production or by increasing the outflow of the aqueous humor. It 
has been accepted that IOP lowering slows glaucoma progression and improves prognosis.
223
 
Only a few modalities to reduce IOP are available, including pharmacological agents, laser 
surgery, and incisional surgery. A detailed discussion of disease management is beyond the 
scope of this thesis. 
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1.13 Vascular reactivity in glaucoma 
Vascular reactivity can be differentiated from autoregulation on the basis that it is driven by non-
myogenic mechanisms. A myogenic response is studied by observing haemodynamics by 
manipulating OPP or cold-stress test, while metabolic response can be observed by measuring 
vascular reactivity to blood-gas change or flicker. 
1.13.1 Haemodynamic regulation in response to perfusion pressure change  
Myogenic response is the increase of the vascular resistance (by means of vasoconstriction) in 
response to perfusion pressure increase.
44
 This normal retinal haemodynamic response is 
intrinsic to smooth muscle cells, which is independent of metabolic and hormonal influences.
15
 
The retinal myogenic response can be investigated by doing isometric/dynamic exercise or 
instigating posture changes including body inversion. BP increment, instigated by the exercise or 
postural change lead to OPP elevation.
122
 Other methods to alter OPP include changing IOP via 
suction cup
302
 and changing the arterial BP by thigh cuff technique
303
.  
Studies have indicated that glaucoma patients have an impaired autoregulatory response to OPP 
changes.
304
 Evans and co-workers
305
 using the CDI technique compared the change in the 
retrobulbar haemodynamics during different body postures. They saw a significant reduction in 
the resistance index of the CRA from sitting to supine in the healthy control group, but not in the 
glaucoma group. A similar observation was reported by Feke and co-workers
281 
where they 
showed a broader range of responses in the retinal blood flow to OPP changes in glaucoma 
patients, compared to the healthy controls. An abnormal ocular haemodynamic response to an 
elevated IOP was also reported in a few studies recruiting glaucoma patients and healthy 
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controls.
306, 307
 A study that induced BP elevation by isometric exercise found that NTG patients 
showed a trend for increased vascular resistance compared to healthy control subjects.
308
 
1.13.2 Reactivity in response to hypercapnia 
Hypercapnic provocation in a healthy eye causes vasodilation and increase in blood flow. The 
mechanism behind this response is not fully understood but it is thought to be primarily due to 
the NO system.
167
 Studies using hypercapnia on glaucoma patients reported mixed results. The 
Hudson lab previously used the BLDV-SVD on untreated and progressive POAG patients and 
found the retinal arterial vascular reactivity was significantly reduced compared to healthy 
controls.
146
 Additionally, using HRF on the ONH capillaries, the untreated POAG group showed 
the smallest magnitude of reactivity compared to treated POAG and controls. Hosking and co-
workers
180
 using the CDI technique found that POAG group showed increased velocity in the 
SPCA and CRA compared to the controls that showed only increased velocity in the CRA. A 
similar observation was reported by Harris and co-workers
309
 in patients with NTG. An 
exaggerated response was noted in the NTG compared to the controls. They argued that the 
observation may be due to reduced baseline velocity in the patient group compared to controls.  
Sines and associates,
183
 also using the CDI, reported a greater percent change of CRA resistive 
index in the OHT group compared to the POAG group. Of note, these studies did not use a 
partial rebreathing technique to reach the targeted PETCO2 and PETO2 level.  
1.13.3 Reactivity in response to hyperoxia 
Hyperoxia causes vasoconstriction in healthy eyes.
158, 160, 172-174, 310, 311
 It is unfortunate that 
hyperoxia has been widely studied in glaucoma as the vasoconstricting effect of O2 may cause 
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further harm to a compromised vascular bed like that proposed to occur in POAG. Hosking and 
associates
180
 measured the retrobulbar reactivity using the CDI using 100% O2 breathing. The 
control group showed reduction in blood velocity in the OA while glaucoma patients were not 
reactive to hyperoxia. They speculated that pre-existing vasospasms in the glaucomatous eye 
causes an inability to further constrict under hyperoxia. Harris and co-workers
312
 studied the 
impact of hyperoxia on cerebral blood flow using a transcranial Doppler device on 16 POAG and 
15 control subjects. While their control group showed reduction in velocity, hyperoxia did not 
cause significant change in POAG.  
1.13.4 Reactivity in response to light flicker 
Flicker stimulation increases retinal metabolism and leads to compensatory vasodilation and an 
increase in retinal blood flow.
313-318
 The reactivity in veins is less pronounced than arteries with 
dilatation recorded between 1 to 7%.
15, 314
 The underlying mechanism is thought to be due to a 
response called functional hyperemia; an increase of blood flow as the neuron gets activated.
319
 
This hyperemic response is also known as neurovascular coupling. In brief, glutamate that is 
released from the synapse activates N-methyl-D-aspartate receptors in neurons and metabotropic 
receptors in astrocytes. The activations lead to accumulation of intercellular calcium ion, 
activating an arachidonic acid pathway that is associated with vasodilator synthesis.
290, 319
 In 
addition, the NO in neurons also contribute to this hyperemic response.
1, 320
 
Vasodilation by flicker stimulation was shown to be reduced in glaucoma.
321-323
 Garhofer and co-
workers
321
 using square wave light of different temporal frequencies investigated vasodilation in 
early POAG and healthy controls using RVA. They observed a significantly smaller flicker-
induced vasodilation in retinal veins of POAG patients compared to the controls. Observation on 
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the dynamics of change under three 20 seconds flicker stimulations with a break of 80seconds in 
between revealed a delayed response in POAG and OHT groups compared to healthy controls.
323
 
1.13.5 Reactivity in response to cold stress test 
The hypothesis of ANS dysregulation association with glaucoma has been tested by using the 
cold stress test. The test involves cold stimulation of the hand by immersing in cold water (0 to 
15° Celsius) to invoke sympathetic system, while measuring the ocular haemodynamics. Other 
variations may include immersion of the upper limb in warm water of 40 degrees following by 
cooling,
324, 325
, wearing a head-vest cooling garment
145
 and by blowing cold air to the nailfold 
area (in nailfold capillaroscopy)
225
. The response from the cooling includes vasoconstriction of 
the arteriolar vessels, elevated BP, and reduction in peripheral blood flow.  
An eye with intact autoregulation will not have blood flow changes upon cold provocation on the 
upper limbs. Gherghel and associates
301
 reported a reduced temporal neuroretinal rim blood 
velocity after 1 minute of cold provocation in POAG patients, compared to the healthy controls 
which did not show any significant changes. The regulatory mechanism responsible to regulate 
blood flow during cold-provocation is not clear. However, plasma ET-1 level has been reported 
to increase among POAG patients after cold provocation test.
145
 It was speculated that an 
increased level of plasma ET-1 in response to cold provocation may be involved in glaucoma 
pathology.  
62 
 
1.14 Conclusions 
The retinal and ONH blood flow anatomy is well documented, although blood flow 
quantification on these structures is far from being perfect. Various methods have been utilized 
to measure aspects of haemodynamics in POAG with conflicting results, however, most of the 
studies indicated ocular haemodynamic reductions. 
Among many methods developed to study haemodynamics, the BLDV-SVD and the prototype 
Doppler SD-OCT are the only instruments, to the best of our knowledge, which enable blood 
flow measurement in real units. The BLDV-SVD produces a flow value immediately after a 
scan, although it only allows measurement for one specific site on a given vessel at a time. The 
prototype Doppler SD-OCT enables total retinal blood flow from all visible venules that traverse 
through the ONH at one scan, although tedious post-scan analyses is required to produce flow 
values. Regardless, both instruments are suitable to study POAG, a disease that affects the ONH 
and retinal blood vessels. Previous published studies using BLDV-SVD indicated reduced 
vascular reactivity in POAG, while retinal reactivity using the prototype Doppler SD-OCT has 
not been studied as yet.  
Pressure variables such as IOP, BP, and OPP are observed to follow circadian rhythms. IOP is at 
its peak during night time while BP normally reduces at the same time. These concomitant 
events in turn result in a decreased OPP which at extreme levels may lead to damaging effects, 
especially in patients with glaucoma. This has led to a thought that patients with glaucoma are 
most vulnerable at night, particularly in patients with extreme NBPR. A few studies have 
indicated that POAG patients with extreme NBPR progress faster than patients with normal or 
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low NBPR. An extreme nocturnal hypotension is thought to represent a vascular dysregulation 
that may be relevant to glaucoma. This hypothesis, however, has never been tested. A study 
examining the retinal vascular reactivity is thus warranted on POAG patients with extreme 
nocturnal hypotension. 
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2 Rationale and hypothesis 
Vascular dysregulation has been associated with glaucomatous optic neuropathy (GON). 
Reduced retinal vascular reactivity to various provocations has been linked to failure of vascular 
regulation in primary open angle glaucoma (POAG). Systemic hypotension has also been 
associated with POAG, and patients with extreme nocturnal hypotension have been shown to 
progress more than those with normal nocturnal blood pressure reduction (NBPR) and reduced 
NBPR status.
1, 2
 Reduced blood velocity in the retrobulbar vessels have been reported in POAG 
patients with high NBPR
3
 but no study, to the best of our knowledge, has yet examined the 
retinal blood flow, or the retinal vascular reactivity response in POAG patients with differing 
nocturnal blood pressure (NBP) characteristics. 
The global aim of this work was to evaluate retinal blood flow, and retinal vascular reactivity in 
POAG patients of differing NBP characteristics using a standardized and stable hypercapnic 
stimulus. A prototypeDoppler spectral domain optical coherence tomography (SD-OCT) and the 
bi-directional laser Doppler velocimetry with simultaneous vessel densitometry (BLDV-SVD) 
methodology were utilized to measure the retinal haemodynamics, while a standardized 
hypercapnic stimulus was achieved using a sequential gas delivery (SGD) breathing circuit and 
prospective gas targeting system, the RespirAct™. Using normoxic hypercapnia, the retinal 
vessels were stimulated to dilate, and the magnitude of retinal vascular reactivity was measured. 
It was anticipated that the study of vascular reactivity in POAG patients with differing NBP 
status would reveal a better understanding to the pathophysiology of glaucoma.  
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Considering the recent application of Doppler phenomenon into the SD-OCT methodology to 
study retinal haemodynamics, in particular the prototype circum-papillary double circular blood 
flow scan protocol, there is no normative data from a sufficient sample size study available in the 
literature (e.g. Wang et al.
4-6
 ). Thus, the first objective in this research project was to investigate 
the haemodynamics in healthy eyes as being assessed by the prototype Doppler SD-OCT 
(Chapter 3). Healthy participants of different ages, with an equal number of males and females, 
were recruited to define the retinal blood flow normative value as measured by the Doppler SD-
OCT. After consideration of intraocular pressure (IOP), age is established strong risk factor for 
developing glaucoma,
7, 8
 however, only a fraction of the elderly population develop the disease. 
Changes in haemodynamics are thought to be gradual, which in turn predispose the eye to 
dysfunction but does not necessarily result in disease. It is not clear how retinal haemodynamics 
change with age, thus this thesis was also aimed to examine the interaction between retinal 
haemodynamics with aging (Chapter 3). It was hypothesized that there was no difference in the 
haemodynamics of healthy participants following an increase age. 
As mentioned earlier, POAG patients with marked drop in their NBP were reported to progress 
more than POAGs with normal and low NBPR.
1, 2
 This subset of POAG patients were also 
reported to have reduced velocity in the retrobulbar vessels.
3
 It was suggested that extreme 
NBPR may be a manifestation of systemic vascular  dysregulation and may be relevant to 
vascular regulation in the POAG ocular vasculature.
3
 To the best of our knowledge, there is no 
study that has yet, examined the retinal vasculature and its association to the NBPR. Using both 
BLDV-SVD and Doppler SD-OCT, retinal haemodynamics can be measured in POAG cohorts 
with differing NBP characteristics. Therefore, this thesis also aimed to elucidate the relationship 
between the retinal haemodynamics and the NBPR in patients with POAG (Chapter 4). In 
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addition, it was also aimed to determine the relationship between the magnitude of NBPR and 
retinal vascular reactivity using normoxic hypercapnic provocation in subjects with POAG 
(Chapter 6). It was hypothesized that POAG patients with extreme NBPR have compromised 
vascular function and a reduced retinal vascular reactivity compared to the healthy controls. 
Glaucoma progresses by altering vision and the optic nerve head (ONH) structure. Standard 
automated perimetry (SAP) retinal sensitivity values and retinal nerve fiber layer (RNFL) 
thickness are lower in glaucoma compared to healthy eyes. While it is clear that severe glaucoma 
results in worse vision and thinner RNFL,
9
 the associations between ONH structures, visual field 
indices, and retinal haemodynamics is currently uncertain. Previous haemodynamic studies using 
different technologies to assess retinal blood flow produced mix reports on the associations.
10-20
 
Histological studies and fundus photography, however, have shown an association between 
retinal vessels attenuation and structural loss in glaucoma which could be independent of IOP.
21, 
22
 Thus, it is interesting to investigate the relationship between retinal haemodynamics, RNFL 
thickness and visual field status in POAG patients (Chapter 5). The hypothesis was 
haemodynamics parameters are associated with neural structure and visual field status in 
susceptible glaucomatous eyes. It was expected that these parameters have a positive correlation, 
where reduced haemodynamics will be evident in thinner RNFL and worse visual field.  
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2.1 Methodology rationale 
2.1.1 Doppler measurement methodologies 
Studies using the established BLDV-SVD have showed that selected POAG patients have 
dysfunctional retinal haemodynamics, including reduced blood flow and retinal vascular 
reactivity to hypercapnia.
17, 23
 A pilot study using the prototype Doppler SD-OCT also showed 
reduction in retinal blood flow in POAG with small samples of patients.
4
 Both BLDV–SVD and 
Doppler SD-OCT measure absolute retinal blood flow but using completely different 
methodologies. The BLDV-SVD measures blood flow of a single retinal arteriole, while the 
prototype Doppler SD-OCT measures blood flow by adding flow from multiple venules around 
the ONH. It is informative to study retinal haemodynamics by analyzing the blood flow signal 
from a selected retinal point, as measured by the BLDV-SVD method, and the signal of a 
relatively global nature as measured by the prototype Doppler SD-OCT. In addition, there is a 
need to test the newer Doppler SD-OCT method to establish normative values in a healthy 
population, and also to investigate disease conditions in particular the POAG. Comparing data 
from these two methodologies may give a better understanding of glaucoma. 
2.1.2 Provocation stimulus 
Hypercapnia was chosen over hyperoxic stimulus to assess retinal vascular reactivity. A 
hyperoxic stimulus may be damaging to a compromised vascular bed such that in POAG 
patients. Vasoconstriction secondary to hyperoxia reduces blood flow and may further aggravate 
the glaucomatous disease process. It may not be ethically correct to use a provocation that 
similarly promotes vasoconstriction and could potentially cause harm on patients. Whereas 
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hypercapnia induces vasodilation, hence an increase in blood flow and thus is likely to be a safe 
stimulus to study vascular reactivity in POAG.  
Blood vessels in compromised vascular beds such as in POAG may already be constricted 
compared to the normal eye. Using hyperoxia to constrict the retinal blood vessels may not cause 
substantial further vasoconstriction, and in turn this may reduce the signal-to-noise ratio of an 
effect that we wish to investigate. 
2.1.3 Blood gas manipulation 
The magnitude of hypercapnia required to produce extreme vasodilation of the retinal arterioles 
was achieved using the SGD breathing circuit and the prospective gas targeting system to 
produce an increase in carbon dioxide end-tidal partial pressure (PETCO2) of 15% relative to 
baseline (i.e. approximately 6mmHg increase in PETCO2). The system we used to manipulate the 
blood gas manages to control the level of desired oxygen end-tidal partial pressure (PETO2) and 
PETCO2 at precision. It has been demonstrated that using this gas sequencer (RespirAct
TM
, 
Thornhill Research Inc., Toronto, Canada) together with SGD breathing circuit, the PETCO2 is 
correlated with arterial partial pressure (Pa) of CO2.
24, 25
 The sequential rebreathing circuit is a 
mask with a clamping ability to maintain normoxia/normocapnia irrespective to minute 
ventilation changes. RespirAct
TM
 uses metabolic O2 and CO2 consumptions, resting PET and 
target PET data which has been pre-programmed in the software to determine the precise 
concentration of gas to be used to achieve desired stimulus.  
Unlike most other vision research labs to date, we have utilized a novel technology that 
optimally stimulates vascular reactivity at much lower levels of PETCO2 which in turn results in 
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minimal change in pulse rate, blood pressure, and PETO2, and far greater comfort and 
sustainability for research participants. For example, many groups have used carbogen (gas 
mixture containing 4 to 7% CO2 and 93 to 96 % O2
26
) to induce vasodilation which would result 
in a highly variable increase of PaCO2. Gas provocation studies in other labs may also have 
achieved PETCO2 by patient rebreathing his exhaled gases
27
 or by adding CO2 manually to the 
breathing air.
28, 29
 Such techniques may trigger  concomitant change in the PETO2, thus response 
in vascular reactivity may not purely from the PETCO2 increase. 
2.2 Summary 
In summary, extreme NBPR has been associated with POAG patients. Literature indicates that 
POAG patients with extreme NBPR progress more and may have reduced ocular blood flow. 
Evidence concerning the effect of NBPR on retinal haemodynamics is still lacking, hence this 
thesis was aimed to investigate any difference in vascular reactivity in POAG as a function of the 
magnitude of reduction in NBP and in normal healthy controls. The established BLDV-SVD 
method, together with the prototype Doppler SD-OCT were used to measure retinal blood flow 
in absolute units. The SGD breathing circuit together with prospective gas targeting system were 
used to achieve precise PETCO2 and PETO2 levels in inducing normoxic hypercapnia. 
Hypercapnia was chosen as provocative stimulus to study the retinal vascular reactivity 
considering it is safer than hyperoxic stimulus which may aggravate glaucomatous disease 
process by means of constricting the blood vessels and reducing retinal blood flow. The concern 
about inducing vasoconstriction in a disease with vasoconstrictive component is not widely 
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discussed but it was a major issue for the research ethics committees that approved this study and 
for the glaucoma specialists involved in this study. 
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3 The Influence of Age on Doppler Spectral-Domain Optical 
Coherence Tomography Derived Retinal Blood Flow 
 
 
 Concept/Design Recruitment Acquisition 
of data 
Analysis Write-up 
Yusof, F X X X X X 
Hudson, C X   X X 
Tayyari, F X X X X  
Vymyslicky, 
M 
  X   
Huang, D X     
Tan, O X     
Flanagan, JG X    X 
Table detailing role of each person (X denotes significant contribution). 
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Purpose: The aim of the study was to evaluate the association between age and retinal 
haemodynamics, as derived by a prototype Doppler spectral-domain optical coherence 
tomography (SD-OCT) system. 
Methods: A total of 100 healthy participants were recruited (48 males), divided into 5 age 
groups of 20 participants each; 18-29 years (25.1±2.6 years, 10 males,), 30-39 years (33.0±2.6 
years, 10 males,), 40-49 years (44.2±3.0 years, 10 males), 50-59 years (55.7±3.1 years, 9 males), 
and above 60 years of age (64.2±3.0 years, 9 males). One eye of each subject was randomly 
selected and dilated. A prototype system based upon the RTVue instrument (Optovue Inc., 
Freemont, CA, USA) was used to measure the retinal haemodynamics, including the parameters 
total retinal blood flow (TRBF), venous area, and velocity. The circum-papillary double circular 
scan protocol was employed and all measurements were centered on the optic nerve head 
(ONH). The flow was calculated using data from valid scans, by summing flow from all 
detectable venules, using Doppler OCT of Retinal Circulation (DOCTORC) software version 
2.1.1.4 (Centre for Ophthalmic Optics and Lasers, CA, USA). Pearson correlation analysis was 
employed to find relationship between the retinal haemodynamics with age, and sex. One-way 
ANOVA was employed to compare values between groups.  
Results: 85.96% of the images taken were deemed valid for the flow calculation. Mean TRBF 
was 43.84±10.47µL/min, while superior and inferior quadrant retinal blood flows were 
22.30±6.49µL/min and 21.35±7.28µL/min, respectively. The venous area and blood velocity 
were 43.83±8.70(x10
-3
) mm
2
, and 14.64±3.01mm/s, respectively. One-way ANOVA showed no 
significant difference in the TRBF between age groups (p=0.30), between superior and inferior 
quadrant (p=0.33), and between the sexes (p=0.30). Correlation analysis showed no significant 
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association between age and; TRBF (r=0.06, p=0.96), venous area (r=-0.08, p=0.426) or velocity 
(r=0.09, p=0.38), indicating that retinal haemodynamics were independent of age, and sex. 
Conclusions: The perfusion to the inner retina is not altered with increasing age, indicating that 
retinal perfusion in healthy eyes is maintained at an overall constant level despite aging. 
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3.1 Introduction 
The impact of aging on the eye, in particular on the retinal vasculature, is important to 
understand age-associated ocular disease. It is well established that aging is a risk factor for 
ocular diseases such as macula degeneration, glaucoma, diabetic retinopathy.
1, 2
 The prevalence 
of people with glaucoma increases 10 fold from 0.7% among the 40-49 year olds, to 7.7% among 
those aged 80 years or over.
3
 Muraoka and associates,
4
 found that the retinal vessel wall 
thickness were highly correlated with advancing age where the elderly had thicker vessel walls 
and consequently smaller lumen diameters, suggesting an increase in vascular resistance. 
However, aging is a physiological process that may, or may not lead to disease. Only a small 
percentage of the elderly develop ocular disease, demonstrating that aging changes vary on an 
individual basis.
1
 The precise connection, if any, between a given age-induced change and the 
onset of disease remains uncertain.
5
 Changes such as in haemodynamics and vascular reactivity 
are gradual, which in turn predispose the eye to disease, but do not necessarily result in disease. 
The influence of sex on retinal haemodynamics is not well explored in the literature. Harris and 
co-workers
5
 measured the retrobulbar perfusion using the colour Doppler imaging (CDI) 
technique and found a significant reduction among women compared to men in the ophthalmic 
artery end diastolic velocity, but not in the central retinal artery. In a different study using laser 
Doppler flowmetry (LDF), choroidal flow was reported to be lower among elderly women.
6
 
Hormonal differences in ocular blood flow are thought to cause the disparity between men and 
women.  
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Several methods have been developed to study retinal haemodynamics using Doppler imaging 
techniques, with each having its own advantages and limitations. The Doppler colour ultrasound 
imaging is limited to measure velocity in large retrobulbar vessels.
7
 It lacks the ability to 
measure diameter, hence quantification of the blood flow is unattainable.
8
 Laser Doppler 
velocimetry (LDV) enables volumetric measurements,
9
 but is limited to one vessel of a certain 
size. In addition, to measure total retinal blood flow, all vessels need to be imaged separately and 
values are later be summed. LDF permits continuous perfusion measurements, but is limited to 
sampling a small tissue volume.
10
 The technique also gives values in arbitrary units. Bi-
directional LDV with simultaneous vessel densitometry (BLDV-SVD) in the Canon Laser Blood 
Flowmeter (CLBF) enables an absolute measurement of retinal blood flow, but permits only 
measurement of one specific vessel site at a time.
11
 Recently, a prototype Doppler spectral 
domain optical coherence tomography (SD-OCT) has emerged as a tool capable of evaluating 
retinal haemodynamics in absolute units.
8
 
The prototype Doppler SD-OCT allows safe, fast, and non-invasive quantitative volumetric 
measurement of retinal blood flow.
12
 Wang and associates
13, 14
 have developed a double circular 
scan pattern that measures the total retinal blood flow. The laser scan pattern is centred on the 
ONH and enables measurement of all blood vessels around the optic nerve head (ONH). This 
prototype Doppler imaging technique was reported to be repeatable with coefficient of variation 
(COV) of 10.9% in healthy group and 14.3% in diseased group.
8
 The overall intra-class 
coefficient of variation (ICC) was 0.85. Our group recently found that the COV for younger 
subjects were at median of 7.5% and elderly at median 9.8% (Tayyari et al., in press). The aim of 
this current study was to investigate any association between age, sex and retinal 
haemodynamics, as derived by a prototype Doppler SD-OCT system. 
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3.2 Methods 
3.2.1 Participants  
An initial 107 healthy, medication-free, non-smoking participants were randomly recruited. 
However, 7 participants failed to complete the study. Written consent was obtained prior to data 
collection. All participants met the following inclusion criteria; log MAR visual acuity of 0.3 or 
better, refractive error within ±6.00DS and/or ±2.00DC, normal 24-2 Humphrey Field Analyzer 
(HFA) automated static perimetry, intraocular pressure (IOP) of ≤ 21 mmHg, no media opacities, 
no history of ocular disease or ocular surgery (with the exception of uneventful cataract surgery), 
no endocrine disease or uncontrolled systemic hypertension, and no history of central nervous 
system disorders. All participants were asked not to consume any caffeinated beverages and/or 
meals containing red meat 4 hours prior to the study as caffeine constricts ocular vessels,
15-17
 
while red meat has been reported to have a vasodilatory effect.
18
 The study was approved by the 
Office of Research Ethics, University of Waterloo, Canada, and follows the tenets in the 
Declaration of Helsinki. 
The sample size calculation used the mean r value of 4 prior studies 
38, 39, 42, 43
. R was estimated 
at -0.30. The number of participants required to reach this r value and to be significant (using a 
power of 90% and a p of 0.05) was calculated to be 92. Based upon prior studies, it was felt that 
the age range of 20 to 70 years of age would be adequate to investigate the effect of blood flow 
with age.  
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3.2.2 Doppler SD-OCT  
A prototype Doppler SD-OCT system was incorporated into the Optovue RTvue OCT (Optovue 
Inc, Freemont, CA, USA), which uses an 841nm infrared light source, with an axial resolution of 
5.4µm in tissue, a transverse resolution of 20µm, and power incident on the eye of 750µW.
8, 14, 19
 
A circum-papillary double circular scan pattern with concentric radii (inner and outer diameters 
measured 3.4 and 3.75mm respectively) was used and centred on the ONH.
20, 21
 The concentric 
scans transect all retinal arterioles and venules around the ONH in two locations (Figure 3.1C).
19
 
In a single blood flow scan, six dual circular frames were acquired consecutively over 2 seconds, 
and then were averaged.
21
 
The principle of the Doppler effect and its application has been described in detail in Chapter 1 
(section 1.11.6.1). Reflected light from a moving particle, such as blood, undergoes a shift in its 
frequency (Doppler shift, Δ  ), relative to the wave frequency prior to reflection (or relative to a 
non-moving structure such as the vessel wall). The shift is proportional to the velocity 
component as given by the formula: 
   
        
  
        Equation 3.1  
where   is the blood velocity,   is the refractive index of the medium, α is the Doppler angle 
(between scanning beam and the flow direction which is dependent upon the position that a 
given retinal blood vessel transects the inner and outer rings of the scan), and λ0 is the center 
wavelength of the beam. The Δ   introduces a phase shift in the interference pattern which is 
captured by the OCT camera. The shifting interference pattern between sequential axial scans is 
78 
 
then Fourier transformed to calculate the Δ  . Rearranging Equation 3.1, the velocity of a 
moving blood can be calculated by: 
  
      
          
        Equation 3.2 
Subsequently, retinal blood flow is calculated by multiplying velocity to the vessel lumen area 
value, a factor determined by vessel diameter.
13
 
3.2.3 Retinal haemodynamics analysis using the semi-automated Doppler OCT of Retinal 
Circulation (DOCTORC) software 
Semi-automated Doppler OCT of retinal circulation (DOCTORC) software version 2.1.1.4 
(Centre for Ophthalmic Optics and Lasers, CA, USA) was used for the retinal blood flow 
calculation. Doppler scans were automatically-processed to identify vessel type, location and the 
strength of the Doppler signal. The Doppler scans were registered using a color fundus image, 
the infrared scanning laser ophthalmoscope image (Figure 3.1A), and the OCT projection image. 
Deletion of vessels with extraneous influences and the addition of missing vessels were then 
performed manually. Vessel classification (arteriole or venule) was reviewed based on the colour 
fundus image. Each vessel was manually defined, as necessary, for location and diameter 
boundary using the Doppler B-scan images. Confidence scores were assigned for each scan 
(maximum of 5, minimum of zero), judged from their Doppler strength, distinctiveness of vessel 
boundary, size agreement between the outer and inner ring, and Doppler signal sign agreement 
between the outer and inner ring (Figure 3.1C). DOCTORC automatically computes the retinal 
haemodynamics giving values for total retinal blood flow (TRBF), venous area, and venous 
velocity. TRBF was calculated by summing all flow from valid venules and the estimated flow 
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of invalid venules. Velocity was computed by dividing flow in each valid venule by the cross 
sectional area of all valid venules.
20
 
 
Figure 3.1: A) Scanning laser ophthalmoscope (SLO) image during the Doppler imaging, with the double para-
papillary circular scan centered on the ONH. B) A still image of the real-time video of the ONH during the Doppler 
imaging, with the OCT beam positioned at the superonasal pupil location. C) A print-screen of the DOCTORC 
software during the analysis of one of the vessels, the top strip shows the vessels transected by the outer circular 
ring scan, and bottom strip for the inner circular ring scan. The smaller ONH image on the right shows the double 
circular scan transecting the retina in two different locations. The vessels were manually refined for their location, 
boundary and type (artery or vein). All these attributes, together with the Doppler signal strength and Doppler 
signal agreement were given a confidence score, following the guidelines in the DOCTORC grading protocol. 
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3.2.4 Procedures 
Refraction, logMAR visual acuity, HFA automated static perimetry, Goldmann applanation 
tonometry, van Herick assessment of the anterior angle depth, and resting blood pressure 
measurement were determined for each volunteer. The HFA Analyzer (Carl Zeiss Meditec, Inc., 
Dublin, CA), SITA-standard 24–2 threshold test was used. Only subjects with <30% fixation 
losses, false positive and false negative responses, within normal limit glaucoma hemifield test 
(GHT) indices, and <5% pattern standard deviation (PSD) values were allowed into the study. 
One eye was randomly selected and dilated using 0.5% tropicamide (Alcon, Mississauga, 
Canada). Participants were then seated and rested for 10 minutes to stabilize baseline 
cardiovascular parameters. The circum-papillary double circular scan protocol was employed, 
and image acquisition was centered on the ONH. An average of 12 scans were acquired using 
two different beam alignments. Six scans were made with the beam passing through the 
superonasal pupil edge, and another 6 were made through the inferonasal pupil edge. Color 
fundus images and high definition 3D disc OCT scan images were also taken to aid blood flow 
grading. Three retinal nerve fiber layer (RNFL) thickness measurements were taken using RNFL 
scan protocol in the RTVue, and values were averaged. Systemic blood pressure (BP) was 
measured on the left arm, before and after Doppler imaging. Systemic mean arterial pressure 
(MAP) was calculated using the formula:
22-24
 
                
 
 
                            Equation 3.3 
The ocular perfusion pressure (OPP) was calculated using the formula:
22, 25
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                        Equation 3.4 
The Doppler scans were then extracted to be processed using DOCTORC. 
3.2.5 Statistical analysis 
All data were presented in mean ± standard deviation. Normality of data was tested using Wilk-
Shapiro test. One-way analysis of variance (ANOVA) was employed to compare retinal 
haemodynamics values between groups, and comparison between males and females. The Tukey 
post-hoc analysis was employed to check for intragroup significance because it is generally 
regarded as not being overly conservative. To test for interaction between parameters, the 
Pearson product-moment correlation was used. The significance level was set at p<0.05. All 
statistical analyses were employed using STATISTICA (StatSoft Inc., Tulsa, OK, USA) version 
11.0.  
3.3 Results 
3.3.1 Demographic data 
Analysis included data from 100 eyes, from 100 healthy participants. Table 3.1 shows the 
demographics of all participants. The mean age for each decade group was 25.10±2.64, 
33.01±3.16, 44.24±2.69, 55.71±3.06, and 64.24±3.02 years. No significant differences were 
recorded between the groups for IOP, MAP, and OPP. Although BP showed incremental change 
past the fourth decade, only diastolic BP showed a significant difference (p=0.02). However, 
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Tukey post-hoc analysis revealed no significant difference between groups, with only the 20-29 
years versus 40-49 years group comparison achieving near significance (p=0.052, Figure 3.2). 
OPP values were not different across the age groups. The mean and the superior RNFL thickness 
were not significantly different across groups. The inferior RNFL thickness showed a significant 
difference across the groups (p=0.022) but intraclass analysis showed no significance (Figure 
3.3).  
 
Figure 3.2: One-way ANOVA showed a significant difference in the diastolic pressure between the age groups 
(p=0.022). The Tukey post-hoc analysis however revealed no intergroup differences. Only the 20-29 vs 40-49 age 
group showed a nearly significant value (p = 0.052).  
p = 0.052 
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Figure 3.3: One-way ANOVA showed significant difference in the inferior retinal nerve fiber layer (RNFL) thickness 
between the age groups (p=0.022). Tukey post-hoc analysis however revealed no intergroup differences, with the 
40-49 vs 50-59 age group showed p = 0.079. 
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Age group 
(Years) 
20 -29 30-39 40-49 50-59 Above 60 p 
Number 20 20 20 20 20  
Male : Female 10:10 10:10 10:10 9:11 9:11  
Systolic BP 
(mmHg) 
123.85±15.50 123.70±17.30 128.45±17.54 127.20±15.99 131.14±13.95 0.547 
Diastolic BP 
(mmHg) 
72.20±6.69 75.30±9.67 80.30±11.12 80.20±10.21 79.37±7.97 0.022 
IOP (mmHg) 13.80±3.16 15.07±2.58 13.37±2.91 14.18±2.81 14.28±1.84 0.364 
MAP (mmHg) 89.42±8.20 91.43±12.00 96.35±12.08 95.87±11.42 96.63±7.89 0.104 
OPP (mmHg) 47.01±6.41 45.79±8.23 50.46±8.67 49.73±8.26 50.12±5.31 0.193 
Mean RNFL 
(µm) 
101.85 8.65 99.88 7.25 102.55 6.79 96.86 10.09 97.33 9.75 0.138 
Superior 
RNFL (µm) 
100.88 10.66 97.10 9.77 102.17 7.42 97.84 11.31 97.20 10.61 0.372 
Inferior 
RNFL (µm)  
101.49 7.67 102.21 7.59 102.95 8.14 95.69 10.47 96.43 9.84 0.022 
 
Table 3.1:  Demographics including blood pressure (BP), intraocular pressure (IOP), mean arterial pressure 
(MAP), ocular perfusion pressure (OPP), mean retinal nerve fiber layer (RNFL) thickness, superior RNFL 
thickness, and inferior RNFL thickness of all participants, by age group.  
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3.3.2 Interaction between age and demographic data 
Pearson correlation analysis showed weak significant correlation between age and; diastolic BP 
(r=0.31, p=0.002; Figure 3.4), MAP (r=0.28, p=0.004; Figure 3.5), OPP (r=0.24, p=0.014; Figure 
3.6), mean RNFL thickness (r=-0.23, p=0.19; Figure 3.7), and inferior RNFL thickness (r=-0.31, 
p<0.001; Figure 3.7). Systolic BP showed a tendency to increase with age (r=0.192, p=0.056). 
IOP and superior RNFL thickness showed no relationship with age (r=-0.04, p=0.669; r=-0.12, 
p=0.230).  
 
 
Figure 3.4: Scatterplot of diastolic blood pressure (BP) against age showing weak positive relationship (r=0.31, 
p=0.02). 
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Figure 3.5 Scatterplot of mean arterial pressure (MAP) against age showing weak positive relationship (r=0.28, 
p=0.004). 
 
Figure 3.6 Scatterplot of ocular perfusion pressure (OPP) against age showing weak positive relationship (r=0.24, 
p=0.014). 
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Figure 3.7: Scatterplot of retinal nerve fiber layer (RNFL) thicknesses against age. Mean RNFL thickness and 
inferior RNFL thickness showed weak correlation against age (r=-0.23 and r=-0.31, respectively). Superior RNFL 
thickness does not correlate with age. 
 
3.3.3 Retinal haemodynamics  
Table 3.2 shows the retinal blood flow parameters (mean ± standard deviation) based on age 
group. The average TRBF for all participants was 43.83±10.47µL/min. One-way ANOVA 
showed no significant difference in the TRBF between the age groups (p=0.693). Average 
venous area and velocity were 49.89±8.70(x10
-3
)mm
2
 and 14.64±3.01mm/s, respectively, and 
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both showed no significant differences across the age groups (p=0.664 and p=0.679, 
respectively).  
 
Age group (years) Total Retinal Blood  
Flow (µL/min) 
Venous Area  
(mm
2
) 
Velocity  
(mm/s) 
20 -29 45.52±8.12 49.95±9.68(x10
-3
) 14.31±2.16 
30-39 43.04±10.55 50.22±9.40(x10
-3
) 13.90±2.75 
40-49 46.79±11.73 51.90±10.06(x10
-3
) 15.12±3.13 
50-59 44.17±9.05 49.75±6.62(x10
-3
) 15.00±3.48 
Above 60 42.65±12.91 47.63±7.81(x10
-3
) 14.88±3.52 
Average value 43.83±10.47 49.89±8.70 (x10
-3
) 14.64±3.01 
 
Table 3.2: Retinal haemodynamics of all participants as a function of age group. The whole group average value for 
each parameter is noted in the bottom row. All parameters were not significantly different across age groups. 
 
3.3.4 Interaction between retinal haemodynamics and age 
Correlation analysis between TRBF and age showed no interaction (r=0.02, p=0.95; Figure 3.8). 
Venous area and venous velocity also showed no relationship against age (r=-0.08 and r=0.09, 
respectively).  
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Figure 3.8: Scatterplot of total retinal blood flow against age showing no relationship (r=0.02)  
 
3.3.5 Interaction between sex and retinal haemodynamics 
Descriptive data segregated by sexare shown in Table 3.3. Fifty two females and 48 males were 
included in this analysis. The mean age for females was 45.39±14.73 years, and for males was 
43.46±14.70 years (p=0.513). There was no significant difference in BP between males and 
females (systolic BP p=0.415, diastolic BP p=0.73). IOP was higher in males with values at 
14.82±2.70mmHg compared to 13.51±2.57mmHg in females (p=0.015). No significant 
difference was found for all retinal haemodynamics. Figure 3.9 shows the box plot for TRBF as a 
function of sex. 
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Correlation analysis was conducted separately for each sex to analyze the relationship between 
retinal haemodynamics and age (Table 3.4). Only velocity in the male group was found to weak 
tendency for a relationship with age (r=0.28; p=0.052, Figure 3.10). 
 
 Female Male p 
Number 52 48  
Age (years) 45.39±14.73 43.46±14.70 0.513 
IOP (mmHg) 13.51±2.57 14.82±2.70 0.015 
Systolic BP (mmHg) 125.60±17.52 128.24±14.30 0.415 
Diastolic BP (mmHg) 77.15±10.61 77.82±8.55 0.730 
TRBF (µL/min) 44.88±10.72 42.70±14.70 0.303 
Venous area (mm
2
) 49.82±7.31(x10
-3
) 49.97±1.01(x10
-3
) 0.934 
Velocity (mm/s) 14.99±2.64 14.26±3.38 0.231 
 
Table 3.3: One way analysis of variance results between sexes. [IOP = intraocular pressure; BP = blood pressure; 
TRBF = total retinal blood flow] 
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Figure 3.9: Box plot of the total retinal blood flow, segregated according to sex. One-way ANOVA revealed no 
significant difference between the gender groups (p=0.33).  
 
 
Age vs. 
Male Female 
r p r p 
Total Retinal 
Blood Flow 
(µL/min) 
0.15 0.301 -0.14 0.334 
Venous Area 
(mm
2
) 
-0.10 0.520 -0.06 0.655 
Velocity (mm/s) 0.28 0.052 -0.15 0.283 
 
Table 3.4: Pearson product-moment correlation coefficient (r) and significance value (p) separately for each sex, 
for correlation analysis between retinal haemodynamics and age. 
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Figure 3.10: Scatterplot of velocity in male group against age. Pearson product-moment correlation coefficient 
shows a weak positive trend with age (r=0.28, p=0.052).  
 
3.4 Discussion 
The current work evaluated the effect of aging on retinal haemodynamics as measured by a 
prototype Doppler SD-OCT which enables the quantification of absolute retinal blood flow, 
along with venous area, and blood velocity. Flow measurement was performed by summing the 
flow from all venules that were transected by the circum-papillary double circular scan pattern. 
This flow value may be considered as the total inner retinal perfusion measurement, a novel 
value that has not been measured previously. Wang and co-workers
14
 argued that the total 
venous flow can be taken as the total retinal flow considering the retina has a closed circulatory 
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system. The Doppler SD-OCT is also unique as it allows rapid, simultaneous measurement of 
blood velocity and vessel size in multiple vessels.  
In this study, the average TRBF was 43.8±10.5µL/min, similar to previous reports.
14, 19
 Wang 
and co-workers
14
 have reported the mean TRBF of 8 healthy participants of 45.6±3.8µL/min. 
Wang and co-workers
19 
repeated their measurements on an additional 20 healthy participants and 
reported a mean value of 47.6±5.4µL/min. The standard deviation reported in this study was 
higher than those by Wang and co-workers’ but this study’s sample age range was larger than 
theirs. The venous area and velocity reported in this study were also in the range of previous 
reports, that is venous area of 50±9(x10
-3
)mm
2 
versus 46±8(x10
-3
)mm
2
 and velocity of 
14.6±3.0mm/s versus 17.7±3.1mm/s, respectively.
19
 Using swept source Fourier domain OCT, 
Baumann and co-workers
26
 reported the retinal arterial total flow of 49.15±2.46µL/min. Choi 
and co-workers
27
 used a prototype Fourier domain OCT reported total retinal arterial flow of 
43.2µL/min, while Dai and co-workers
28
 recently reported total retinal venous flow of 
49.19µL/min. The values they reported are in agreement with values in this study. There were 
studies using LDV that investigated the total retinal blood flow among healthy eyes. As LDV can 
only measure one vessel per time, individual vessel blood flow was summed to derive the total 
perfusion value. Riva and co-workers
29
 reported the total retinal flow of 33µL/min while 
Garhofer and co-workers
30
 reported value of 44µL/min. A few groups also have reported mean 
values in the range of 65 to 80µL/min.
31-33
 The large discrepancy between these LDV reports 
may be due to the variability induced by a single vessel flow measurement. In the LDV studies, 
vessels were measured at locations which may have variable diameter and hence result in 
aberrant projected TRBF estimations. Also, multiple measurements over period of time to derive 
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the total flow, may suffer with bias stemming from changes that may occur during the 
measurement duration such as cardiac output or hormone level. 
This current study did not observe changes in the retinal haemodynamics following age. This is 
in agreement with the work reported by Nagaoka and associates.
34
 Using LDV with the 
simultaneous vessel densitometry technique, they compared 3 groups of young, middle-aged and 
elderly males. None of the hemodynamic parameters showed significant differences across the 
three groups. Their findings can be considered as the closest comparison to our study as the LDV 
technique measures the same vasculature in a single scan. The major disparity is that they 
measured only one major arteriole to generate all three hemodynamic parameters, whereas 
values in this current study were from many venules around the ONH. Nevertheless, the 
similarity of the Doppler calculated parameters and their relationship to aging was comparable. 
Yoshida and co-workers
32
 studied 2 healthy groups; younger aged 25-38 years and older aged 
54-58 years. They used the LDV without simultaneous diameter measurement and also found no 
significant difference in flow with age. It is interesting that we saw positive weak relationships in 
BP, MAP and OPP with age, but not in IOP and retinal haemodynamics. However, consideration 
needs to be given to the fact that the correlation coefficients for MAP and OPP were relatively 
weak and neither of these 2 factors were found to be significant for the ANOVA. The findings 
suggest that healthy eyes are regulated to maintain a constant blood flow in the inner retinal 
circulation, despite change in the OPP. 
Other groups have investigated retrobulbar flow,
5, 35-37
 choroidal flow,
38-42
 ONH flow
37, 43
 and 
perifoveal capillary flow
37, 44
 with aging. This study did not found any relationship between the 
TRBF and age. Similar observations were reported by Lovasic and associates
38
. They 
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investigated sub-choroidal blood flow in 120 healthy participants, using the LDF technique. 
They recruited 20 participants for each age decade from 20 years to 80 years, and found no 
correlation with age (r=0.005). However, they found a significant negative relationship of age 
with velocity (r=-0.22), and positive significant correlation of age with scanned Doppler volume 
(r=0.22). Ambarki and co-workers
36
 investigated the ophthalmic artery flow, using magnetic 
resonance imaging, and found no significant difference between groups of healthy young and 
healthy elderly adults. They did find a significant increase in the resistive index and arterial 
volume pulsitility in the elderly compared to the young groups, suggesting reduced vascular 
compliance as vessels age. A study of choroidal flow using indocyanine green angiography, 
investigated 35 healthy eyes and reported a reduction in arterial fluorescence intensity with 
increasing age, but interestingly, the same result was not observed for venous florescence 
intensity.
41
 Dallinger and associates
42
 used the laser interferometry method to measure pulsatile 
ocular blood flow (POBF), a measurement relating primarily to choroidal flow, on 130 healthy 
participants. They reported a negative relationship with age (r=-0.24). Ravalico and co-workers
39
 
also investigated the POBF in 105 healthy participants where they observed a negative 
correlation with age, in the sitting position (r=-0.36) and in the supine position with induced IOP 
increase (r=-0.28). Nevertheless, it is imperative to stress that pulsatile flow primarily measures 
the choroidal circulation with little contribution from the retinal flow. Moreover, the 
measurement is also highly related to scleral rigidity, a mechanical ocular property that may 
change with age. Reports on ONH flow and age were not unanimous. Groh and co-workers
37
 
used scanning laser Doppler flowmetry (SLDF), a method which gives arbitrary flow values, 
showed no relationship with age. Boehm and co-workers
43
 on the contrary reported a weak 
negative relationship between flow and age for both temporal and nasal neuroretinal rim flow. 
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The female estrogen hormone has vasodilatory capability and this may influence the retinal 
haemodynamics. A few studies have reported an estrogen influence on the systemic 
circulation,
45, 46
 as well as on the ocular circulation.
5, 6, 47
 We compared our hemodynamic values 
between the sexes and our analysis showed no significant differences, in agreement with the 
preliminary findings of Wang and associates
19
 using the same flow measurement technique. On 
the contrary, Harris and co-workers
5
 reported a significant difference between men and women 
in the end-diastolic velocity for both the ophthalmic artery and short posterior arteries, with the 
female values reducing with advancing age. No differences were reported from the central retinal 
artery. Interestingly, their sample included post-menopausal women who had not received 
estrogen replacement therapy and it was speculated that this could increase vascular resistance. 
Kavroulaki and colleagues
6
 used LDF to investigate the sub-macular choroidal flow between the 
sexes and reported that mean flow was highest in younger women when compared to older 
women, and male groups. In agreement to that finding was a study by Geyer and co-workers
47
 
which have observed the highest POBF values in younger women compared to elderly female, 
young male, and elderly male groups. Contradictory findings were reported in an Asian 
population study where the mean POBF value for women was significantly higher than men.
48
 
The different findings were speculated to be caused by a different sample population and race. In 
addition, that study on Asian population also did not find age influence on blood flow. 
The results of this study can be interpreted in 2 ways. Firstly, the lack of any statistical 
relationship between retinal blood flow and age could be due to inadequate power to detect any 
effect. For this reason, we conducted a post-hoc power analysis. Using a power of 90% and a 
type I error of 0.05, the estimated sample size to determine a significant difference in total retinal 
blood flow was 715. However, an alternative interpreatation would be that there is no effect of 
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age on retinal blood flow. This is supported by the fact that the r and p values were remarkably 
unconvincing and also that the inspection of the plot of retinal blood flow as a function of age 
showed a strikingly flat regression line.  
A potential criticism of our study relates to the fact that we used a cross-sectional experimental 
design. It would be preferable to measure retinal haemodynamics of the same individual over say 
6 to 7 decades. Instead, this study cross-sectionally compared values from different individuals 
of different ages, in order to study any possible effect. Although correlation analysis is highly 
suggestive to a relationship between the selected parameters, a true temporal effect of aging may 
ideally be investigated longitudinally. Nonetheless, a longitudinal age study was obviously not 
feasible for this current study since it involves a follow-up over a number of years. Another 
limitation is that the age range of the sample was limited to between 20 to 70 years of age. Also, 
even our oldest participants were remarkably healthy, such that none of them were receiving 
systemic medications. In effect, this study focuses on healthy controls and is not typically 
representative of the general population. As a result, the study could be criticized on the basis 
that we were insvestigating changes in the retinal blood flow in a sample that had no health 
effect. 
In conclusion, we found that the total retinal blood flow, as measured by a prototype Doppler 
SD-OCT system, is independent of age and sex. Venous area was also independent of age and 
sex, but blood velocity showed a weak, negative relationship with age in men. 
  
98 
 
4 Retinal blood flow in primary open angle glaucoma patients with 
differing nocturnal blood pressure profiles. 
 
 
 Concept/Design Recruitment Acquisition 
of data 
Analysis Write-up 
Yusof, F X X X X X 
Hudson, C X   X X 
Cheng, R  X X   
Espahbodi, N  X    
Buys, YM X X   X 
Trope, GE X X   X 
Flanagan, JG X   X X 
Table detailing role of each person (X denotes significant contribution). 
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Purpose: To evaluate retinal blood flow (RBF) in patients with primary open angle glaucoma 
(POAG) and differing nocturnal blood pressure (NBP) profiles. 
Methods: All participants underwent 48 hours of non-invasive ambulatory blood pressure 
monitoring (ABPM) and the magnitude of the NBP reduction (NBPR) was calculated using data 
from the second day. The participants included 17 healthy controls (mean age 61.9±6.8 years; 
NBPR 13.5±8.2%); 17 early POAG patients with normal NBPR (age 66.1±9.2 years; NBPR 
10.9±4.7%) and 16 early POAG patients with high NBPR (age 63.5±7 years; NBPR 24.1±4.7%). 
RBF was measured using a prototype Doppler SD-OCT (Optovue Inc., Freemont, CA) and using 
the established bi-directional laser Doppler velocimetry with simultaneous vessel densitometry 
(BLDV-SVD) methodology in Canon Laser Blood Flowmeter (CLBF; Canon, Inc., Tokyo, 
Japan). Six Doppler SD-OCT scans were acquired using a circum-papillary double circular scan 
protocol in one eye. Six BLDV-SVD measurements of the superior temporal arteriole were 
taken. 
Results: In general, RBF parameters were reduced in the early POAG groups, and particularly 
being lowest in the high NBPR group. Using the Doppler SD-OCT, the high NBPR group had 
the lowest flow of 29.57±8.930µL/min, followed by the normal NBPR group at 
31.59±9.79µL/min, and the control group at 37.05±7.42µL/min (p=0.048). Post-hoc analysis 
showed a significant difference in RBF between the high NBPR group and the control group 
(p=0.047). The venous area was the lowest in the high NBPR group with 39.91±7.00(x10
-3
)mm
2
, 
compared to the normal NBPR group with 43.33±8.66 (x10
-3
)mm
2
 and the control group with 
46.57±6.60 (x10
-3
)mm
2
 (p=0.047). Post-hoc analysis showed a significant difference in venous 
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area between the high NBPR group and the control group (p=0.037). The BLDV-SVD retinal 
blood flow parameters were not significant between groups. 
Conclusions: 
Patients with early POAG who exhibited an exaggerated nocturnal reduction in MAP also 
demonstrated lower RBF values as shown by the measurement of Doppler SD-OCT.  
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4.1 Introduction 
A subset of treated primary open angle glaucoma (POAG) patients experience deteriorating 
vision despite well-controlled intra-ocular pressure (IOP), suggesting the involvement of other 
risk factors in the patho-physiology. The vascular theory of glaucoma advocated that optic 
neuropathy is a consequence of inadequate blood supply to the optic nerve head (ONH), which 
may be caused by either increased IOP or other causes such as vasospasm or abnormally reduced 
systemic blood pressure, or a combination of these factors.
1
 The potential role of blood pressure 
(BP) in the pathogenesis of glaucoma has been a subject of interest for many investigators since 
it is clinically modifiable and therefore can potentially be used to modify IOP,
2
 although this is 
still controversial. It is hypothesized that chronic hypertension will induce changes to small 
vessels and increase peripheral resistance, thus affecting the ONH perfusion. On the other hand, 
hypotension reduces perfusion pressure which may cause ischemia, oxidative stress or both. This 
can lead to ganglion cell death at the level of the ONH, particularly in the presence of coexisting 
IOP elevation or poor autoregulation.
2
 
BP is known to have circadian variability with the values obtained at night, usually around 2 to 4 
A.M.
3, 4
 being much lower than those obtained during the day.
5, 6
 It is hypothesized that an 
excessive systemic BP falls that occur nocturnally may result in optic nerve ischemia especially 
if the autoregulation of the vascular beds is compromised, as this leads to a reduced local 
ONH/peripapillary retina perfusion.
4, 7
 The magnitude of the physiological nocturnal blood 
pressure reduction (NBPR) is generally a 10-20% reduction from the average daytime BP.
6, 8, 9
 
Two thirds of the normal population are believed to have a 10-20% NBPR.
4
 A non-physiological 
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value has been showed to be a predictor of a compromised cardiovascular system and carries a 
higher risk of cardiovascular mortality.
4, 9
 
The relationship of the systemic BP to the retinal perfusion pressure seems to be apparent. The 
ocular perfusion pressure (OPP) is the driving force for the retinal blood circulation and is 
defined as the difference between the systemic mean arterial pressure and the venous pressure, 
the value of which approximates to the IOP value. Therefore, it is important to determine 
whether an abnormal NBPR is an indicator for an abnormal ocular perfusion. Gherghel and co-
workers
10
 have investigated the relationship between the NBPR and retrobulbar blood flow using 
the colour Doppler imaging (CDI) method in patients with POAG. They showed that in the 
central retinal artery, high NBPR group exhibited a lower end-diastolic velocity (EDV), and 
higher resistivity index (RI) value, compared to control patients. That may suggest that the 
magnitude of the NBPR may be a relevant manifestation of the systemic vascular system for 
vascular dysregulation, at least among the POAG population. To the best of our knowledge, 
current literature has yet given attention to the retinal vascular bed and its association to the 
NBPR. Therefore, this study was sought to elucidate the relationship between the retinal blood 
flow and the NBPR in patients with POAG. 
4.2 Methods 
4.2.1 Participants  
Approval for the study was granted by the Research Ethics Boards of the University Health 
Network, University of Toronto, and the Office of Research Ethics of the University of 
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Waterloo. The study abided by the Declaration of Helsinki. Written consent was obtained from 
all participants.  Non-smoking participants with POAG and also age-matched healthy controls 
were recruited. POAG patients were recruited from the Toronto Western Hospital glaucoma 
clinic, and their diagnosis was made by a glaucoma specialist (either YMB or GET). 
All participants had a corrected logMAR visual acuity (VA) of 0.3, or better, in each eye with 
ametropia less than ±6.00DS and ±2.50DC. All healthy controls had no immediate history of 
glaucoma or diabetes and all had normal visual field (VF) as assessed by program 24-2 SITA 
Standard VF of the Humphrey Visual Field Analyser (HFA). The HFA result was deemed valid 
when fixation loses, false positive and false negative responses were each less than 30%. None 
of the participants with POAG; had any history of other ocular pathology (other than POAG), 
any history of ocular surgery (with the exception of uneventful cataract surgery), history of 
stroke or chronic lung disease, poorly controlled hypertension, diabetes mellitus and any other 
endocrine diseases, ocular media opacities significant enough to hinder retinal imaging, 
pseudoexfoliation, pigment dispersion, closed iridocorneal angles, retinal/neuro-
ophthalmological disease that could result in VF defects, and blood abnormality including 
hyperviscosity. 
Participants refrained from consuming any caffeinated beverages and/or meals containing red 
meat four hours prior of the study. Several studies showed that caffeine consumption may 
constrict ocular blood vessels,
11-13
 while red meat consumption has been reported to have a 
vasodilatory effect.
14
 Participants with POAG were dichotomized into two groups based on the 
NBPR profile; normal NBPR group exhibited a NBPR˂20%, and high NBPR group exhibited an 
NBPR≥20%. By calculation, the OPP is increased about 15mmHg when a person takes a supine 
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position to sleep due to hydrostatic column pressure.
9
 Thus, the NBP should reduced more than 
15mmHg, or more than 20% than the diurnal value to potentially cause an ischemic insult. 
During the Doppler measurements, the operators (FY and RC) were masked to the NBPR status 
of the subject.  
Using the data from Wang and co-workers
26
, the sample size estimation for studies involving 
POAG patients using prototype Doppler SD-OCT were calculated. Homeostatic blood flow for 
20 healthy controls was 47.6 ±5.4µl/min and 16 glaucoma patients was 34.1±4.9µl/min. The 
effect size was calculated conservatively as two-third of the difference in homeostatic blood flow 
between controls and patients, i.e. 2/3*(47.6-34.1). The standardized effect size for blood flow = 
2/3*(47.6-34.1)/((5.4
2
 + 4.9
2
) / 2)
 1/2
  = 1.7. Using a two-tailed α = 0.05 and β = 0.20, the minimal 
required sample size is 9. 
 
4.2.2 Ambulatory blood pressure monitoring (ABPM) 
The A&D TM2430 ambulatory blood pressure recorder system (A&D Co. Ltd., Saitama, Japan) 
was utilized to record 48 hours of BP readings. The system is an oscillatory type 
sphygmomanometer. Typically, the pressure cuff was placed on the left arm, and attached to the 
recorder in a portable pouch which the participant wore around their waist. The measurement 
frequency was set at every half an hour for 48 hours. It has been suggested that sleep disturbance 
due to BP monitoring is minimal when the frequency of measurement is between 15 to 30 
minutes.
4
 All data were stored in the recorder’s memory chip and then transferred for analysis. 
The A&D ABPM Data Analysis Software for windows (A&D Co. Ltd., Saitama, Japan) was 
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utilized. Parameters recorded by the monitor included diastolic blood pressure (DBP), systolic 
blood pressure (SBP) and pulse rate (PR). Mean arterial pressure (MAP) was calculated using 
the formula:
10, 15, 16
 
        
 
 
                  Equation 4.1  
Non-physiological findings were excluded, i.e. (1) when the pulse pressure (SBP - DBP) was 
less than 10mmHg, (2) when pulse pressure was less than 10% of SBP with the SBP>100mmHg, 
or (3) if DBP was more than 160mmHg.
10, 17, 18 
Faulty readings were detected automatically and 
the monitor would then initiate a new measurement to avoid missing data.  
The magnitude of the NBPR was calculated from the BP readings of the second half of the 48 
hours (i.e. day two). A few studies have suggested that the circadian rhythm is still adjusting on 
the first 24 hours of ABPM, hence artificial effects may bias the measurement during this 
period.
19, 20
 NBPR was calculated using the formula:
21, 22
 
     
                                         
                  
         Equation 4.2 
The ambulatory BP monitoring was done in the participants own home. With a familiar sleep 
arrangement, it was postulated that a better nocturnal reading was acquired. Besides, a hospital 
admission type of ABPM probably will not measure a true value due to controlled activities. 
Although the monitor is automatic and can function independently, participants were briefed on 
how the monitor works and were supplied with working instructions, i.e. manual deflation, 
cancelling measurement, missed readings, arms position, and machine location/fitting. 
Participants were advised to minimize movement when the measurement was actually being 
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acquired. An activity diary was given for participants to record any activity that may affect BP. 
Participants also noted the time they sleep and wake-up for a precise NBPR calculation.  
4.2.3 Instrumentation  
4.2.3.1 Retinal blood flow measurement using Doppler SD-OCT 
Doppler imaging was performed using the Optovue RTvue OCT (Optovue Inc, Freemont, CA, 
USA). The optical build-up of this instrument has been discussed in detail in Chapter 1 (section 
1.11.6.6) and Chapter 3 (section 3.2.2). Briefly, the infrared light source used by the OCT 
traverses through a beam splitter and diverged into both, eye (i.e. the sample arm) and reference 
mirror (i.e. reference arm). Both arms reflect the light causinginterference, and is read by a 
spectrometer. The interference pattern is Fourier-transformed to produce depth profile of the 
sample tissue (A-scan image). Different layer of the sample have a different reflectance 
properties, hence producing many A-scan images. The combination of these A-scans images 
produce a B-scan, a detailed image of the tissue. Using prototype software, the Doppler shift of 
the reflected light frequency was determined by the phase difference between sequential axial 
scans.
23
  
The retinal blood flow imaging was performed using the circum-papillary double circular scan, 
centred on the ONH. The inner and outer concentric circular scans has radii of 3.4mm and 
3.75mm, respectively.
24 -26
 The concentric radii transected all retinal arterioles and venules 
around the ONH at two locations corresponding to where a given vessel crossed each circle. In a 
single blood flow scan, six dual circular frames were taken consecutively over 2 seconds and 
were averaged.
25
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The Doppler principle has been described in detail in Chapter 1 (section 1.11.6.1). In brief, 
reflected light from moving blood cells experiences a frequency shift (the Doppler shift), Δ  , 
while the non-moving structures (such as the vessel wall) do not generate a change in frequency. 
Using the Doppler formula, Δ   is proportional to the velocity of the moving particle; hence the 
moving blood velocity can be calculated if the Doppler shift is known. Blood flow can later be 
quantified by multiplying the calculated velocity by the vessel diameter, to produce flow value in 
µL/min. 
4.2.3.2 Retinal haemodynamics analysis using the Semi-automated Doppler OCT of Retinal 
Circulation (DOCTORC) software 
The blood flow scans taken by the Doppler SD-OCT were processed using the semi-automated 
DOCTORC software version 2.1.1.4 (Centre for Ophthalmic Optics and Lasers, CA, USA). The 
Doppler scans were pre-processed by the software to identify candidate vessels type, location 
and the Doppler signal. Deletion of vessels with extraneous influences and the addition of 
missing vessels were then performed manually. Vessels type was manually reviewed based on 
the colour fundus image. Each vessel was manually refined for its location and diameter 
boundary. A confidence score for each scan was assigned, by judging the Doppler signal 
strength, vessel boundary, size agreement between outer and inner ring, and Doppler signal sign 
agreement between outer and inner ring. Automatic computation was then initiated producing 
retinal haemodynamics values which included the total retinal blood flow (TRBF), venous cross-
sectional area and the blood velocity. TRBF was calculated by summing all flow from valid 
venules and the estimated flow of invalid venules. Velocity was computed by dividing TRBF 
from all valid venules by the valid cross sectional area of all the venules.
24
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4.2.3.3 Bidirectional laser Doppler velocimetry with simultaneous vessel densitometry 
(BLDV-SVD) 
BLDV-SVD is incorporated into the Canon laser blood flowmeter (CLBF). The CLBF utilizes 
the Doppler principle to measure retinal blood flow in absolute units. The instrument measures 
the Doppler shift produced by the fastest moving blood particles in the central part of a vessel 
lumen. The CLBF can only measure blood flow at a specific site of a single blood vessel at a 
time, hence the measurement site in this study was standardized at 1 to 2 disc diameters from the 
ONH along the superotemporal arteriole, on a relatively straight vessel segment distant from 
bifurcations. 
The instrument comprises a fundus-camera plus a red laser for measuring Doppler shift and a 
green rectangular laser to measure vessel diameter. Light scatter by red blood cells at the 
illuminated site is detected simultaneously in two distinct directions separated by a known angle 
to detect the absolute Doppler shift, irrespective of the angle between the photodetectors and the 
moving red blood cells. This angle is termed as Doppler shift angle. Using this BLDV-SVD 
methodology, maximum frequency shift from the centreline of a blood vessel is calculated taking 
the difference in frequency shifts between the two photodetectors which are separated at a fixed 
angle (Δα). Maximum Doppler shift can be calculated using: 
              
     
 
        Equation 4.3  
The CLBF uses a red laser (675nm, 80µm x 50µm oval) to measure blood velocity every 0.02 
seconds over 2 seconds measurement window. A green laser (543nm, 1500µm x 150µm 
rectangle) is used to measure vessel wall diameter using densitometric reflection analysis, 
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acquired every 4ms during the first and last 60ms of the 2s measurement window. RBF was 
derived from the velocity and diameter data.
27-29
 
4.2.4 Procedures 
Participants attended for 2 visits. During the first visit, participants were screened for eligibility. 
The following procedures were executed; refraction, log MAR visual acuity, automated static 
perimetry, Goldmann applanation tonometry, resting blood pressure, A-scan pachymetry and 
fundus imaging. Morphometric retinal scans were taken using the Doppler SD-OCT, with each 
scans repeated three times. The choice of selected eye was often driven by study recruitment 
criteria in the POAG groups, but was chosen randomly in the control group. Participants were set 
for the ABPM at the end of the first visit. After 48 hours, participants returned to the lab and the 
ambulatory BP readings were collected. The NBPR status for each participant was calculated last 
after finishing all blood flow measurement procedures. 
The study eye was then dilated with tropicamide 0.5% (Mydriacyl 0.5%, Alcon Laboratories, 
Mississauga, Canada). Participants were then rested for 10 minutes, or longer if required, to 
stabilize the cardiovascular parameters. BP and heart rate were monitored using a rapid response 
critical care gas analyser (Cardiocap 5, Datex-Ohmeda, Helsinki, Finland). RBF measurement 
was undertaken using the Doppler SD-OCT and the BLDV-SVD at random order. Measurements 
consisted of six BLDV-SVD readings and six circum-papillary double-circular scan in the 
Doppler SD-OCT. IOP was reassessed after the blood flow scans. 
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4.2.5 Statistical analysis 
All data were graphically presented showing the mean ± standard deviation. Normality of data 
was tested using Wilk-Shapiro test. One-way analysis of variance (ANOVA) was employed to 
compare retinal blood flow values between groups. The Tukey post-hoc analysis was employed 
to check for intra-groups significance. Statistical significance was taken at the p<0.05 level. All 
statistical analyses were employed using STATISTICA (StatSoft Inc., Tulsa, OK, USA) version 
11.0. 
4.3 Results 
4.3.1 Demographic data  
Seventeen POAG patients with normal NBPR, 16 POAG patients with high NBPR, and 18 
healthy controls were recruited. In the healthy control group, one participant was excluded for 
the SD-OCT analysis, reducing the number of analyzed data sets to 17. A different participant 
was also excluded in the healthy control group for the BLDV-SVD, reducing the number of 
analyzed data sets to 17. Two POAG patients with normal NBPR and 1 POAG patient with high 
NBPR were excluded in the BLDV-SVD analysis, reducing the number to 15 in each group. The 
reason for exclusion was due to fatigue and inability to continue with the procedure. 
Analyzing the Doppler SD-OCT participants demographic data (Table 4.1), there was a 
significant difference in the NBPR value between groups (ANOVA p<0.001) with the high 
NBPR group value significantly higher than the value in the normal NBPR and control groups 
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(Tukey HSD p<0.001; Figure 4.1). The mean RNFL thickness in the control group was 
significantly greater than both of the POAG groups but the RNFL thickness values between the 
POAG groups were not significantly different. The same observation was recorded for the 
superior and inferior RNFL thickness (Figure 4.2). There were no significant differences for age, 
VA, central corneal thickness (CCT), IOP, and MD between the groups (p>0.05). However, PSD 
was significantly different between groups (p=0.038), with the high NBPR POAG group have a 
borderline higher PSD than the control group (Tukey HSD p=0.053, Figure 4.3). In general, the 
visual field MD and PSD indices can be interpreted as representing an early POAG group. There 
were equal number of patients in each of the POAG groups who were taking topical beta-
blockers for glaucoma (p=0.784). The number of patients using alternative, or additional, topical 
IOP-lowering medications were not large enough in total number per group to justify further 
analysis. There was no statistical difference in the number of participants who were taking 
systemic hypotensive medication between all groups. 
The demographics for participants that completed the BLDV-SVD session showed a similar 
trend to Doppler SD-OCT (Table 4.2). The NBPR showed significant difference between groups 
(ANOVA p<0.001) with the high NBPR group value was significantly higher than the normal 
NBPR and control groups (Tukey HSD p<0.001). The healthy controls have the thickest RNFL 
and significantly different to both high NBPR and normal NBPR POAG groups, for mean 
RNFL, superior RNFL and inferior RNFL thickness. The PSD was significantly different 
between groups (ANOVA p=0.038), with the Tukey post-hoc test showed a near significant 
difference between the control and the normal NBPR group (p=0.054). No significant differences 
were noted for age, VA, CCT, IOP and MD. In general, the visual field MD and PSD indices can 
be interpreted as representing an early POAG group. There were equal number of patients in 
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each of the POAG groups who were taking beta-blockers for glaucoma (p=0.784). The number 
of patients using alternative, or additional, topical IOP-lowering medications were not large 
enough in total number per group to justify further analysis.There was no statistical difference in 
the number of participants who were taking systemic hypotensive medication between all 
groups. 
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Doppler SD-OCT Controls Normal NBPR High NBPR P (ANOVA) 
Number 17 17 16 - 
Male : Female 7 : 10 5 : 12 10 : 6 - 
Age (years) 61.91±6.82 66.12±9.23 63.48±7.26 NS 
VA (log) 0.03±0.07 0.06±0.08 0.03±0.07 NS 
CCT (µm) 540.88±26.87 515.53±41.00 525.13±26.77 NS 
IOP (mmHg) 14.76±3.23 14.68±3.07 12.88±2.60 NS 
NBPR (%) 13.47±8.19 10.85±4.64 24.06±4.70%* <0.001 
Mean RNFL 
thickness (µm) 
102.97±7.73 ** 82.25±13.15 83.08±10.72 <0.001 
Superior RNFL 
thickness (µm) 
103.65±8.07** 85.14±13.77 84.47±9.84 <0.001 
Inferior RNFL 
thickness (µm) 
102.39±8.33** 80.34±14.20 81.68±13.83 <0.001 
MD -0.75±1.49 -2.82±4.59 -1.70±2.90 NS 
PSD 1.64±0.72*** 3.93±3.67 4.22±3.88 0.038 
Patients taking β-
blockers for 
glaucoma 
- 12 12 NS 
Participants taking 
systemic 
hypotension 
medication 
2 5 1 NS 
 
Table 4.1: Participants demographics and baseline data for the 3 groups, for Doppler SD-OCT. The values 
presented are as mean ± standard deviation. One-way ANOVA was undertaken to compare the parameters between 
groups, and the p-values are shown in the right hand column [VA = visual acuity, CCT = central corneal thickness, 
IOP = intraocular pressure, NBPR = nocturnal blood pressure reduction, RNFL = retinal nerve fiber layer, MD = 
mean deviation, PSD = pattern standard deviation, NS = not significant]. 
Note: * denotes the group is significantly different to the healthy control group and normal NBPR group (Tukey’s 
HSD post-hoc test). ** denotes the group is significantly different to both POAG groups. *** denotes the group is 
significantly different to the high NBPR group.  
114 
 
BLDV-SVD Controls Normal NBPR High NBPR P (ANOVA) 
Number 17 15 15 - 
Male: Female 8 : 9 5 : 10 10 : 5 - 
Age (years) 62.06±6.97 65.59±9.25 63.15±7.39 NS 
VA (log) 0.04±0.08 0.05±0.08 0.02±0.03 NS 
CCT (µm) 541.59±26.72 512.73±42.90 525.87±27.54 NS 
IOP (mmHg) 14.35±3.62 15.17±2.93 12.80±2.68 NS 
NBPR (%) 13.62±8.22 10.85±4.95 24.11±4.86* <0.001 
Mean RNFL 
thickness (µm) 
102.61±7.61 ** 82.51±14.02 82.36±10.68 <0.001 
Superior RNFL 
thickness (µm) 
103.39±8.02** 85.70±14.62 83.31±9.00 <0.001 
Inferior RNFL 
thickness (µm) 
101.95±8.17** 80.42±15.14 81.40±14.27 <0.001 
MD -0.74±1.49 -2.98±4.83 -1.72±3.00 NS 
PSD 1.62±0.72*** 4.25±3.81 3.97±3.88 0.038 
Patients taking β-
blockers for 
glaucoma 12 NS 2 5 5 NS 
- 12 12 NS 
Participants taking 
systemic 
hypotension 
medication 
2 5 1 NS 
 
Table 4.2: Participants demographics and baseline data for the 3 groups, for BLDV-SVD. The values presented are 
as mean ± standard deviation. One-way ANOVA was undertaken to compare the parameters between groups, and 
the p-values are shown in the right hand column [VA = visual acuity, CCT = central corneal thickness, IOP = 
intraocular pressure, NBPR = nocturnal blood pressure reduction, RNFL = retinal nerve fiber layer, MD = mean 
deviation, PSD = pattern standard deviation, NS = not significant]. 
Note: * denotes the group is significantly different to the healthy control group and normal NBPR group (Tukey’s 
HSD post-hoc test). ** denotes the group is significantly different to both POAG groups. *** denotes the group is 
significantly different to the normal NBPR group.  
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Figure 4.1: The box plot showing the group mean magnitude of the nocturnal blood pressure reduction (NBPR) for 
all groups. The p-values indicated significant interaction between groups, as computed by the Tukey post-hoc test. 
The analysis showed that both normal NBPR and control groups were different to the high NBPR group. 
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Figure 4.2: Retinal nerve fiber layer (RNFL) thickness box plots for each group; A) Mean RNFL thickness, B) 
Superior RNFL thickness, C) Inferior RNFL thickness. The p-values indicated significant differences between the 
groups (Tukey HSD test). The analysis showed that both of the POAG groups had a significantly lower RNFL 
thickness than the controls, but were not different from each other. 
 
p<0.001 
p<0.001 
p<0.001 
p<0.001 
p<0.001 
p<0.001 
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Figure 4.3: Box plot for pattern standard deviation (PSD) for each groupduring ther SD-OCT session. PSD values 
were recorded from the Humphrey Field Analyzer. The Tukey HSD test indicated a significantly higher PSD in the 
high NBPR group than in the control group. 
4.3.2 Ambulatory blood pressure parameters 
The blood pressure parameters are tabulated in Table 4.3. All of the diurnal parameters were not 
significant between the groups, except for the pulse rate (PR). The high NBPR group day PR 
(69.74±8.20beats/min) was significantly lower than the control’s (77.84±12.00beats/min, Tukey 
HSD p=0.048). The mean diurnal BP values for all 3 groups were found to be in the normal 
clinical range. Conversely, all nocturnal parameters significantly different between groups, 
except for the PR. The high NBPR group exhibited a significantly lower systolic BP, diastolic 
BP and MAP (Figure 4.4). Although significance differences were recorded for the nocturnal 
ambulatory values, the BP was not different between groups during the measurement of RBF 
(Table 4.3).  
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 Controls Normal NBPR High NBPR P 
(ANOVA) 
Day SBP (mmHg) 127.34±11.29 124.87±11.38 131.95±20.22 NS 
Day DBP (mmHg) 77.54±7.22 72.33±8.44 78.16±9.57 NS 
Day MAP (mmHg) 94.14±8.30 89.83±8.90 96.00±12.34 NS 
Day PR (beats/min) 77.84±12.00 71.06±7.62 69.74±8.20* 0.040 
Night SBP (mmHg) 111.81±11.61 112.15±9.67 100.56±15.90** 0.016 
Night DBP (mmHg) 65.80±7.58 64.40±6.60 58.53±7.97* 0.016 
Night MAP (mmHg) 81.13±8.43 80.26±6.91 72.54±10.22** 0.011 
Night PR (beats/min) 67.48±11.84 64.30±8.24 59.96±9.19 NS 
SBP during Doppler SD-
OCT (mmHg) 
122.41±10.40 126.71±14.25 125.56±23.53 NS 
DBP during Doppler SD-
OCT (mmHg) 
77.82±6.56 76.76±12.18 77.38±12.28 NS 
PR during Doppler SD-
OCT (beats/min) 
66.68±8.71 66.15±10.23 63.49±6.71 NS 
SBP during BLDV-SVD 
(mmHg) 
124.12±12.50 129.36±18.33 128.87±24.64 NS 
DBP during BLDV-
SVD(mmHg) 
79.65±8.12 77.00±12.23 78.67±11.73 NS 
PR during BLDV-SVD 
(beats/min) 
68.51±9.83 63.37±9.99 62.21±6.43 NS 
Table 4.3: Blood pressure parameters for all participants presented as mean± standard deviation. One-way ANOVA 
was used to compare the parameters between groups [SBP = systolic blood pressure, DBP = diastolic blood 
pressure, MAP = mean arterial pressure, PR = pulse rate, NS = not significant]. 
Note: * denotes the group is significantly different to the healthy control group (Tukey’s HSD post-hoc test). ** 
denotes the group is significantly different to the normal NBPR group and to the control group. *** denotes the 
group is significantly different to the high NBPR group. 
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Figure 4.4: Box plot for night time blood pressure parameters for each group; A) night time systolic blood pressure 
(SBP), B) night time diastolic blood pressure (DBP), C) night time mean arterial blood pressure (MAP). The p-
values indicate significant differences between the groups, as computed by the Tukey HSD test.  
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4.3.3 Doppler SD-OCT’s retinal hemodynamic parameters 
The retinal haemodynamics from the Doppler SD-OCT were compared between groups. The 
TRBF in the high NBPR group was found to be the lowest at 29.57±8.93µl/min, compared to 
31.59±9.79µl/min in the normal NBPR group, and 37.05±7.42µl/min in the control group 
(p=0.048; Figure 4.5). The Tukey HSD test indicated that the high NBPR group had a 
significantly lower RBF than the controls (p=0.047). There were no significant differences for 
superior RBF, inferior RBF, and blood velocity between the groups. The venous area showed 
significant difference between groups (p=0.047). The Tukey HSD test indicated that high NBPR 
group have lower blood velocity than the controls (p=0.037; Figure 4.6). A summary is tabulated 
in Table 4.4. 
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 Controls Normal NBPR High NBPR P (ANOVA) 
Total Retinal 
Blood Flow 
(µl/min) 
37.05±7.42 31.59±9.79 29.57±8.93* 0.048 
Superior 
Retinal Blood 
Flow (µl/min) 
18.45±4.78 16.81±6.18 14.24±5.72 0.105 
Inferior Retinal 
Blood Flow 
(µl/min) 
18.59±4.82 14.78±6.37 15.33±6.03 0.127 
Venous area 
(mm
2
) 
46.57±6.60 (x10
-3
) 43.33±8.66 (x10-3) 39.91±7.00 (x10-3)* 0.047 
Velocity (mm/s) 13.23±2.21 12.05±2.16 12.19±2.54 0.274 
 
Table 4.4 : The retinal haemodynamics as measured by the Doppler SD-OCT. Values presented by their means ± 
standard deviation. One-way ANOVA was done to compare the parameters between groups and the p-values are 
stated on the right hand column.  
Note: * denotes the group is significantly different to the healthy control group (Tukey’s HSD test).   
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Figure 4.5 : Box plot for the total retinal blood flow (TRBF) for each group, as derived by the Doppler SD-OCT. 
The Tukey HSD test indicated a significant difference between the high NBPR group and the control group. 
 
Figure 4.6 : Box plot for the venous area of each group, as derived by the Doppler SD-OCT. The Tukey HSD test 
indicated a significant difference between the high NBPR group and the control group. 
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4.3.4 BLDV-SVD’s retinal hemodynamic parameters  
The retinal blood flow parameters from the BLDV-SVD were compared between groups. Group 
mean values for all parameters were found to be generally lower among POAG patients in 
comparison to the control group, although the differences were not significant. In addition, most 
RBF values were lowest in the high NBPR group, although statistically insignificant. Table 4.5 
summarizes the findings. 
 
  Controls Normal NBPR High NBPR P (ANOVA) 
Diameter (µm) 107.84±16.11 103.35±15.29 101.00±13.26 0.604 
Velocity (mm/s) 34.10±7.88 29.25±8.17 30.60±6.13 0.175 
Flow (µL/min) 9.38±4.12 7.77±3.42 7.57±2.67 0.281 
 
Table 4.5 : Retinal blood flow parameters measured using BLDV-SVD as a function of group. Values presented are 
group means ± standard deviation. One-way ANOVA was done to compare the parameters between groups, and the 
p-values are stated in the right hand column.  
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4.4 Discussion 
There is little consensus regarding any possible relationship between NBPR and glaucoma. Some 
studies have found glaucoma to be associated with an exaggerated NBPR,
4, 16, 17, 30
 while some 
have reported it to be associated with a lower NBPR
18, 21
. There are also studies which relate 
glaucoma to patients with both low and high NBP profiles,
3, 22
 while several studies did not find 
any association with NBPR
31, 32
. It is interesting to note that even though the studies of Plange 
and co-workers
31
 and of Riccadonna and co-workers
32
 did not find any definitive association 
between glaucoma and NBP status, they reported that glaucoma patients experience a higher 
variability in NBP parameters, proposing that fluctuation in the perfusion pressure in POAG may 
be pathogenic. The inconsistency of the results between studies may be explained by: (1) 
variation in the definition, or the calculation of an NBPR, (2) the different frequencies and 
durations in the ABPM measurements, (3) the location of BP measurements, i.e. home versus 
hospital admission, and (4) the different characteristics of glaucoma being recruited.  
The consequence of an excessive BP fall at night is a loss of perfusion to some of the organs and 
tissues in the body. Some authors have suggested that the greater NBP fall, may represent a form 
of vascular dysregulation.
10
 In a compromised vascular bed, excessive systemic hypotension may 
initiate ischemic tissue damage. Many findings in the past have indicated that glaucoma patients 
with extreme NBPR may have a less favourable prognosis.
22, 30, 33-36
 Grunwald and co-workers
37
 
assessed the ONH blood flow in glaucoma patients with and without systemic hypertension. It 
was found that patients without hypertension had a 26% reduction in the ONH flow, suggesting a 
higher BP provides a better perfusion to the eye. Krasinska and colleagues
33
 showed that 
medication induced nocturnal hypotension lowers retrobulbar velocity. Their prospective study 
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was conducted on glaucoma patients at 6 months interval. These findings may implicate a 
negative effect of hypotension, and perhaps a benefit of hypertension, on ocular and particularly 
ONH perfusion. 
The relationship of the NBPR and ONH/peri-papillary retinal perfusion is uncertain. To the best 
of our knowledge, no study has ever been conducted to investigate the relationship between 
NBPR and ONH/peri-papillary retinal perfusion. A few groups have reported a linkage between 
NBPR to the ocular perfusion among glaucoma patients but all used the color Doppler imaging 
(CDI) technology that measure haemodynamics in the retrobulbar area.
10, 30
 The CDI is an 
ultrasound technique which measures the velocity profile of the retrobulbar arteries, usually the 
ophthalmic or the central retinal artery. A study by Pache and co-workers,
38
 used nail-fold 
capillaroscopy to investigate the relationship of peripheral blood flow and the NBPR but this 
study also measured blood velocity rather  than blood flow. In this current study, we used 
technologies that quantified retinal blood flow in absolute units, by measuring velocity and 
vessel diameter. 
The response of blood pressure to nocturnal factors is complex, since activity levels are reduced 
and posture is horizontal rather than vertical. The immediate response of the retinal vasculature 
to adoption of a supine position is vasoconstriction in order to protect the terminal capillaries 
from the sudden rise in OPP which occurs due to elevation of the heart relative to the eye, i.e. 
hydrostatic column effect. However with longer adoption of supine position, vagus nerve 
responses are initiated which lower the blood pressure and as a result the retinal vessels 
subsequently dilate. This study essentially measures all aspects of these changes and takes into 
account the maximum and the minimum of the blood pressure over the 24-hour recording period, 
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irrespective of causality. In addition, the conditions experienced across the groups were 
equivalent, and therefore the results of valid irrespective of the role of posture upon NBPR. 
An overall look at the prototype Doppler SD-OCT results suggested that early POAG patients 
with a high NBPR have an impaired retinal blood flow in comparison to healthy controls. 
Eventhough comparison to the normal NBPR POAG group yields no statistical significance, the 
values in the high NBPR group were usually lower. Our findings confirmed that the high NBPR 
group has a lower blood flow than the controls. At this time, we are unaware of any other studies 
that measure retinal perfusion among early POAG with different NBP characteristics. The 
previous haemodynamic studies pertaining to the NBPR only measured blood velocity, rather 
than flow, by means of the CDI technique. Nevertheless, flow is presumably reduced in a high 
NBPR group. Ramli and co-workers
39
 demonstrated that their glaucoma patients have lower 
perfusion pressure (OPP) compared to healthy controls. They measured the diurnal and nocturnal 
OPP on 72 normal tension glaucoma and 55 healthy controls. The OPP for their glaucoma group 
was 55.5mmHg and 49.7mmHg for day and night, respectively, lower than the healthy groups 
which exhibited OPP values of 56.7mmHg at daytime and 53.2mmHg at night (p=0.005). Joe 
and co-workers
16
 examined normal tension glaucoma (NTG) patients of Asian descent and 
showed that large reductions in NBP were correlated with the structural parameters that they 
measured using scanning laser polarimetry. Their linear regression analysis revealed that the 
high NBPR patients were associated with decreasing ONH anatomical score (i.e. TSNIT score), 
proposing that high NBPR patients have a thinner RNFL. A few studies have reported 
relationship between reduced haemodynamics and RNFL loss.
40-44
 Taking the link between 
haemodynamics and RNFL thickness, together with the link between RNFL thickness and 
NBPR, it may be appropriate to deduce that POAG patients with excessive NBPR have reduced 
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blood flow. Our findings using Doppler SD-OCT confirms this. RBF values derived using 
BLDV-SVD method did not show a significant difference between groups, although the high 
NBPR group generally exhibited lower RBF parameters. A related study from our group also 
found no difference between baseline hemodynamic (homeostatic) parameters acquired using the 
BLDV-SVD in untreated POAG, progressive POAG and healthy control groups.
45
 However, 
vascular reactivity was found to be significantly reduced in the POAG groups using a 
hypercapnic provocation. Whether a reduced vascular reactivity occurs in POAG patients with 
different NBPR profiles needs to be further investigated (see Chapter 6). 
Any association of the NBPR and blood velocity is unclear. Gherghel and associates
10
 reported 
reduced end diastolic velocity (EDV) and increased resistive index (RI) in the central retinal 
artery among glaucoma patients with high NBPR. They divided their glaucoma patients into 
three groups of NBPR<10%, NBPR 10-20% and NBPR>20% based on 24-hour ABPM 
measurement. Nevertheless, they did not find a significant difference in ophthalmic artery 
haemodynamic parameters between the groups. Krasinska and co-workers
30, 33
 also published a 
series of reports utilizing CDI and observed a similar finding to those by Gherghel and co-
workers.
10
 In an earlier study, Krasinska and co-workers
30 
found that POAG with the highest 
NBPR was associated to the lowest peak systolic velocity (PSV) and EDV in both the 
ophthalmic and central retinal arteries. Both arteries also showed a significantly higher RI in the 
high NBPR POAG group. Of note, they also observed greater visual field defect in the same 
group. Their subsequent study,
33
 a prospective designed study, showed that increase reduction of 
the NBPR, by means of taking antihypertensive medication before sleeping resulted a significant 
reduction of PSV and EDV in the short posterior ciliary arteries relative to baseline 6 months 
earlier. These studies suggest that blood velocity is negatively correlated to the NBPR in 
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glaucomatous eyes. Conversely, Pache and co-workers
38
 reported no differences in the nail-fold 
velocity across glaucoma groups with different NBPR characteristics. However, it is important to 
highlight that Pache and co-workers measured the blood velocity in the finger’s vessels using a 
nail-fold capillaroscopy technique. A recent study by Karadag and colleagues
46
 on healthy eyes 
using the CDI did not find a significant difference between normal NBPR (>10%) and low 
NBPR (<10%) subjects. Their result is somehow expected as only healthy eyes was considered, 
where autoregulation should still be intact thus maintaining stable perfusion. In the current study, 
we did not find any significant difference for the retinal blood velocity between the 3 groups, 
using both Doppler SD-OCT and BLDV-SVD. The different outcome may be due to the 
assessment of different vascular beds. 
The venous area measured by the Doppler-SD OCT is a summed value of all detectable venules 
transected by the double circular scan pattern. Our study found that the high NBPR group had a 
significantly smaller venous area than the controls, but not significantly different to the normal 
NBPR POAG group. Using Doppler SD-OCT, Wang and co-workers
26
 compared retinal 
haemodynamics of glaucoma patients to those of controls, plus patients with non-arteritic 
ischemic optic neuropathy (NAION) and with proliferative diabetic retinopathy (PDR). They did 
not observe any significant difference in the venous area in glaucoma and the controls, but 
positively larger venous area to those in the NAION and PDR group. The different observation 
in our findings may be caused by different selection criteria of glaucoma patients. Nevertheless, 
many studies investigating vessel’s caliber size and its association with glaucoma indicated that 
narrower vessels are consistent with glaucoma.
47-50
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Our non-significant findings in the retinal blood flow assessed using the BLDV-SVD method 
may be due to the anatomical variability of the retina among participants. Despite our best effort 
to standardize the measurement site on a superotemporal retinal arteriole, different retinal vessel 
size may have reduced the signal-to-noise ratio. A previous study from our group did not find 
any difference in homeostatic RBF between glaucomatous and healthy groups using BLDV-
SVD.
45
 They reported significant changes only for the vascular reactivity experiment which used 
a hypercapnic provocation. The BLDV-SVD methodology detected significant change within the 
group whereas the SD-OCT detected differences between the groups. This implies that the 
methodology measuring the total RBF offers an improved signal-to-noise-ratio, evident from our 
significant findings from the Doppler SD-OCT. Doppler SD-OCT covers a much larger 
measurement area than the BLDV-SVD, enables a more comprehensive measurement. We 
suggest that the difference found between the two techniques, that is Doppler SD-OCT and 
BLDV-SVD, was most probably because the NBPR profiles is a global vascular dysregulatory 
indicator that generates a stronger signal-to-noise ratio as a result of a diffuse change of 
perfusion. A localized measurement, in BLDV-SVD case, may not be sensitive enough to 
differentiate a significant effect between the various NBPR groups. It has been advocated that 
vascular dysregulation may be transient in presentation.
7
 Inhomogeneity of flow may exist in an 
ischemic retinal tissue, such as in glaucomatous eye, causing preferential perfusion.
10 
However 
the difference in findings between the two techniques may be explained by possibility that the 
BLDV-SVD methodology was underpowered relative to SD-OCT Doppler. In this study, a post-
hoc power analysis demonstrated that the sample of 18 POAG patients would yield a power of 
80% for the detection of a difference in TRBF between the groups, while 39 subjects would be 
required to gain the same power using BLDV-SVD. In addition, longitudinal studies are required 
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to determine if reduced perfusion associated with exaggerated NBPR is a cause of POAG or an 
effect.  
The ambulatory pressure parameters showed a striking difference between the groups, 
particularly during sleep. The high NBPR group in this study had the lowest value for all the 
nocturnal BP parameters and the highest diurnal BP parameters which resulted in a prominent 
NBP fall. This same trend was observed by Gherghel and co-workers
10
, where they reported an 
average day to night MAP of 100:73mmHg for high NBPR patients (versus ours of 
96:73mmHg). In their study, the diurnal value was not significantly different between groups, 
but the nocturnal parameters were significantly different, also in agreement with the findings of 
our study. Of note, Joe and co-workers
16
 and Krasińska and co-workers30 also recorded the same 
trend. The trend suggests that high NBPR patients have normal-like BP values if clinicians only 
consider the daytime readings. The reduced BP during sleep suggests a deficiency of systemic 
autoregulation in the cardiovascular system, and this may in turn reduce local perfusion. In our 
study, only the diurnal PR was found to be significantly different. A reduction of PR during the 
night is expected because the heart is responding to lack of physical activity. It is postulated that 
the reduction in the sympathetic activity causes the reduction in pulse, cardiac output, and 
peripheral vascular resistance.
51
 
The ambulatory BP recordings in this study were acquired for 48 hours, instead of 24 hours as 
measured by the majority of ABPM studies.
3, 4, 10, 16-18, 30-32, 38, 52
 A longer recording duration was 
selected because it has been reported that the circadian rhythm only stabilized in the 25
th
 hour of 
ABPM recording.
19, 20
 In consequence, our NBPR calculation using the last 24-hour recordings 
(from the two days interval) was expected to present a valid estimate of the NBPR value. We had 
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also conducted the ABPM measurements in the patients home instead of in a hospital settings 
with sleep lab facilities, as in most other studies.
3, 10, 16, 18, 30, 31, 38, 38, 52-54
 Such a controlled setting 
of a hospital or laboratory may produce aberrant BP measurements.
55
 Kashiwagi and 
colleagues
21
 debated that daily data obtained in a hospital setting would probably reduce the 
diurnal BP because the patient was less active than when at home. Sleeping in an unfamiliar 
surrounding may also disturb sleep quality which may result in an abnormal low NBPR profile. 
Pikilidou and co-workers
55
 studied the effect of hospitalization on the 24 hour ABP measurement 
in hypertensive adults with POAG. They reported that the daytime SBP during hospitalization 
was lower compared to those done at home. They observed a larger SBP reduction in the out-
patients of 11%, compared to an 8% reduction during hospitalization (p=0.02). The inpatient 
setting probably produces a false diurnal reading, which may lead to underestimation of the BP 
and over diagnosis of low NBPR. 
In this study, the NBPR was calculated based on the patient real sleeping time. An activity diary 
was supplied for each participant and they were asked to note their sleep time(s). We postulated 
that an activity diary provided a means to improve the validity of the NBPR. The majority of 
previous studies simplified the NBPR calculation by defining day time and night time periods. 
We assumed that sleep time may differ individually, hence the NBPR calculation in our study 
was based on true sleep time. 
To conclude, early POAG patients with a high NBPR have a reduced venous flow and venous 
lumen area which may indicate impaired RBF. This may occur secondary to a systemic 
autoregulatory dysfunction of the cardiovascular system, exhibiting as abnormal circadian BP 
regulation. It may be a form of vascular dysregulation that affects the ocular circulation, at least 
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in glaucomatous eyes. Our retinal blood flow measurements were acquired outside the period of 
NBPR episode. Whether or not the same reduction of retinal perfusion occurs during the NBPR 
period needs to be further investigated. 
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5 The Relationship between Retinal Nerve Fiber Layer Thickness 
and Retinal Haemodynamics in Primary Open Angle Glaucoma 
 
 
 Concept/Design Recruitment Acquisition 
of data 
Analysis Write-up 
Yusof, F X X X X X 
Hudson, C X   X X 
Tayyari. F X X X   
Cheng, R  X X   
Buys. YM X X   X 
Trope, GE X X   X 
Flanagan, JG X   X X 
Table detailing role of each person (X denotes significant contribution). 
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Purpose: To investigate the relationship between Doppler SD-OCT derived retinal 
haemodynamics and the retinal nerve fiber layer (RNFL) thickness in patients with primary open 
angle glaucoma (POAG) and healthy age-matched controls.  
Method: Thirty three POAG patients (age, 64.84±8.31 years; Humphrey Field Analyzer, HFA, 
mean deviation, MD, -2.28±3.85) and 33 healthy controls (age, 62.86±5.32 years; HFA MD -
0.48±1.56) were recruited. The Doppler SD-OCT retinal blood flow measurement was taken 
using the prototype circum-papillary double circular scan protocol in the RTVue system 
(Optovue Inc., Freemont, CA, USA). A minimum of six retinal blood flow (RBF) scans were 
acquired. Peri-papillary RNFL thickness was measured using RTVue’s RNFL scan protocol. 
Results: The total RBF in the POAG group was significantly lower (30.61±9.29µL/min) than the 
control group (40.68±11.32µL/min; p<0.001). Superior and inferior RBF were also significantly 
lower in the POAG group (superior RBF p=0.001, inferior RBF p=0.004). The mean, superior, 
and inferior RNFL thickness were significantly lower in the POAG group (p<0.001). Pearson 
correlation analysis showed a significant positive relationship between the total RBF and mean 
RNFL thickness (r=0.382, p=0.028), between the superior RBF and superior RNFL thickness 
(r=0.37, p=0.032), between the mean RNFL thickness and venous area (r=0.35, p=0.050), and 
between the RNFL thickness and MD (r=0.47 to 0.7, p≤0.006). In the control group, only the 
mean RNFL thickness showed a relationship with venous area (r=0.58, p<0.001).   
Conclusion: The change in retinal circulation in POAG is related to reduced mean RNFL. 
Larger venous area is associated with thicker RNFL among controls.  
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5.1 Introduction 
Glaucomatous optic neuropathy (GON) causes death to ganglion cells and leads to thinning of 
the retinal nerve fiber layer (RNFL), clinically apparent in the optic nerve head (ONH) as 
excavation of the cup. Study evidence has shown a strong relationship between the reductions of 
neuroretinal rim structure with deterioration of function, measured by the mean deviation (MD) 
index of the standard automated perimetry (SAP).
1-4
 
Morphological changes in glaucomatous eyes were shown to be accompanied with capillary 
drop-out. Gottanka and associates
5
 autopsied POAG eyes and concluded that the capillary count 
and capillary density was reduced in the region of ONH retro laminar area, relative to healthy 
eyes. In addition, various imaging studies suggested vascular narrowing in eyes with POAG.
6-8
 It 
is however unsure whether capillary drop-out and vascular alterations in glaucoma are a primary 
cause, or a secondary phenomenon to the disease. Regardless, the alteration in vascular structure 
in POAG eyes may have an impact to vascular haemodynamics. 
In the previous chapter, we demonstrated a significant reduction in venous flow and venous 
velocity in POAG patients (Chapter 4, section 4.3.3). We have also presented that the RNFL 
thickness in the POAG group was significantly thinner than the controls (Chapter 4, section 
4.3.1). The relationship between retinal haemodynamics and the structural glaucomatous damage 
is still not clear. This study thus, was conducted to investigate the relationship between retinal 
haemodynamics and RNFL thickness in patients with POAG. It is hypothesized that the 
haemodynamics impairment is related to the RNFL loss.  
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5.2 Methods 
5.2.1 Participants  
The Research Ethics Boards of the University Health Network, University of Toronto, and the 
Office of Research Ethics of the University of Waterloo approved the study. The study follows 
the Declaration of Helsinki and written consent was obtained prior to data collection. Two 
groups were recruited comprising a POAG group and a group of age matched healthy controls. 
All healthy participants did not have any immediate history of glaucoma or diabetes, and had 
normal visual field (VF). All participants had a corrected log MAR visual acuity (VA) of 0.3 or 
better in each eye with ametropia less than ±6.00DS and ±2.50DC. Program 24-2 SITA Standard 
of the Humphrey Visual Field Analyzer (HFA; Carl Zeiss Meditec, Dublin, CA) was undertaken, 
and the field result was deemed valid when fixation loses, false positive and false negative 
responses were less than 30%. None of the participants with POAG; had any history of other 
ocular pathology, history of ocular surgery (exception to uneventful cataract surgery), history of 
stroke or chronic lung disease, poorly controlled hypertension, diabetes mellitus and other 
endocrine diseases, ocular media opacities significant enough to hinder retinal imaging, 
pseudoexfoliation, pigment dispersion, closed iridocorneal angles, retinal/neuro-
ophthalmological disease that could result in VF defects, and blood abnormality including 
hyperviscosity. All participants were refrained from taking any caffeinated beverages and/or 
meals containing red meat four hours prior of the study to prevent bias in blood flow reading. 
Using the data from Wang and co-workers
12
, the sample size estimation for studies involving 
POAG patients using prototype Doppler SD-OCT were calculated. Homeostatic blood flow for 
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20 healthy controls was 47.6 ±5.4µL/min and 16 glaucoma patients was 34.1±4.9µL/min. The 
effect size was calculated conservatively as two-third of the difference in homeostatic blood flow 
between controls and patients, i.e. 2/3*(47.6-34.1). The standardized effect size for blood flow = 
2/3*(47.6-34.1)/((5.4
2
 + 4.9
2
) / 2)
 1/2
 =1.7. Using a two-tailed α = 0.05 and β = 0.20, the minimal 
required sample size is 9. 
5.2.2 Retinal blood flow measurement using Doppler SD-OCT 
The Optovue RTvue OCT (Optovue Inc, Freemont, CA, USA) was utilized for the Doppler 
imaging. The optical principles of this instrument have been discussed in Chapter 1 (section 
1.11.6.6), Chapter 3 (section 3.2.2) and Chapter 4 (section 4.2.3.1) of this thesis. Blood flow 
measurement was performed using the circum-papillary double circular blood flow scan, 
centered on the ONH. Doppler images were analyzed using DOCTORC software to give 
haemodynamic parameters that include total retinal blood flow (TRBF), venous area, and venous 
velocity.
9
 
5.2.3 Para-papillary RNFL thickness measurement 
Para-papillary RNFL thickness measurement was acquired using SD-OCT (RT-Vue, Optovue 
Inc., Freemont, CA) using the RNFL scan mode. RNFL scan mode measures nerve fiber layer 
thickness along a circular diameter of 3.45mm around the ONH centre. The OCT completes 4 
circular scans in 0.16s and values are averaged and presented within the normative range. Three 
scan repetitions were obtained, and values from each scan were added and averaged. Only 
images with signal strength >40 were used in the analysis. The para-papillary RNFL sectors 
considered in this study were global (mean), superior quadrant, and inferior quadrant thickness. 
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The SD-OCT segmentation algorithm was manually checked and at least the best 3 scans were 
taken into the analysis.  
5.2.4 Procedures 
All participants underwent a standard assessment including refraction, log MAR VA, program 
24-2 SITA-standard HFA, Goldmann tonometry, resting blood pressure measurement, and 
fundus imaging. The study eye was determined in the POAG group based upon the study criteria, 
but was chosen randomly in the control group. Selected eye was dilated using 0.5% tropicamide 
(Alcon, Mississauga, Canada). The participants were seated and rested for at least 10 minutes to 
stabilize baseline cardiovascular parameters. The participant’s head was stabilized on the OCT’s 
chin rest. Participant was then instructed to look at the internal fixation target. A real-time video 
display of the fundus was used to aid Doppler imaging. An average of 6 scans were taken at two 
different beam alignment; 3 scans were made with the beam passing through the superonasal 
pupil edge, and another 3 were made through inferonasal pupil edge. Three scans of the para-
papillary RNFL thickness measurement were then executed using RNFL scan mode. Color 
fundus image and high definition 3D disc scan image were also taken to aid blood flow grading.  
5.2.5 Statistical analysis 
All data were presented in mean ± standard deviation. Normality of data was tested using Wilk-
Shapiro test. One-way analysis of variance (ANOVA) was employed to compare demographic 
values between groups, RNFL thickness and retinal haemodynamics. Pearson product-moment 
correlation analysis was used to study correlation between RNFL thickness and haemodynamics, 
and between RNFL thickness and VF indices. Upon comparing haemodynamic parameters to 
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MD, the values were converted to decibel (dB) scale by 10 x log10 [value/(average value of the 
normal group)]. The significance level (p) was taken at ˂0.05. All statistical analyses were 
employed using STATISTICA (StatSoft Inc., Tulsa, OK, USA) version 11.0.  
5.3 Results 
5.3.1 Demographic data 
The demographic of participants are shown in Table 5.1. Thirty three participants in each group 
were recruited with 13 males in the control and 15 males in the POAG group. No significant 
difference for age (p=0.253), VA (p=0.190), intraocular pressure (IOP; p=0.281), systolic blood 
pressure (SBP; p=0.912), diastolic blood pressure (DBP; p=0.876), and mean ocular perfusion 
pressure (MOPP; p=0.704) were noted between groups. The controls had thicker cornea 
(539.48±33.23µm) compared to POAG (520.18±34.65µm; p=0.024). The POAG group showed 
worse MD (p=0.016) and pattern standard deviation (PSD; p<0.001) compared to the controls 
(Figure 5.1). In general, the visual field MD and PSD indices can be interpreted as representing 
an early POAG group. 
In the control group, 2 participants were taking systemic hypertensive-lowering medications, 
while 6 patients were on the same medications. The number of patients in the POAG group who 
were taking beta-blockers for glaucoma was 12.  
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 Controls POAG p (ANOVA) 
Number 33 33 - 
Male : Female 13 : 20 15 : 18 - 
Age (Years) 62.86±5.32 64.84±8.31 0.253 
VA (log MAR) 0.03±0.07 0.05±0.08 0.190 
IOP (mmHg) 14.54±2.50 13.80±2.95 0.281 
SBP 125.72±11.91 126.15±19.01 0.912 
DBP 77.44±6.74 77.06±12.04 0.876 
MOPP 47.81±5.05 48.48±8.77 0.704 
CCT (µm) 539.48±33.23 520.18±34.65 0.024 
MD (dB) -0.52±1.44 -2.28±3.85 0.016 
PSD (dB) 1.80±0.68 4.07±3.72 <0.001 
Patients taking β-
blockers for 
glaucoma 
- 12 - 
Participants taking 
systemic hypotension 
medication 
2 6 - 
 
Table 5.1: Participants’ demographic values presented as mean ± standard deviation. One-way ANOVA was used to 
compare parameters between groups.  
[VA = visual acuity, IOP = intraocular pressure, SBP = systolic blood pressure, DBP = diastolic blood pressure, 
MOPP = mean ocular perfusion pressure, CCT = central corneal thickness, MD = mean deviation, PSD = pattern 
standard deviation]  
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Figure 5.1: Box plot of mean deviation (MD) and pattern standard deviation (PSD) of each group measured using 
Humphrey Visual Field Analyzer. One-way ANOVA showed that the POAG group has worse visual field indices 
compared to the controls. 
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5.3.2 RNFL thickness profile 
Table 5.2 shows the RNFL profiles for both groups. The mean, superior and inferior RNFL 
thickness in the POAG group are significantly thinner than the control group (p<0.001, Figure 
5.2).  
RNFL (µm) Controls POAG p (ANOVA) 
Mean thickness 100.04±9.58 82.65±11.85 <0.001 
Superior quadrant 100.36±10.36 84.81±11.84 <0.001 
Inferior quadrant 99.65±9.95 80.99±13.82 <0.001 
 
Table 5.2: The retinal nerve fiber layer (RNFL) thickness values presented as mean ± standard deviation. One-way 
ANOVA was used to compare parameters between groups. [RNFL = retinal nerve fiber layer, POAG = primary 
open angle glaucoma] 
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Figure 5.2: Box plot for the retinal nerve fibre layer (RNFL) thickness profiles for the control group and the 
primary open angle glaucoma (POAG) group; A) mean RNFL thickness, B) superior RNFL thickness, and C) 
inferior RNFL thickness. One-way ANOVA revealed that the POAG group has thinner RNFL for all RNFL profiles 
(p<0.001).  
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5.3.3 Retinal Haemodynamics 
Table 5.3 shows the retinal haemodynamics for the control and POAG groups. In general, the 
POAG group showed significantly lower values compared to the healthy control group. TRBF 
was 30.61±9.29µL/min in POAG, compared to 40.68±11.32µL/min in controls (p<0.001, Figure 
5.3A). The superior RBF and inferior RBF were also significantly lower in POAG (p=0.001, and 
p=0.004 respectively, Figure 5.3B and Figure 5.3C). The venous area in the control group was 
larger by approximately 14% than the POAG group (p=0.003, Figure 5.4). The venous velocity 
was also reduced in the POAG group with values lower by approximately -18% than those in the 
control group (p=0.003, Figure 5.5). 
 
Retinal 
haemodynamics 
 
Controls 
 
POAG 
p 
(ANOVA) 
TRBF (µL/min) 40.68±11.32 30.61±9.29 <0.001 
Superior RBF 
(µL/min)  
20.38±5.30 15.56±6.01 0.001 
Inferior RBF 
(µL/min) 
20.30±8.17 15.05±6.12 0.004 
Venous area (mm
2
) 47.31±7.06 (x10
-3
) 41.67±7.97 (x10
-3
) 0.003 
Venous velocity 
(mm/s) 
14.28±3.19 12.12±2.31 0.003 
Table 5.3: Retinal haemodynamics values presented as mean ± standard deviation. One-way ANOVA was used to 
compare parameters between groups. [TRBF = total retinal blood flow, RBF = retinal blood flow, POAG = primary 
open angle glaucoma] 
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Figure 5.3: Box plot for retinal blood flow (RBF) profiles for the control group and the primary open angle 
glaucoma (POAG) group; A) total retinal blood flow, B) superior retinal blood flow, C) inferior retinal blood flow. 
One-way ANOVA revealed that the POAG group has lower values for all the retinal blood flow parameters 
(p≤0.004).   
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Figure 5.4: Box plot for venous area for the control group and the primary open angle glaucoma (POAG) group. 
One-way ANOVA revealed POAG has a significantly smaller venous area than the controls (p=0.003). 
 
 
Figure 5.5: Box plot for venous velocity for the controlgroup and the primary open angle glaucoma (POAG) group. 
One-way ANOVA revealed that the POAG group has significantly slower venous velocity than the controls 
(p=0.003).  
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5.3.4 Correlation analysis between retinal haemodynamics, RNFL thickness profile, and 
visual field sensitivity  
5.3.4.1 Control group 
Table 5.4 shows the correlation analysis between RNFL thickness, haemodynamics, and visual 
field sensitivity in the control group. The relationship between mean RNFL thickness and venous 
area was significant (r=0.58, p<0.001; Figure 5.6). The other retinal haemodynamic parameters 
did not show a relationship with RNFL thickness, although TRBF has a tendency to be higher 
with increase in mean RNFL (r=0.30, p=0.09). The RNFL thickness and MD did not show any 
significant association.  
Correlation analysis between retinal haemodynamic parameters and MD did not show any 
association. 
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Correlation between r p 
Mean RNFL  thickness TRBF 0.30 0.089 
Superior RNFL thickness Superior RBF 0.23 0.204 
Inferior RNFL thickness Inferior RBF 0.28 0.113 
Mean RNFL  thickness Venous area 0.58 <0.001 
Mean RNFL  thickness Venous velocity -0.11 0.529 
Mean RNFL  thickness 
(dB) 
MD 0.06 0.761 
Superior RNFL thickness 
(dB) 
MD 0.12 0.49 
Inferior RNFL thickness 
(dB) 
MD -0.01 0.94 
 
Table 5.4: Pearson product-moment correlation coefficient (r) and significance value (p) for correlation analysis 
between retinal nerve fiber layer thickness, retinal haemodynamics, and visual field sensitivity in the healthy control 
group. [RNFL = retinal nerve fiber layer, TRBF = total retinal blood flow, RBF = retinal blood flow, MD = mean 
deviation] 
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Figure 5.6: Scatterplot of mean RNFL against venous area in the control group. Pearson product-moment 
correlation coefficient shows a medium positive relationship, r=0.58 (p<0.001).  
 
5.3.4.2 POAG group 
Table 5.5 shows the correlation analysis between RNFL thickness, haemodynamics, and visual 
field sensitivity in the POAG group. Mean RNFL was observed to have a moderate correlation 
with TRBF (r=0.38, p=0.03; Figure 5.7). Superior RBF was also found to have a moderate 
positive relationship with superior RNFL thickness (r=0.37, p=0.03; Figure 5.8). Inferior RBF 
had a tendency to be higher in thicker inferior RNFL (r=0.31, p=0.09). Venous area showed a 
moderate positive correlation with mean RNFL (r=0.35, p=0.05; Figure 5.9). No relationship was 
observed between venous velocity and mean RNFL thickness in POAG group (r=0.25, p=0.15). 
The structure-function relationship between mean RNFL thickness and MD showed a strong 
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positive relationship (r=0.63, p<0.001; Figure 5.10). The superior and inferior RNFL thickness 
also showed correlation with MD (r=0.47, p=0.006; r=0.70, p<0.001, respectively). 
Correlation analysis between retinal haemodynamics and MD did not show any association.  
  
Correlation between r p 
Mean RNFL  thickness TRBF 0.38 0.028 
Superior RNFL thickness Superior RBF 0.37 0.032 
Inferior RNFL thickness Inferior RBF 0.30 0.085 
Mean RNFL  thickness Venous area 0.35 0.050 
Mean RNFL  thickness Venous velocity 0.25 0.154 
Mean RNFL  thickness (dB) MD 0.63 <0.001 
Superior RNFL thickness 
(dB) 
MD 0.47 0.006 
Inferior RNFL thickness 
(dB) 
MD 0.70 <0.001 
 
Table 5.5: Pearson product-moment correlation coefficient (r) and significance value (p) for correlation analysis 
between the retinal nerve fiber layer thickness and the retinal haemodynamics, and visual field sensitivity in the 
POAG group. [RNFL = retinal nerve fiber layer, TRBF = total retinal blood flow, RBF = retinal blood flow, MD = 
mean deviation] 
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Figure 5.7: Scatterplot of mean RNFL against total retinal blood flow in the POAG group. Pearson product-moment 
correlation coefficient shows a medium positive relationship (r=0.38, p=0.03). 
 
 
Figure 5.8: Scatterplot of superior RNFL against superior quadrant retinal blood flow in the POAG group. Pearson 
product-moment correlation coefficient shows a medium positive relationship, r=0.37 (p=0.03). 
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Figure 5.9: Scatterplot of mean RNFL against venous area in the POAG group. Pearson product-moment 
correlation coefficient shows a medium positive relationship, r=0.34 (p=0.05). 
 
Figure 5.10: Scatterplot of mean (blue), superior (red), and inferior (green) RNFL thickness (in decibel) against 
MD in the POAG group. Pearson product-moment correlation coefficient shows a strong relationship for all RNFL 
profile. [RNFL=retinal nerve fiber layer, MD=mean deviation, dB=decibel, POAG=primary open angle glaucoma] 
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5.4 Discussion 
As expected, POAG patients showed a significant reduction in the RNFL thickness, relative to 
healthy eyes. All three RNFL profiles, namely the mean, superior and inferior RNFL were 
valued around 83µm in glaucoma group, in comparison to 100µm in the control group. Retinal 
flow was lower in the glaucoma patients, with venous total retinal blood flow recorded at 
31µL/min, compared to 41µL/min in the healthy group. The glaucoma group also recorded a 
significantly smaller venous area and venous blood velocity compared to the healthy controls. 
This observation is in agreement with other reports in the literature which have used the same 
flow measuring methodology.
10-12
 The lower haemodynamic values in the glaucoma group 
indicates vascular components in its pathogenesis. Previous work has shown that there is an 
association between structural changes in the retinal vessel wall and neural loss in glaucoma, 
which could be independent to IOP.
5, 13
  
Retinal haemodynamic parameters are significantly correlated with RNFL loss in the early 
POAG group. In this current study, our analysis indicated that the total RBF is reduced in thinner 
mean RNFL, and superior RBF being lower in thinner superior RNFL. In addition, lower venous 
velocity is correlated with a thinner mean RNFL. The significant correlations, in general, suggest 
a vascular component in the early POAG pathology.  Reduction in blood flow or blood velocity 
may primarily promote the disease, or, a secondary effect as a result of the RNFL loss. 
Regardless, the association confirms perfusion impairment in POAG. We also saw significant 
associations between RNFL loss and visual field deterioration, although we did not find 
associations between retinal haemodynamics and field loss. Nevertheless, since haemodynamics 
reduction is correlated with RNFL loss, it may be possible that the haemodynamic impairment 
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may lead to field deterioration, although this may need further investigation. To confirm this 
hypothesis, it is suggested that in the future, retinal blood flow and RNFL thickness is monitored 
over time.  
The association between ocular haemodynamics and RNFL structure was a subject of interest of 
many groups, and studies have been conducted using various methods on different ocular 
vessels. Association between RNFL thickness and vascular parameters were evident in 
retrobulbar,
14, 15
 ONH,
16-22
  retinal
10, 17, 23
 and choroidal blood vessels
17
. Some studies showed no 
relation between these parameters,
10, 17, 19
 but most have reported relationships between reduced 
haemodynamics and RNFL loss.
14, 15, 17, 18, 20
  Hwang and associates
10
 using Doppler SD-OCT on 
subjects with perimetric glaucoma cohort saw associations between field loss with reduced 
retinal flow and reduced RNFL thickness. They failed to see any relationship between reduced 
blood flow and RNFL loss, which lead them to conclude that impaired flow and structural loss 
are independent determinant of field deterioration. It is not clear why we observed a different 
result, but we speculated that it may be attributed to the different patient composition. The 
POAG subjects in the prior work had more severe field loss than ours, with lower MD of -
4.39dB and PSD of 6.54 dB, compared to our sample with -2.28dB and 4.07dB, respectively. Of 
note, the same group published an earlier pilot data where they reported a strong correlation 
between flow with visual field loss in 19 perimetric glaucoma patients (r=0.83, p=0.003).
12
  
A few studies reported a different observation with an inverse association between RNFL 
structure and retinal flow in POAG.
16, 23
 They argued that neural layer thinning in GON is 
associated with an increase in flow as a result of compensatory response attributed to 
autoregulation. It was further speculated that the relationship between flow and progressing 
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glaucoma is bimodal, where an up-regulation in flow occurs in the beginning of the disease until 
a certain critical point, and afterwards will gradually decrease with progression.
23
 Nevertheless, 
this theory cannot be clarified and a longitudinal study measuring blood flow over the course of 
glaucoma progression needs to be undertaken. A longitudinal study on macaque eyes, was in 
agreement with this hypothesis of bimodal flow alteration.
24
 Following experimental glaucoma 
for an mean of 8 months, the ONH flow as measured using laser speckle flowgraphy was 
observed to increase during 10% of RNFL loss, which later reduced when nerve fiber layer 
further deteriorated. The authors speculated that induction of experimental glaucoma, by means 
of increasing IOP, caused vascular dysregulation which leads to altered perfusion level. They 
further theorized that the increment in flow may also be justified to an increased metabolism due 
to energy demand up-take caused by ONH gliotic alterations or lamina cribosa remodeling.  
A lower flow value in POAG and its association with neural loss, and vision loss, can be 
explained in a number of ways. The simplest explanation may be attributed to the supply and 
demand theorem whereby neural loss reduces metabolic needs,
25 
which eventually results in 
lower perfusion. At the same time, the neural loss will affect the visual field. Alternatively, 
vascular deficits may exist before alteration to neural count or field sensitivity.
26
 Ischaemia as a 
result to vascular dysregulation, in combination with other factors such as elevated pressure may 
impact the neural layer, leading to RNFL loss and eventually field loss. Another possible 
explanation is that flow reduction may cause field loss independently to neural loss, as well as 
neural loss can cause field loss independently to impaired flow.
10
 Cherecheanu and colleagues
27
 
proposed a model to explain vascular involvement in the development and progression of GON. 
They suggested two levels of attack to the neural beds which dampen the retinal ganglion cell 
axons. Primary insult occurs in the ONH region, taking form in an increase of IOP and ischaemia 
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of the post-laminar nerve bundle. Cerebrospinal fluid pressure, together with surrounding 
tissues’ biomechanical properties play their role to modulate the primary insult. This initial insult 
causes ganglion cells to function at a reduced level resulting in increased vulnerability to further 
damage. Secondary insults may occur when perfusion pressure falls beyond the autoregulation 
limit, or failure of neurovascular coupling (perfusional needs following neural activity).  
It has been suggested by Kochkorov and co-workers
28
 that a low level reduction in perfusion will 
result in tissue atrophy over the long term but will avoid clinically visible infarction. Fluctuation 
of perfusion, however, is claimed to be damaging as it promotes oxidative stress to the tissue 
bed. Based on the ischaemia-perfusion damage concept, free oxygen radicals are abundant 
during reperfusion after an ischaemic attack.
28
 Varying perfusion levels prompt a varying oxygen 
supply, hence, triggering a cascade of reperfusion damage stemming from oxidative stress. 
Erratic perfusion has been associated with glaucomatous damage.
29, 30
 Kochkorov and co-
workers
28
 reported that the POAG patients have a significantly higher variability in blood 
pressure and choroidal blood flow compared to controls and ocular hypertensives. In a different 
study, it was reported that POAG patients with more severe field defect have higher variability in 
para-papillary blood flow, compared to POAG patient with less field defect, and controls.
19
 
The regular clinical assessment to monitor glaucoma progression is usually comprises the 
assessment of neural morphology and visual function. Additionally, improved diagnosis can be 
made by combining structural and functional discriminant functions, rather than making 
diagnosis based on function or neural structure alone.
31
 On top of this, pairing the assessment of 
structural features with ocular perfusion evaluation allows scientists to discriminate other 
glaucoma risk factors independent to IOP. A clinical risk factor of vascular origin should be 
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taken into consideration, especially in cases where progression exists despite well controlled 
IOP. Nevertheless, the clinical role for retinal haemodynamic measurement and the relevance of 
vascular alterations are still ambiguous. Further study is needed.This study has some limitations. 
First, the POAG patients recruited are confined to early POAG with relatively small field 
sensitivity depression. It would be interesting to see the relationship between haemodynamics, 
neural structure, and field loss, in more advanced glaucoma. However, Doppler imaging may be 
difficult in patients with poor vision as they may experience difficulty to fixate which is pivotal 
for reliable, valid, scans. Secondly, a cross-sectional design study like this can only identify 
associations rather than to identify causations. Although correlation analysis is highly suggestive, 
yet debatable, of causation, further investigation using different study designs is needed to equate 
the link between perfusion, neural structure and visual function, in glaucoma. 
To summarize, the reduction of venous blood flow and blood velocity among early POAG 
patients is associated with neural structure loss. Impaired haemodynamics in early POAG group, 
together with non-correlating parameters in the control group signifies vascular dysfunction in 
our early POAG group. Whether this is primary or secondary of the disease is equivocal. 
Prospective longitudinal clinical trial studies are warranted to test the prognostic value of 
impaired retinal haemodynamics in POAG.  
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6 Vascular reactivity in primary open angle glaucoma patients 
with differing nocturnal blood pressure status  
 
 
 Concept/Design Recruitment Acquisition 
of data 
Analysis Write-up 
Yusof, F X X X X X 
Hudson, C X   X X 
Cheng, R  X X   
Buys, YM X X   X 
Trope, GE X X   X 
Flanagan, JG X   X X 
Table detailing role of each person (X denotes significant contribution). 
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Purpose: To evaluate the vascular reactivity in patients with primary open angle glaucoma 
(POAG) with different nocturnal blood pressure (NBP) profiles using normoxic hypercapnia. 
Methods: Nocturnal and diurnal blood pressure data was collected using 48 hours ambulatory 
blood pressure monitoring (ABPM). The NBP reduction (NBPR) magnitude was calculated by 
taking the difference between mean arterial pressure (MAP) during the day and night while 
awake and asleep, respectively. The study included 17 healthy controls (group mean age 
61.9±6.8 years; group mean NBPR 13.5±8.2%); 17 POAG with normal NBPR (age 66.1±9.2 
years; NBPR 10.9±4.7%); and 16 POAG with high NBPR (age 63.5±7 years; NBPR 
24.1±4.0%). An automated gas sequencer (Respiract™, Thornhill Research Inc., Toronto, 
Canada) was used to achieve normoxic hypercapnia (15% increase in the end-tidal carbon 
dioxide partial pressure, PETCO2, relative to homeostatic baseline). Retinal haemodynamics were 
measured using the Doppler SD-OCT in the RTVue system (Optovue Inc., Freemont, CA), and 
bi-directional Laser Doppler Velocimetry with simultaneous vessel densitometry (BLDV-SVD) 
in the Canon Laser Blood Flowmeter 100 (CLBF; Canon, Inc., Tokyo, Japan). Six blood flow 
scans were acquired for each instrument during baseline, normoxic hypercapnia, and recovery 
period.  
Results: Using Doppler SD-OCT, there was no change in retinal haemodynamics in response to 
normoxic hypercapnia in the high NBPR POAG group. Normal NBPR POAG group showed a 
significant increase in the TRBF (3.82±4.71µl/min; reANOVA p=0.01). The control group 
demonstrated a significant increase in the TRBF (8.20±10.75µl/min, p<0.01) and velocity 
(2.41±3.33mm/s, p<0.01). Comparison between normal NBPR, high NBPR and control groups 
showed that velocity change in response to hypercapnia was significantly smaller in the high 
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NBPR group (-0.58±3.10mm/s) than the controls (2.41±3.33mm/s; Tukey HSD p=0.01). TRBF 
change in the high NBPR group was significantly lower (0.95±8.64µL/min), in comparison to 
the controls (8.20±10.75µL/min; Tukey HSD p=0.04). The BLDV-SVD did not show any 
significant vascular hemodynamic differences between POAG with normal NBPR, POAG with 
high NBPR and control groups. 
Conclusions: Patients with POAG who exhibited an exaggerated nocturnal reduction in MAP 
also demonstrated vascular dysregulation.  
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6.1 Introduction 
Glaucoma is a multifactorial disease of the optic nerve resulting in progressive loss of ganglion 
cells, distinctive changes to the optic nerve head (ONH) structure and visual field defects. 
Glaucoma has increasingly been accepted as a manifestation of both ocular and systemic risk 
factors. Multiple studies have suggested that glaucomatous optic neuropathy (GON) seems to be 
associated with changes in ocular haemodynamics in the ONH,
1
 retina,
2, 3
 choroid
4
 and 
retrobulbar area
5
. Some studies have even found reduced blood flow in the brain
6
 and peripheral 
vasculatures of patients with glaucoma
7
. Although those reports indicated peculiarities in the 
vascular system, it is still unknown whether haemodynamic changes cause nerve degeneration, 
or if they occur secondary to the disease itself. It is hypothesized that the involvement of 
vascular risk factors in glaucoma may be due to vasospasm or dysregulation, or both.
8, 9
  
Autoregulation is defined as the ability of a vascular tissue to maintain stable blood supply 
despite changes to perfusion pressure.
10
 Vascular reactivity is the measurement of change in the 
retinal blood flow, to provocation, designed to drive the retinal vascular system to the extremes. 
Our group has previously investigated retinal vascular reactivity using mixtures of oxygen (O2) 
and carbon dioxide (CO2) in healthy
11-15, 49
 and diseased cohorts.
3, 16, 17
  
O2 is known as a potent vasoconstrictor while CO2 is a potent vasodilator.
8, 15, 18
 An increase in 
the arterial partial pressure (Pa) of CO2, termed as hypercapnia, can be indirectly measured from 
the peak concentration of CO2 during expiration, as indicated by the parameter end-tidal partial 
pressure (PET). It has been demonstrated that hypercapnia causes vasodilation in healthy retinal 
vessels, raising the retinal blood flow.
14
 Thus, the absence of reactivity in lieu with the CO2 
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increase represent deficient vascular reactivity which, in turn, may suggest an impaired 
autoregulation in the vascular bed. Using hypercapnia stimulus, Venkataraman and associates
3
 
have shown that untreated primary open angle glaucoma (POAG) patients did not experience 
significant change in their haemodynamics as measured using bi-directional laser Doppler 
velocimetry with simultaneous vessel densitometry (BLDV-SVD). However, treated POAG 
patients and healthy controls were observed to have a significant increase for their arteriolar 
diameter, blood velocity and blood flow.  
The cardiovascular system exhibits variability following the circadian rhythm and experiences a 
slow down during sleep. The nocturnal blood pressure (NBP) reduces normally 10-20%, or 
15mmHg from its diurnal value.
19, 20
 It has been advocated that the decline at night is due to the 
physiological attenuation in the sympathetic tone.
21
 An exaggerated nocturnal hypotensive 
condition, in theory, may cause ischemia to organs such as the eye, especially in people with 
impaired autoregulation.
19, 22, 23
 Graham and co-workers
19
 in their study have reported an 
association between POAG and excessive NBP reduction (NBPR). They had observed lower 
values in the nocturnal BP parameters among POAG patients with progressive field defect, in 
comparison to POAG patients with stable field. Gherghel and co-workers
24
 have evaluated the 
relationship between NBPR and retrobulbar blood flow using colour Doppler imaging (CDI) on 
patients with POAG. They reported lower blood velocity in the central retinal artery in the 
POAG group with high NBPR compared to POAG groups with normal and lower NBPR. We 
observed a similar finding in the retinal vessels, as reported in chapter 4 (Section 4.3.3). Caprioli 
& Coleman
20
 calculated that ocular perfusion pressure (OPP) is increased about 15mmHg, due to 
the position of the hydrostatic column pressure, when a person sleeps in a typical supine 
position. Thus, the NBP should fall more than 15mmHg for the OPP to cause an ischemic insult. 
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Reduction of such value is equal to an NBP fall of more than 20%, i.e. in patient with high 
NBPR. 
In chapter 4, we have demonstrated that glaucoma patient whom exhibits extreme NBPR have a 
significantly lower homeostatic retinal blood flow and smaller venous area, compared to the 
healthy controls. It is not clear whether a differing characteristic of the NBPR would also exhibit 
different vascular reactivity. To the best of our knowledge, there has been no study that has 
addressed this and related questions. Hence, this study was aimed to determine the relationship 
between NBPR status and vascular reactivity in subjects with POAG, using normoxic 
(homeostatic level oxygen partial pressure, PaO2) hypercapnia provocation. It is interesting to 
determine whether increased NBPR is truly a manifestation of vascular dysregulation in a POAG 
cohort.  
6.2 Methods 
6.2.1 Participants  
The study was approved by the Research Ethics Boards of the University Health Network, 
University of Toronto and the Office of Research Ethics of the University of Waterloo. Written 
informed consent was obtained prior to the commencement of the Procedures with participants 
being explained to the nature and probable consequences of the study according to the 
Declaration of Helsinki. Non-smoking, treated patients with POAG and age-matched healthy 
controls were recruited. POAG patients were recruited from the Toronto Western Hospital 
glaucoma clinic, and their diagnosis was made by a glaucoma specialist (either YMB or GET).  
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All participants had a corrected log MAR VA of 0.3, or better, in each eye with ametropia less 
than ±6.00DS and ±2.50DC. Automated perimetry comprising Humphrey Visual Field Analyser 
(HFA) program 24-2 with SITA Standard thresholding was undertaken on all participants and 
the result was deemed valid when fixation losses, false positive and false negative responses 
were less than 30%. All healthy participants did not have any immediate history of glaucoma or 
diabetes and had a normal visual field (VF). None of the participants with POAG; had any 
history of other ocular pathology, history of ocular surgery (exception to uneventful cataract 
surgery), history of stroke and chronic lung disease, poorly controlled hypertension, diabetes 
mellitus and other endocrine diseases, ocular media opacities significant enough to hinder retinal 
imaging, pseudoexfoliation, pigment dispersion, closed iridocorneal angles, retinal/neuro-
ophthalmological disease and blood abnormalities including hyperviscosity. All participants 
were refrained from taking any caffeinated beverages and/or meals containing red meat four 
hours prior of the study to prevent the potential impact of diet related extraneous factors that may 
impact flow readings. Caffeine consumption has been shown to constrict ocular vessels,
25-27
 
while red meat induces vasodilatation.
28
 Participants with POAG were further divided into 
groups based on their NBPR profile; normal NBPR of <20%, and high NBPR of ≥20%). By 
calculation, the OPP is increased about 15mmHg when a person takes a supine position to sleep 
due to hydrostatic column pressure.
20
 Thus, the NBP should reduced more than 15mmHg, or 
more than 20% than the diurnal value to potentially cause an ischemic insult. During the Doppler 
measurements, the operators (FY and RC) were masked to the NBPR status of the participants.  
Using data from Venkataraman and co-workers
3
, arteriolar blood flow change from baseline to 
hypercapnia for treated POAG group was ~25±11%). Assuming that retinal blood flow changed 
is reduced by 50% in the group with an exaggerated NBPR, the standardized effect size was 
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calculated as (0.5*25%)/11=1.14. Using a two-tailed α = 0.05 and β = 0.20, the minimal required 
sample size is 15. 
6.2.2 Ambulatory blood pressure monitoring (ABPM) 
The A&D TM2430 ambulatory blood pressure recorder system (A&D Co. Ltd., Saitama, Japan) 
was used in the study. All participants were monitored for 48 hours, and the measurement 
frequency was set at every half an hour. The ambulatory BP monitoring was done in the 
participants own home. The A&D ABPM Data Analysis Software for windows (A&D Co. Ltd., 
Saitama, Japan) was utilized for analysis. Mean arterial pressure (MAP) was used to calculate the 
NBPR profile. Explanation of the formula to calculate MAP and NBPR profile was fully 
explained in Chapter 1(section 1.8.1.1) and Chapter 4 (section 4.2.2).  
6.2.3 Gas delivery system and provocation 
A sequential gas delivery (SGD) breathing circuit (HiOx, Viasys Healthcare Inc, Yorba Linda, 
California) was used together with an automated gas sequencer (RespirAct
TM
, Thornhill 
Research Inc., Toronto, Canada). The SGD circuit comprised of two gas reservoirs and a face 
mask (Figure 6.1). The automatic gas sequencer supplies fresh gas into the inspiratory reservoir, 
while breathed gas fills the expiratory reservoirs. Each reservoir is connected to the mask with a 
separate one-way valve. The two reservoirs are interconnected by a positive end-expiratory 
pressure (PEEP) valve, which enables participants to rebreathe the exhaled gas in situations 
where fresh gas reservoir is emptied. Participant’s values of metabolic O2 consumption (VO2) 
and metabolic CO2 production (VCO2), together with their basal PETO2 and PETCO2, are entered 
in the RespirAct
TM
 program in order for the software to compute the needed gas concentrations 
166 
 
to achieve the targeted PET value. The novelty of the breathing system with the SGD circuit and 
the automated gas sequencer is its efficiency to target the desired PET concentrations and to 
maintain the stability of the PET concentrations.
11-14
 The system is able to manipulate O2 or CO2 
PET concentration independently, irrespective of minute ventilation.
29
   
 
Figure 6.1: Schematic diagram of sequential gas delivery (SGD) circuit. [PEEP = positive end-expiratory pressure] 
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6.2.4 Instrumentation  
6.2.4.1 Retinal blood flow measurement using Doppler SD-OCT 
The Optovue RTvue OCT (Optovue Inc, Freemont, CA, USA) was utilized for the prototype 
Doppler imaging. The optical set-up of this instrument has been discussed in detail previously in 
Chapter 1 (section 1.11.6.6), Chapter 3 (section 3.2.2) and Chapter 4 (section 4.2.3.1). Blood 
flow measurement was performed using the circum-papillary double circular blood flow scan, 
centred on the ONH. The concentric scan transects all retinal arterioles and venules around the 
ONH using two concentric circles.
30
 In a single blood flow scan, six dual circular frames were 
taken consecutively over 2 seconds, and then were averaged.
31
 Doppler images taken were then 
analysed and processed externally using software to generate haemodynamic parameters which 
included the total retinal blood flow, venous area, and blood velocity. 
6.2.4.2 Bidirectional laser Doppler velocimetry with simultaneous vessel densitometry 
(BLDV-SVD) in the Canon Laser Blood Flowmeter (CLBF) 
The CLBF utilizes the Doppler principle to assess blood flow in absolute unit. The instrument 
measures the Doppler shift produced by the fastest moving blood particles in the central part of a 
vessel. It measures blood velocity and vessel diameter simultaneously to calculate the rate of 
retinal blood flow.
3, 11, 32
 The CLBF can only measure one blood vessel at a time, hence the 
measurement site for this study was standardized at the superotemporal retina, on a straight 
segment of an arteriole that lies within one to two disc diameter to ONH. Detailed explanation on 
the instrument has been described in Chapter 1 (section 1.11.6.5) and Chapter 4 (section 4.2.3.3).  
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6.2.5 Procedures 
Each participant attended two visits. During visit 1 after testing for eligibility, morphometric 
retinal scans were acquired using the RTVue Doppler SD-OCT, with each scan being repeated 
three times. The choice of selected eye was often driven by study recruitment criteria in the 
POAG groups, but was chosen randomly in the controls group. The ABPM device was attached 
to the upper arm of every participant at the end of the first visit. Patients were instructed in the 
appropriate response to obvious instrument malfunction and instrument induced discomfort.  
Participants returned to the lab after 48 hours and the ambulatory BP readings were collected. 
The study eye was then dilated with tropicamide 0.5% (Mydriacyl 0.5%, Alcon Laboratories, 
Mississauga, Canada). Participants were then rested for a period of time, often 10 to 15 minutes, 
until their cardiovascular parameters stabilized.  
Using Tegaderm
TM
 adhesive tape (3M Health Care, St Paul, Minnesota), the face mask (HiOx, 
Viasys Healthcare Inc, Yorba Linda, California) which connected to the automated gas flow 
controller was then attached to the participants face. The absolute integrity of the mask fitting to 
the face was then inspected so that it provided a 100% seal and so that it covered both the mouth 
and nose. Inspired and expired gas concentrations were monitored and sampled continuously. 
Blood pressure, heart rate, and oxygen saturation were monitored using a rapid response critical 
care gas analyser (Cardiocap 5, Datex-Ohmeda, Helsinki, Finland) throughout the procedures. 
The retinal hemodynamic that was measurement consisted of six BLDV-SVD readings and 6 
circum-papillary double-circular scan protocol in the Doppler SD-OCT, in each of the following 
3 breathing conditions; 
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i) Baseline homeostatic breathing. Participants breathed room air. The retinal blood flow 
measurements were taken to establish baseline hemodynamic parameters. 
ii) Normoxic hypercapnia. The PET CO2 was increased 15% relative to the homeostatic 
baseline while PET O2 was kept at homeostatic level. 
iii) Recovery. The PET CO2 was reduced to original homeostatic level. 
For each breathing condition, a minimum of 5 minutes stabilization time was given prior to 
retinal blood flow imaging.  
6.2.6 Analysis 
6.2.6.1 Doppler SD-OCT blood flow analysis 
The Doppler images were processed using the semi-automated Doppler OCT of retinal 
circulation (DOCTORC) software version 2.1.1.4 (Centre for Ophthalmic Optics and Lasers, 
CA, USA). A description of the grading procedure has been explained in detail in Chapter 3 
(section 3.2.3). The Doppler image of each vessel was manually refined for its location and 
diameter boundary. A confidence score for each scan was assigned, by judging the Doppler 
strength, vessel boundary, size agreement between outer and inner rings, and the Doppler signal 
sign agreement between the outer and inner rings. An automated processing algorithm calculated 
values which included the total retinal blood flow (TRBF), venous area, and velocity. TRBF was 
calculated by summing all flow from valid venules and the estimated flow of invalid venules. 
Velocity was computed by dividing flow in valid venules to the valid cross sectional area of all 
venules.
33
 To calculate changes that resulted from the provocation (i.e. vascular reactivity 
values), values during normoxic hypercapnia were subtracted to its baseline. 
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6.2.6.2 CLBF velocity waveform analysis 
The CLBF analysis software was employed to analyse each velocity waveform. As the waveform 
could be affected by eye movement, tear film break-up, or improper measurement laser tracking, 
a standardized protocol was performed to eliminate aberrant waveforms.
32
 At least one complete 
waveform (trough-to-trough or peak-to-peak, a complete cycle) was considered as a valid 
waveform. The maximum number of acceptable waveforms in each measurement was made for 
analysis purposes. To calculate vascular reactivity, values during normoxic hypercapnia were 
subtracted to their baseline value. 
6.2.6.3 Statistical analysis 
All data were presented in mean ± standard deviation. Normality of data was tested using the 
Shapiro-Wilk test. Repeated measures Analysis of Variance (reANOVA) was performed in each 
group (i.e. normal NBPR, high NBPR, and healthy controls) to detect significance of change for 
each hemodynamic variable during homeostatic baseline, normoxic hypercapnia and recovery. 
The dependent variables for Doppler SD-OCT were change (Δ) in the total retinal venous blood 
flow (TRBF), Δ in the venous area, and Δ in the venous blood velocity, whereas for the BLDV-
SVD the variables were Δ in the arteriolar diameter, Δ in the arteriolar blood velocity, and Δ in 
the arteriolar blood flow. A separate reANOVA was executed to analyze possible changes for 
PETCO2, PETO2, respiration rate, pulse rate, systolic and diastolic BP, and oxygen saturation. 
Tukey honestly significant difference (HSD) post-hoc test was performed for any significant 
findings by reANOVA to determine the inter-condition (i.e. during baseline, hypercapnia, and 
recovery) significance.  
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One-way analysis of variance (ANOVA) was employed to compare (between groups) the 
amount of change for each haemodynamics. Tukey HSD post-hoc test was performed for any 
significant findings by ANOVA to determine the inter-group significance (i.e. normal NBPR, 
high NBPR, and healthy controls). Significance was set at p≤0.05.  
Pearson product-moment correlation analysis was used to study correlation between retinal 
vascular reactivity parameters, RNFL thickness, MD and NBPR. 
6.3 Results 
6.3.1 Demographic data  
Table 6.1 summarizes the demographic of the participants for both sessions. Seventeen POAG 
patients with normal NBPR, 16 POAG patients with high NBPR, and 18 healthy controls were 
recruited. In the healthy control group, one participant was excluded for the SD-OCT, reducing 
the number of analyzed data sets to 17. A different participant was also excluded in the healthy 
control group for the BLDV-SVD, reducing the number of analyzed data sets to 17. Two POAG 
patients with normal NBPR and 1 POAG patient with high NBPR were excluded in the BLDV-
SVD analysis, reducing the number to 15 in each group. The reason for exclusion was these 
participants were fatigued and were unable to continue with the procedure.  
Participants who completed the Doppler SD-OCT showed mean NBPR of 24.06±4.07% in the 
high NBPR POAG group, 10.85±4.64% in the normal NBPR POAG group, and 13.47±8.19% in 
the control group (ANOVA p<0.01). There was a significant difference in NBPR between the 
high NBPR POAG group and the normal NBPR POAG group (Tukey HSD p<0.011) and also 
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between the control group (Tukey HSD p<0.01).There was no difference for the age, IOP, and 
MD between groups. PSD was significantly different between groups (ANOVA p =0.04) with 
the POAG group with high NBPR showed a higher PSD value compared to the healthy control 
group (Tukey HSD p=0.05). In general, the visual field MD and PSD indices can be interpreted 
as representing an early POAG group. Both normal and high NBPR POAG groups exhibited a 
lower mean RNFL thickness in comparison to the healthy controls (Tukey HSD p<0.01).  
The demographics for participants who completed the BLDV-SVD showed that there was a 
significant difference in the NBPR value between the high NBPR POAG group and the normal 
NBPR POAG group (Tukey HSD p<0.001) and also the control group (Tukey HSD p<0.01). 
Both normal and high NBPR POAG groups exhibited a lower mean RNFL thickness in 
comparison to the healthy controls (Tukey HSD p<0.01). No significant difference was noted 
between groups for the age, IOP and MD. PSD showed significant difference between groups 
(ANOVA p=0.04) with the control group was lower than the normal NBPR POAG group (Tukey 
HSD p=0.05). In general, the visual field MD and PSD indices can be interpreted as representing 
an early POAG group. 
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 Controls Normal NBPR High NBPR p (ANOVA) 
Doppler SD-OCT 
Number 
 
17 
 
17 
 
16 
 
- 
Age (years) 61.91±6.82 66.12±9.23 63.48±7.26 NS 
NBPR (%) 13.47±8.19 10.85±4.64 24.06±4.07 * <0.01 
IOP (mmHg) 14.76±3.23 14.68±3.07 12.88±2.60 NS 
Mean RNFL 
thickness (µm) 
102.97±7.73 * 82.25±13.15 83.08±10.72 <0.01 
MD -0.75±1.49 -2.82±4.59 -1.70±2.90 NS 
PSD 1.64±0.72 3.93±3.67 4.22±3.88 ** 0.04 
BLDV-SVD 
Number 
 
17 
 
15 
 
15 
 
- 
Age (years) 62.06±6.97 65.59±9.25 63.15±7.39 NS 
NBPR(%) 13.62±8.22 10.85±4.95 24.11±4.86 * <0.01 
IOP (mmHg) 14.35±3.62 15.17±2.93 12.80±2.68 NS 
Mean RNFL 
thickness (µm) 
102.61±7.61 * 82.51±14.02 82.36±10.68 <0.01 
MD -0.74±1.49 -2.98±4.83 -1.72±3.00 NS 
PSD 1.62±0.72  4.25±3.81** 3.97±3.88 0.04 
Table.6.1: Participants’ demographics and the values presented are as mean ± standard deviation. P-value denotes 
significant across groups using one-way ANOVA. [IOP = intraocular pressure, NBPR = nocturnal blood pressure 
reduction, RNFL = retinal nerve fiber layer, MD = mean deviation, PSD = pattern standard deviation, NS = not 
significant] 
Note: * denotes the group is significantly different to other groups, and **denotes the group is significantly to the 
healthy control group (Tukey HSD post-hoc test).  
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6.3.2 Retinal vascular reactivity assessed by Doppler SD-OCT  
Table 6.2 shows the magnitude of retinal vascular reactivity from baseline to normoxic 
hypercapnia for all groups, measured using Doppler SD-OCT. Figures 6.2A, 6.2B and 6.2C 
illustrate the retinal vascular reactivity response to normoxic hypercapnia for TRBF, venous 
area, and blood velocity, respectively. Using reANOVA, there was no retinal vascular reactivity 
observed in the high NBPR POAG group in terms of TRBF, venous area, and velocity (Figure 
6.2). The POAG with normal NBPR group exhibited an increase in their TRBF of 
3.82±4.71µl/min (p=0.02; Figure 6.2A), whereas the healthy controls exhibited an increase in 
TRBF of 8.20±10.75µl/min (p<0.01; Figure 6.2A) and an increase in blood velocity of 
2.41±3.33mm/s (p<0.01; Figure 6.2C). There was no retinal vascular reactivity in terms of the 
venous area was observed in any group.  
The magnitude of vascular reactivity in terms of blood velocity response was significantly 
different between the groups (one-way ANOVA p=0.02; Table 6.2). The Tukey HSD test 
revealed that the POAG group with high NBPR showed a significantly lower magnitude of 
reactivity in the blood velocity compared to the control group (p=0.01; Figure 6.2C). The 
magnitude of reactivity in the TRBF was significantly different between the groups (one-way 
ANOVA p=0.05) and the post-hoc analysis showed that the high NBPR group exhibited a lower 
magnitude of retinal vascular reactivity in terms of total retinal blood flow response than the 
healthy controls (p=0.04; Figure 6.2A).  
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Figure 6.2 The magnitude of change measured using Doppler SD-OCT, in A) total retinal blood flow; B) venous 
area; and C) blood velocity, in response to normoxic hypercapnia. P-value denotes significance using Tukey HSD 
post-hoc test. 
Note: * indicates significance when compared across the three breathing conditions (baseline, normoxic 
hypercapnia and recovery) within the groups at the level of p≤0.05 (ReANOVA).   
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 Controls Normal NBPR High NBPR p (ANOVA) 
Δ Total Retinal 
Blood Flow 
(µl/min) 
 
8.20±10.75 
 
3.82±4.71 
 
0.95±8.64 ** 
 
0.05 
Δ Superior 
Retinal Blood 
Flow (µl/min) 
 
4.21±4.16 
 
1.74±3.21 
 
1.57±6.93 
 
0.24 
Δ Inferior 
Retinal Blood 
Flow (µl/min) 
 
3.99±8.51 
 
2.09±3.70 
 
-0.63±4.17 
 
0.09 
Δ Venous area 
(mm
2
) 
2.09±2.34 (x10
-3
) 1.82±3.86 (x10
-3
) 4.32±10.32 (x10
-3
) 0.48 
Δ Velocity 
(mm/s) 
2.41±3.33 0.88±2.00 -0.58±3.10 ** 0.02 
 
Table 6.2: The magnitude of reactivity from baseline to normoxic hypercapnia measured using Doppler SD-OCT. 
Values are presented by their means ± standard deviation. P-value denotes significant across groups using one-way 
ANOVA.  
Note: ** denotes the group is significantly different to the healthy control group (Tukey’s HSD post-hoc test).  
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6.3.3 Retinal vascular reactivity assessed by BLDV-SVD 
Table 6.3 shows the magnitude of retinal vascular reactivity from baseline to normoxic 
hypercapnia for all groups, measured using the BLDV-SVD technique. Figure 6.3A, 6.3B and 
6.3C illustrate the retinal vascular reactivity response to normoxic hypercapnia for arterial 
diameter, blood velocity, and blood flow, respectively. In the healthy control group, the retinal 
vascular reactivity for diameter was 1.79±13.86µm (ReANOVA p=0.01; Figure 3A), for blood 
velocity it was 3.01±4.98mm/s (p<0.01; Figure 6.2B), and for retinal blood flow it was 
1.29±2.05 µl/min (p<0.01; Figure 6.3C). The normal NBPR POAG group exhibited a retinal 
vascular reactivity for velocity of 3.86±7.13mm/s (p=0.02; Figure 6.3B) and for retinal blood 
flow of 1.00±1.79 µl/min (p=0.02; Figure 6.3C). In the high NBPR POAG group, the retinal 
vascular reactivity for diameter was 1.39±2.83µm (p=0.03; Figure 6.3A), and RBF it was 
1.27±2.16µl/min (p=0.02; Figure 6.3C).  
There was no significant difference in the retinal vascular reactivity response to normoxic 
hypercapnia between the normal NBPR POAG group, the high NBPR POAG group, and the 
healthy control group (Table 6.3).  
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Figure 6.3 The magnitude of change measured using BLDV-SVD, in A) total retinal blood flow; B) venous area; and 
C) blood velocity, in response to normoxic hypercapnia in POAG patients with normal NBPR, POAG patients with 
high NBPR, and healthy controls.  
Note: * indicates significance when compared across the three breathing conditions (baseline, normoxic 
hypercapnia and recovery) within the groups at the level of p≤0.05 (ReANOVA).  
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 Controls Normal NBPR High NBPR p (ANOVA) 
Δ Diameter (µm) 1.79±13.86 0.93±2.65 1.39±2.83 0.71 
Δ Velocity 
(mm/s) 
3.01±4.98 3.86±7.13 4.23±8.18 0.87 
Δ Flow (µl/min) 1.29±2.05 1.00±1.79 1.27±2.16 0.91 
 
Table 6.3: Magnitude of change in the retinal haemodynamics measured by the BLDV-SVD. Values presented by 
their means ± standard deviation. P-value denotes significant across groups using one-way ANOVA.  
 
6.3.4 Correlation analysis between retinal vascular reactivity and RNFL thickness 
Table 6.4 shows the Pearson product-moment correlation coefficient and the p values for 
analysis between retinal vascular reactivity and RNFL thickness, for the POAG with normal 
NBPR, POAG with high NBPR and healthy control groups. No significant association was 
evident in any parameters. 
Table 6.5 shows the Pearson product-moment correlation coefficient and the p values for 
analysis between controls and POAG groups; between retinal vascular reactivity parameters, 
RNFL thickness, MD, and NBPR. Only the control group shows medium correlation strength to 
the total retinal blood flow (TRBF) change (r=-0.50, p=0.04; Figure 6.4). No significant 
association was evident for other parameters.  
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 Controls 
 (n = 17) 
Normal NBPR  
(n = 17) 
High NBPR 
 (n = 16) 
r p r p r p 
Δ TRBF vs Mean 
RNFL 
0.33 0.20 0.34 0.18 0.34 0.20 
Δ Venous area vs 
Mean RNFL 
0.43 0.09 0.09 0.73 0.45 0.08 
Δ Vein velocity vs 
Mean RNFL  
0.27 0.30 0.17 0.51 0.01 0.98 
       
 Controls  
(n = 17) 
Normal NBPR 
(n = 15) 
High NBPR  
(n = 15) 
r p r p r p 
Δ Arterial flow vs 
Mean RNFL 
-0.43 0.09 -0.11 0.69 0.02 0.96 
Δ Arterial velocity vs 
Mean RNFL  
-0.23 0.37 -0.23 0.41 0.03 0.91 
Δ Arterial diameter 
vs Mean RNFL 
-0.31 0.23 0.22 0.43 -0.40 0.14 
 
Table 6.4: Pearson product-moment correlation coefficient (r) and significance value (p) for correlation analysis 
between retinal nerve fiber layer (RNFL) thickness and retinal vascular reactivity parameters, in the control, POAG 
with normal NBPR, and POAG with high NBPR groups. [Δ = change]  
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 Controls (n = 17) POAG (n = 30) 
r p r p 
Δ TRBF vs Mean RNFL 0.33 0.20 0.30 0.09 
Δ Venous area vs Mean RNFL 0.43 0.09 0.29 0.11 
Δ Venous velocity vs Mean RNFL  0.27 0.30 0.07 0.72 
Δ TRBF vs MD -0.17 0.52 0.07 0.70 
Δ Venous area vs MD -0.13 0.61 0.25 0.16 
Δ Venous velocity vs MD -0.14 0.60 -0.11 0.54 
Δ TRBF vs NBPR -0.50 0.04 -0.11 0.54 
Δ Venous area vs NBPR -0.33 0.20 0.09 0.62 
Δ Venous velocity vs NBPR -0.47 0.06 -0.16 0.38 
Δ Arterial flow vs Mean RNFL  -0.43 0.09 -0.05 0.79 
Δ Arterial velocity vs Mean RNFL  -0.23 0.37 -0.11 0.58 
Δ Arterial diameter vs Mean RNFL -0.31 0.23 -0.06 0.76 
Δ Arterial flow vs MD  -0.33 0.20 0.12 0.54 
Δ Arterial velocity vs MD  -0.23 0.38 0.19 0.32 
Δ Arterial diameter vs MD -0.13 0.62 -0.25 0.18 
Δ Arterial flow vs NBPR -0.20 0.45 0.04 0.82 
Δ Arterial velocity vs NBPR  -0.02 0.95 -0.06 0.76 
Δ Arterial diameter vs NBPR -0.28 0.28 0.05 0.79 
 Table 6.5: Pearson product-moment correlation coefficient (r) and significance value (p) for correlation analysis 
between retinal vascular reactivity parameters, retinal nerve fiber layer (RNFL) thickness, mean deviation (MD) 
and nocturnal blood pressure reduction (NBPR), in healthy control group and POAG group. [Δ = change]   
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Figure 6.4 : Scatter plot of retinal vascular reactivity in terms of total retinal blood flow (TRBF) against nocturnal 
blood pressure reduction (NBPR). Pearson product-moment correlation coefficient shows the control group a 
medium negative relationship, r = -0.50 (p = 0.04). 
 
6.3.5 Breathing and relevant systemic parameters 
Table 6.6 and Table 6.7 show detailed breathing and relevant systemic parameters during the 
retinal haemodynamic assessment using Doppler SD-OCT and BLDV-SVD, respectively for all 
groups.  
In the POAG group with normal NBPR, the mean percentage increase in PETCO2 relative to 
baseline during hypercapnia was 14.26±2.10% (p<0.01) with a concomitant increase in mean 
PETO2 of 3.21±2.05% (p<0.01) during the Doppler SD-OCT session. During the BLDV-SVD 
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session, there was 14.99±2.46% increase in mean PETCO2 (p<0.01) relative to baseline with a 
non-significant concomitant increase in PETO2 by 2.59±4.36%.  
In the POAG group with high NBPR, the mean PETCO2 increment during hypercapnia was 
15.36±3.55% (p<0.01) with a concomitant increase in mean PETO2 of 2.79±4.35 (p=0.03) during 
the Doppler SD-OCT session. During the BLDV-SVD session, there was 16.18±3.91% increase 
in PETCO2 (p<0.01) relative to baseline with non-significant concomitant increase in mean PETO2 
(2.00±3.71%). 
The healthy control group mean PETCO2 was increased by 14.92±2.91% (p<0.01) relative to 
baseline with non-significant concomitant increase in mean PETO2 (1.49±5.22%) during the 
Doppler SD-OCT session. During the BLDV-SVD session, there was 16.41±3.75% increase in 
PETCO2 (p<0.01) with a concomitant increase in mean PETO2 of 1.04±2.97% (p=0.02). 
Using one-way ANOVA, all of the parameters at baseline were deemed not significant between 
the groups in both sessions.  
184 
 
Breathing and Relevant 
Systemic Parameters 
 
Baseline 
 
Hypercapnia 
 
Recovery 
P 
(ReANOVA) 
Healthy controls 
  PETCO2 (mmHg) 
 
37.34±1.74 
 
42.89±1.63 
 
37.10±1.94 
 
<0.01 
  PETO2 (mmHg) 112.05±5.20 113.59±5.62 112.32±5.45 NS 
  Respiration rate (breaths/min) 17.23±4.31 18.80±4.35 18.48±3.40 0.01 
  Pulse rate (beats/min) 66.68±8.71 67.35±9.15 66.00±9.49 NS 
  Systolic BP (mmHg) 122.41±10.40 124.59±11.21 122.76±10.46 NS 
  Diastolic BP (mmHg) 77.82±6.56 80.31±7.35 77.65±7.08 <0.01 
  O2 saturation (%) 97.67±0.94 97.95±0.92 97.75±1.04 NS 
POAG with normal NBPR 
  PETCO2 (mmHg) 
 
37.49±3.34 
 
42.80±3.41 
 
37.32±3.29 
 
<0.01 
  PETO2 (mmHg) 115.59±6.8 119.21±5.65 115.90±6.81 <0.01 
  Respiration rate (breaths/min) 16.69±3.36 17.27±3.87 15.76±2.97 <0.01 
  Pulse rate (beats/min) 66.15±10.23 66.00±10.52 65.84±10.32 NS 
  Systolic BP (mmHg) 126.71±14.25 129.82±15.70 126.24±15.81 0.03 
  Diastolic BP (mmHg) 76.76±12.18 78.76±11.93 75.59±10.85 0.01 
  O2 saturation (%) 97.36±1.37 97.66±1.16 97.49±1.20 NS 
POAG with high NBPR 
  PETCO2 (mmHg) 
 
37.23±3.59 
 
42.86±3.47 
 
36.99±3.65 
 
<0.01 
  PETO2 (mmHg) 110.55±8.39 113.35±5.24 111.41±7.02 0.03 
  Respiration rate (breaths/min) 15.81±3.39 16.20±3.16 16.13±3.48 NS 
  Pulse rate (beats/min) 63.49±6.71 63.33±7.66 63.18±6.87 NS 
  Systolic BP (mmHg) 125.56±23.53 129.31±23.78 126.00±23.82 0.05 
  Diastolic BP (mmHg) 77.38±12.28 78.81±11.17 75.88±11.70 0.04 
  O2 saturation (%) 97.25±1.01 97.64±0.80 97.69±0.86 0.04 
 
Table 6.6: The group mean ± SD of breathing and relevant systemic parameters in normal NBPR POAG group, 
high NBPR POAG group, and healthy control group during measurement using Doppler SD-OCT. The p-value 
denotes significance across three breathing conditions using reANOVA (p≤0.05). [PETCO2 = partial pressure of 
end-tidal carbon dioxide, PETO2 = partial pressure of end-tidal oxygen, BP = blood pressure, O2 saturation = 
oxygen saturation NS = not significant].   
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Breathing and Relevant 
Systemic Parameters 
 
Baseline 
 
Hypercapnia 
 
Recovery 
p 
(ReANOVA) 
Healthy controls 
  PETCO2 (mmHg) 
 
36.55±2.25 
 
42.51±2.16 
 
36.72±2.29 
 
<0.01 
  PETO2 (mmHg) 112.82±5.8 113.95±6.03 111.56±6.36 0.02 
  Respiration rate (breaths/min) 18.34±4.06 19.43±3.62 19.49±4.22 NS 
  Pulse rate (beats/min) 68.51±9.83 67.27±9.05 67.56±9.17 NS 
  Systolic BP (mmHg) 124.12±12.50 126.98±12.83 125.65±11.25 NS 
  Diastolic BP (mmHg) 79.65±8.12 80.92±7.62 80.94±6.17 NS 
  O2 saturation (%) 98.01±1.18 98.11±0.91 98.26±0.85 NS 
POAG with normal NBPR 
  PETCO2 (mmHg) 
 
37.18±3.52 
 
42.68±3.41 
 
37.11±3.59 
 
<0.01 
  PETO2 (mmHg) 113.34±7.49 116.09±6.24 113.16±6.08 NS 
  Respiration rate (breaths/min) 16.01±2.55 16.90±2.95 15.83±2.68 0.01 
  Pulse rate (beats/min) 63.37±9.99 64.38±11.23 64.26±11.85 NS 
  Systolic BP (mmHg) 129.36±18.33 132.21±19.07 128.93±18.55 <0.01 
  Diastolic BP (mmHg) 77.00±12.23 77.36±12.43 75.50±11.98 0.04 
  O2 saturation (%) 97.65±1.23 97.70±1.08 97.65±0.23 NS 
POAG with high NBPR 
  PETCO2 (mmHg) 
 
36.92±3.40 
 
42.79±3.08 
 
37.05±3.35 
 
<0.01 
  PETO2 (mmHg) 110.36±5.36 112.45±4.25 110.56±4.43 NS 
  Respiration rate (breaths/min) 16.51±4.52 16.41±3.37 16.49±3.57 NS 
  Pulse rate (beats/min) 62.21±6.43 63.27±7.12 63.13±6.69 NS 
  Systolic BP (mmHg) 128.87±24.64 133.67±22.40 129.93±23.31 <0.01 
  Diastolic BP (mmHg) 78.67±11.73 81.20±10.26 78.67±11.39 <0.01 
  O2 saturation (%) 97.60±0.99 97.88±0.64 97.87±0.90 NS 
 
Table 6.7: The group mean ± SD of breathing and relevant systemic parameters in normal NBPR POAG group, 
high NBPR POAG group, and healthy controls group during measurement using BLDV-SVD. The p-value denotes 
significance across three breathing conditions using reANOVA (p≤0.05). [PETCO2 = partial pressure of end-tidal 
carbon dioxide, PETO2 = partial pressure of end-tidal oxygen, BP = blood pressure, O2 saturation = oxygen 
saturation, NS = not significant].  
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6.4 Discussion 
In this current study, we are the first to report evidence of vascular dysregulation, by means of 
using hypercapnic provocation, in early POAG patients with an extreme nocturnal hypotension. 
Early POAG patients with an NBPR of ≥20% showed no significant reactivity upon 15% 
increment of PETCO2 relative from the baseline (while keeping PETO2 at homeostatic level) in all 
retinal haemodynamics, as measured using Doppler SD-OCT. On the other hand, early POAG 
patients with a normal NBPR and healthy controls showed a significant change in the TRBF, 
with the normal NBPR POAG group’s magnitude being lower than the control group, although 
not statistically significant. We also observed the retinal vascular reactivity in terms of venous 
blood velocity in the high NBPR POAG group being significantly lower than the control group.  
The reduced retinal vascular reactivity in all venular blood flow parameters upon hypercapnic 
provocation in the high NBPR POAG cohort indicated vascular dysregulation in this group. The 
inefficiency in regulating the cardiovascular system at night, translated into an excessive NBPR, 
possibly leads to abnormal retinal vascular regulatory function.
24, 34
 No study, to the best of our 
knowledge, has ever investigated vascular dysregulation among early POAG patients with 
different NBP profiles using a hypercapnic stimulus. It is difficult to directly compare our 
findings with the literature considering the differences in the technology we used to quantify 
retinal vascular reactivity and the specific selection of our NBPR groups. 
The response of blood pressure to nocturnal factors is complex, since activity levels are reduced 
and posture is horizontal rather than vertical. The immediate response of the retinal vasculature 
to adoption of a supine position is vasoconstriction in order to protect the terminal capillaries 
from the sudden rise in OPP which occurs due to elevation of the heart relative to the eye, i.e. 
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hydrostatic column effect. However with longer adoption of supine position, vagus nerve 
responses are initiated which lower the blood pressure and as a result the retinal vessels 
subsequently dilate. This study essentially measures all aspects of these changes and takes into 
account the maximum and the minimum of the blood pressure over the 24-hour recording period, 
irrespective of causality. In addition, the conditions experienced across the groups were 
equivalent, and therefore the results of valid irrespective of the role of posture upon NBPR. 
Our findings in the arterial retinal vessels showed no significant difference in the magnitude of 
change between the groups. However, most of the haemodynamics measured by the BLDV-SVD 
showed significant change upon hypercapnia within its individual group. The control group 
showed significant vascular reactivity upon hypercapnic provocation in all retinal blood flow 
parameters, while early POAG with high NBPR group showed only significant reactivity in 
diameter and blood flow upon hypercapnic provocation. The early POAG with normal NBPR on 
the other hand showed significant increase in arterial velocity and blood flow upon hypercapnia. 
Our colleagues previously reported an increase of +3% in arterial diameter, +18% in velocity, 
and +22% in the arterial flow among their control group upon hypercapnia.
3
 In addition, the 
progressive POAG group only showed +9% increase in flow, while untreated POAG showed no 
significant change for all haemodynamics upon hypercapnia.  
The results from the BLDV-SVD method suggest it has advantages in detecting significant 
retinal vascular reactivity within a group, over the Doppler SD-OCT method. On the other hand, 
the Doppler SD-OCT showed better identification of different retinal vascular reactivity between 
the groups. These different observations between the two instruments may be advocated to the 
nature of the each instrument’s Doppler measurement. The BLDV-SVD measures the retinal 
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blood flow of a single retinal arteriole, while Doppler SD-OCT measures total retinal blood flow 
by summing flows from multiple venules around the ONH. A fine local signal as measured by 
the BLDV-SVD is sensitive to detect changes introduced by a provocation, but may lacking the 
signal-to-noise ratio upon effects originating from a global signal such as the signal that might be 
associated with diseased induced vascular dysregulation. Hence, comparison of vascular 
reactivity between the groups yields no significance since BLDV-SVD measurements may have 
missed the strongest signal in another retinal location. A measurement that is derived from the 
global retinal area such as in the Doppler SD-OCT contains information from a large number of 
observations. Based upon the Central Limit Theorem,
35
 the average of this global signal will be 
distributed according to the normal distribution curve, and any difference in peak values between 
groups will be evident. The signal-to-noise ratio when comparing local effects within the group 
following provocation may not alter the peak value large enough to be detected globally as 
significantly different. 
In this study, retinal vascular reactivity was investigated using a hypercapnic stimulus. As 
hypercapnia induces vasodilation, it may be safer to be used in POAG patients as it increases 
blood flow. In a compromised vascular bed such as that in POAG, a hyperoxic stimulus may be 
damaging as it induces vasoconstriction. Vasoconstriction secondary to hyperoxia reduces blood 
flow and may further aggravate the glaucomatous disease process. Relative to a normal eye, it is 
also thought that the vasculature in a diseased eye may already be relatively constricted, and 
thus, hyperoxia may not cause substantial further vasoconstriction which in turn may reduce the 
signal-to-noise ratio effect that we wish to investigate. 
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Gas provocation studies in other labs may have achieved hypercapnia by patients’ rebreathing 
their exhaled gases
36
 or by adding CO2 manually to breathing air.
8, 37
 Such techniques may 
trigger concomitant change in the PETO2, thus response in vascular reactivity may not be purely 
from the PETCO2 increase. In addition, those techniques that aimed to induce hypercapnia 
introduce relatively large amounts of inhaled CO2 to achieve a highly variable level of PETCO2
38
 
and therefore cause uncertain magnitude of hypercapnia which will significantly increase pulse 
rate and blood pressure. Our lab uses the automatic gas sequencer in the Respiract™ system, 
together with the SGD breathing circuit to produce stable, standardized and accurate targeted 
PETCO2 and PETO2 levels. In this study, an increase in PETCO2 of 15% relative to participants’ 
homeostatic baseline (i.e. approximately 6mmHg increase in PETCO2) was achieved to induce 
hypercapnia. The magnitude of hypercapnia in this study is much lower than what has been used 
in other gas perturbation methods, resulting to minimal change in pulse rate, blood pressure and 
PETO2. It has been demonstrated that the PETCO2 is correlated with the CO2 arterial partial 
pressure (PaCO2) using the technique that we use.
29, 39
 The SGD breathing circuit is a mask with 
series of valves, tubes and reservoirs that provide the ability to clamp or maintain normoxia/ 
normocapnia irrespective to minute ventilation changes. Our technique is unique as it enables a 
precise targeting of the PaCO2 and PaO2 at the same time. Venkataraman and co-workers
14
 has 
shown that the technique we used in the current study is highly repeatable in achieving desired 
PETCO2, whilst maintaining normoxia. 
A recent study in the Hudson lab used the Doppler SD-OCT to assess vascular reactivity, using 
normoxic hypercapnia stimulus on young healthy- smokers and non-smokers.
40 
The findings 
were comparable to this current study whereby an increase in the venous area, venous velocity 
and TRBF by +7%, +18%, and +26%, respectively, were reported. In this current study, the 
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magnitude of retinal vascular reactivity that we observed among our control group was +4.5%, 
+18%, and +21% in the venous area, venous velocity, and TRBF, respectively. Our smaller 
magnitude change in venous area may have been caused by the fact that our sample population 
was elderly. Confounding factors such as atherosclerosis may lessen the retinal vascular 
reactivity response to hypercapnia. Also, the power of the study needs to be considered when 
interpreting these results. Post-hoc power analysis of our results demonstrated a requirement to 
attained 21 POAG patients to achieve a power of 80% with a type I error of p≤0.05 when using 
Doppler SD-OCT, while the BLDV-SVD methodology required a sample of 432 to achieve an 
equivalent power. In addition, longitudinal studies are required to determine if reduced vascular 
reactivity is associated with exaggerated NBPR is a cause of POAG or an effect.  
Other studies using a hypercapnic stimulus on glaucoma patients reported a mixed results as 
various techniques were used on various vascular beds. Using BLDV-SVD, our lab previously 
measured the retinal vascular reactivity upon normoxic hypercapnia provocation on untreated 
and progressive POAG group which found that the retinal arterial vascular reactivity was 
significantly reduced compared to the healthy controls.
3
 The untreated POAG group did not 
show any reactivity to normoxic hypercapnia while the progressive POAG only showed 
reactivity in terms of the retinal blood flow response. In the same study, capillary vascular 
reactivity in response to normoxic hypercapnia in the ONH showed that the untreated POAG and 
progressive POAG groups have a smaller magnitude of vascular reactivity for the blood velocity 
and blood flow compared to healthy controls. Using carbogen as provocation stimulus, Gugleta 
and co-workers
41
 used the LDF technique on vasospastic non-glaucomatous healthy patients to 
measure the ONH neuroretinal rim and subfoveal choroidal vascular reactivity. Interestingly, 
they reported an increase in blood flow in the vasospastic patients and decrease in flow in the 
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non-vasospastic patients to carbogen breathing. Using the CDI method, Harris and co-workers
37
 
reported an increase velocity in the central retinal artery (CRA), short posterior ciliary artery 
(SPCA), and ophthalmic artery (OA) in the normal tension glaucoma group, whereas the control 
group only experienced increase velocity in the CRA during hypercapnia. Hosking and 
colleagues
42
 measured the retrobulbar vascular reactivity to 15% increase of PETCO2 above 
baseline. They found that glaucoma group showed an increased velocity in the short posterior 
ciliary artery (SPCA) and central retinal artery (CRA), in comparison to the controls which 
showed only increase in the CRA. These results are completely contrary to our findings and the 
work of others. Sines and associates
43
 also used the CDI technique to compare patients with 
POAG and ocular hypertensive (OH). They reported a significant velocity increase in the CRA 
but decrease velocity in the ophthalmic artery (OA) in the POAG group, while the OH group 
showed normal vasodilatory response during hypercapnia. The disparate reports suggest 
variability in the haemodynamic response to hypercapnia across different vascular beds. It was 
hypothesized that the vascular bed response to a stress situation, such as increment in PaCO2, 
may vary from one location to another.
22
 
A few studies have inspected the values of haemodynamics during sleep. Osusky and 
associates
44
 used laser Doppler flowmetry (LDF) in healthy eyes, to investigate whether ONH 
perfusion drops nocturnally. They reported that the mean LDF-flow and LDF-volume decreases 
from daytime to midnight, whereas the velocity did not change. Of note, they took the LDF 
measurement at 0800, 1200, 1600, 2000, 2400 and 0800 hours. Whether perfusion reduction was 
present during sleep is equivocal. Claridge and Smith
45
 used the pulsatile ocular blood flow 
(POBF) method on OH, POAG and healthy controls, to investigate the diurnal variation of the 
ocular haemodynamics. Their measurement was repeated every three hours during diurnal and 
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nocturnal hours. They failed to show a significant difference between the diurnal and nocturnal 
haemodynamic values in all groups, but noticed a large individual variation. In a different study, 
Harris and co-workers,
46
 measured haemodynamics in retrobulbar and cranial arteries using the 
CDI and transcranial Doppler, respectively, among stable POAG patients, in the evening 
(baseline) and during the NBPR episode. The BP measurement was set at 15 minutes frequency, 
and the nocturnal haemodynamics measurement was initiated once the MAP fell 10% or more 
below baseline. Their findings indicated that blood velocity in the POAG group was unaltered 
during nocturnal hypotension periods compared to baseline. Their control group showed a 
reduction in the SPCA only, and the analysis between POAG and control groups indicated no 
significant difference. Results from sleep studies with experimental intervention during sleep 
need to be interpreted with care. With the current technological capability, it may be impossible 
to monitor nocturnal haemodynamic without disturbing patient’s sleep. 
A few limitations exist in this study. First, there was a significant PETO2 increase during 
hypercapnia, in all early POAG groups during Doppler SD-OCT measurement and in the healthy 
control group during BLDV-SVD measurement. By calculation, those increment were, at 
maximum, amounting to 3.6mmHg (or 3%) extra relative to the baseline PETO2. Although 
statistically significant, such a small amount of PETO2 increase is not strong enough to influence 
the reactivity induced by hypercapnia. Unpublished data from our group indicated that 1mmHg 
increase of PETO2 will only decrease flow by 0.1% (Cheng et al., unpublished)
48
. Second, this 
study also showed a significant increase in systolic BP in the normal and high NBPR groups 
during both Doppler SD-OCT and BLDV-SVD sessions. A similar increment was noted for 
diastolic BP in all groups during Doppler SD-OCT, and in the normal and high NBPR groups 
during BLDV-SVD session. By calculation, these increments were only between 0.4 to 4.8 
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mmHg (0.5% to 3.7%) relative to the BP baseline value. Such a small amount will not alter OPP 
and cause a significant effect to retinal perfusion. Third, the subjective element in the Doppler 
SD-OCT blood flow analysis grading may result in bias in the total venous blood flow value. 
The Doppler image of each vessel was manually refined for its location and diameter boundary 
using the semi-automatic DOCTORC software. This element of subjectivity may be the reason 
for insignificance observations in the retinal vascular reactivity pertaining to the venous area, in 
all intra- and intergroup analysis. However, one may speculate that the insignificant observation 
in the venous area upon hypercapnia provocation may also stemmed from the fact that venules 
are less reactive to CO2 compared to arterioles.
47
 Fourth, our protocol was a little bit long, which 
took more than two days to complete (48 hours of ambulatory BP monitoring and extra few 
hours for haemodynamics measurements). We saw a few participants dropout due to this. Fifth, 
the participants’ daily activity during ABPM was conducted manually using activity diary which 
may not be accurate compared to by using an electronic actigraph system. 
To conclude, normoxic-hypercapnia provocation did not stimulate significant venular retinal 
vascular reactivity in the early POAG with high NBPR group, in comparison to the early POAG 
with normal NBPR group response and the healthy control group response. The early POAG 
patients with extreme NBPR showed reduced venular reactivity compared to other groups. This 
observation suggests vascular dysregulation in this particular group of early POAG patients. Our 
vascular reactivity investigation was done outside the nocturnal sleeping time, whether similar 
finding is observed at night is unsure.  
194 
 
7 General discussion  
Although nocturnal blood pressure reduction (NBPR) is normal physiological phenomenon, an 
excessive magnitude of NBPR may be dangerous to susceptible tissues such that occurs in 
glaucoma. Excessive ocular perfusion pressure (OPP) reduction may cause ischaemia to the optic 
nerve head (ONH) and an unstable OPP may trigger reperfusion injury. These two separate 
events have possibly been advocated to contribute to glaucomatous optic neuropathy (GON). 
While many have linked systemic hypotension to primary open angle glaucoma (POAG), a 
report pertaining to retinal haemodynamics and its relationship to systemic blood pressure is still 
lacking. The work in this thesis may be the first covering all aspects in retinal blood flow in early 
POAG cohorts with different NBPR profiles. In addition, this is the first study to examine the 
retinal vascular reactivity among early POAG patients with different NBPR using a standardized 
normoxic hypercapnic provocation. No study has directly measured the effect of the NBPR on 
retinal haemodynamics. In the literature, two studies have investigated POAG patients with 
differing NBPR profiles, one using color Doppler imaging (CDI)
1
 and the other using nail-fold 
capillaroscopy
2
 to measure peripheral blood flow. The work in this thesis thus provided an 
assessment of retinal vascular haemodynamics at sites that encompassed total retinal blood flow 
in glaucoma patients with different NBPR.  
The Doppler methodologies used in this thesis measure the retinal blood flow in absolute units. 
Unlike other methodologies reported in the literature, the circum-papillary double circular blood 
flow in the prototype Doppler SD-OCT and the established bi-directional laser Doppler 
velocimetry with simultaneous vessel densitometry (BLDV-SVD) derived retinal blood flow in 
actual flow values (µL/min), apart from other parameters such as blood velocity (mm/s) and 
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vessel area/diameter (mm
2
/µm). The prototype Doppler SD-OCT measures total retinal blood 
flow (TRBF) from all valid venules traversing through the ONH, while the BLDV-SVD 
measures retinal arteriolar blood flow at one specific retinal location. Considering the different 
nature of measurement that each instrument provides, the retinal haemodynamics that we have 
studied focused on local and global aspects of retinal haemodynamics. By doing so, this thesis 
enable a better understanding of retinal haemodynamics, especially in POAG cohort with special 
characteristics of NBPR. 
A normoxic hypercapnic stimulus was used in this thesis to study the retinal vascular reactivity. 
The novel methodology included an automatic gas sequencer together with a sequential gas 
delivery (SGD) breathing circuit. This allowed a precise and stable targeting of end-tidal partial 
pressure (PET) of carbon dioxide (CO2) and oxygen (O2). Normoxic hypercapnia in this thesis 
was set at an increment of 15% in PETCO2 relative to baseline while maintaining the PETO2 at 
homeostatic level. 
In Chapter 3, the normative data of retinal blood flow were gathered on 100 participants 
consisting of healthy, medication free, participants of different ages and an equal number of 
males and females. The retinal blood flow was assessed using the circum-papillary double 
circular blood flow scan protocol in the prototype Doppler SD-OCT. Our retinal blood flow 
parameters were comparable to other small sample/pilot studies. The correlation analysis showed 
no relationship of age to any retinal blood flow parameters, although the systemic blood pressure 
(BP) increased with age and the RNFL thickness reduced with age. These findings suggest that 
in the healthy population perfusion is constant regardless of aging. Analysis between sexes also 
revealed no significant difference in the haemodynamics. The haemodynamics correlation 
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analyses against age in each sex also showed no association. Overall, it is concluded that the 
retinal blood flow, as measured by a prototype Doppler SD-OCT is independent of age and 
gender. This experiment also advocated the Doppler SD-OCT as a promising tool in measuring 
the retinal haemodynamics. 
Chapter 4 details the retinal haemodynamics in early POAG patients with different 
characteristics of NBPR. BLDV-SVD and Doppler SD-OCT were used. POAG patients were 
divided by NBPR status, after following a 48-hours ambulatory blood pressure monitoring 
(ABPM) assessment. There was a marked difference in the TRBF and venous area in early 
POAG patients with high NBPR compared to the healthy controls. Retinal blood flow 
measurement using the BLDV-SVD, however, did not show any significant difference between 
groups. It was thought that BLDV-SVD results were equivalent between groups due to its 
measurement at a fine retinal location. Anatomical variation between patients may have given 
different homeostatic values, despite effort to standardize measurement site for all participants. 
The work in this chapter is the first to study homeostatic retinal blood flow in early POAG 
patients with different NBPR. The findings concluded that POAG patients with high NBPR have 
impairment in the retinal blood flow compared to healthy people. An abnormal circadian BP 
regulation may represent a form of systemic vascular dysregulation that is relevant to the retinal 
vasculature, at least in glaucomatous eyes. Since the retinal blood flow measurement was done 
outside the nocturnal period, it is unknown whether the same blood flow reduction happens 
during the real nocturnal hypotension event.  This experiment also warranted the ABPM 
assessment in managing POAG cases. Knowing a patient’s BP circadian variation may give an 
idea of the extent of OPP variation throughout the day. It has also been suggested to treat 
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hypertension in POAG patients cautiously as overtreatment may set the cardiovascular system 
into extreme hypotension that may jeopardize the ocular perfusion. 
The experiment in Chapter 5 describes the relationship between retinal blood flow parameters as 
assessed with Doppler SD-OCT, ONH structure (i.e. retinal nerve fiber layer, RNFL thickness 
profiles) and visual function (i.e. the Humphrey field analyzer, HFA, mean deviation, MD 
values). There was a positive correlation between TRBF and mean RNFL thickness in the early 
POAG group while no relationship was observed in the control group. In addition, positive 
relationships between RNFL thickness profiles and the MD were present in the early POAG 
group only. Correlation analysis of MD and retinal haemodynamics did not show significance in 
both early POAG and control groups. These results indicated that reduction of retinal blood flow 
among early POAG patients is associated with neural structure loss, but to a lesser extent than 
with visual function disruption. It was speculated that the failure to see relationship between 
haemodynamics and MD were caused by the non-extreme early POAG sample that were 
recruited. Considering together the non-correlating blood flow parameters in the control group, 
the situation signifies vascular dysfunction in POAG. It is however unknown whether the retinal 
blood reduction occurred primarily, or secondary to the structural loss. A prospective 
longitudinal clinical trial study is warranted to test prognostic value of impaired retinal blood 
flow in POAG. 
In Chapter 6, the retinal vascular reactivity of early POAG patients with different NBPR 
characteristics were tested. A standardized normoxic-hypercapnic provocation was achieved by 
means of increasing PETCO2 to 15% relative to the baseline, while keeping PETO2 at homeostatic 
levels. Retinal vascular reactivity was taken by measuring the change in the retinal blood flow 
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parameters during hypercapnia relative to its homeostatic value. This experiment is the first of its 
kind to measure retinal vascular reactivity in a sample consisting patients with early POAG of 
different NBPR characteristics. It was observed that early POAG patients with high NBPR, in 
general, exhibited reduced vascular reactivity, with TRBF and venous velocity change 
magnitude being significantly smaller than the controls. No significant difference was noted 
between groups in magnitude of change measured by the BLDV-SVD method.  These results 
point to a vascular dysregulation in the early POAG patient group with excessive nocturnal 
hypotension. This experiment was conducted, however, outside the nocturnal sleeping time. 
Whether or not similar findings will be observed at night is equivocal. 
One general proviso to consider about the overall aspects of this work relates to the method of 
recruitment of normal controls. POAG patients were recruited in the Glaucoma Clinics of the 
Toronto Western Hospital by YMB and GET, whereas healthy controls were recruited by leaflet 
and poster exposure. The glaucoma patients are therefore motivated by health concerns while the 
healthy controls maybe motivated by different factors. We are unable to conclude whether or not 
this is a significant bias. 
7.1 Future work 
The work in this thesis has raised a number of questions for future investigations: 
 POAG patients with low NBPR were not included in the studies. It would be interesting 
to know how nocturnal hypertension may affect haemodynamics and reactivity. In a 
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susceptible eye such as glaucoma, high OPP may provide a better perfusion, which is 
possibly of protective in nature to the neural tissue. 
 Reperfusion injury has been suggested as a mechanism in glaucoma pathology. Variation 
in OPP leading to blood flow variability may trigger the formation of reactive oxygen 
species (ROS) and oxidative injury. Analysis of nocturnal variability in the 
haemodynamics, or pressures value such as OPP, BP and IOP should be considered in 
future studies of POAG patients with different NBPR status. In addition the vascular 
reactivity assessment should incorporate the retinal oximetry measurements to judge the 
degree of impairment in each glaucoma group.    
 Considering that NBPR is closely related to the function of the autonomic nervous 
system, one may hypothesize that an abnormal NBPR may occur due to autonomic 
dysfunction. It is interesting to study the involvement of autonomic dysfunction in POAG 
patients, in particular among POAG patients with different characteristics of NBPR. This 
may be possible by including biochemical studies to measure certain blood markers 
indicating disturbed autonomic activity such as catecholamines levels
3
 or plasma 
cortisol.
4
 However longitudinal studies are required to determine if reduced perfusion and 
vascular reactivity due to exaggerated NBPR is associated with POAG or an effect.   
 The observed haemodynamics and reactivity reduction in this study were conducted 
outside the nocturnal hypotension event(s). Given current technological capabilities, it is 
impossible to measure haemodynamics without disrupting sleep. Keenly with 
technological advancement, haemodynamics study while patient is sleeping would 
benefit to better understand the pathophysiology of GON. 
200 
 
 NBPR may change depending on diurnal activities,5 and sleep quality.6, 7 In addition, 
lifestyle has been reported to influence positively to higher OPP.
8
 It is interesting to know 
how POAG patients with different activities and sleep patterns, as well as having active 
or passive lifestyles, behave in terms of retinal haemodynamics assessment. 
7.2 Summary 
Perfusion to the retina was not altered with increasing age among healthy poeple. Patients with 
early POAG who exhibited an exaggerated nocturnal reduction in mean arterial pressure (MAP) 
also demonstrated lower RBF values as shown by the measurement of Doppler SD-OCT. The 
change in retinal circulation in early POAG is related to reduced RNFL thickness. A larger 
venous area may be associated with thicker RNFL among controls. Patients with early POAG 
who exhibited an exaggerated nocturnal reduction in MAP also demonstrated disturbance of 
retinal vascular reactivity. 
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